Kronos Worldwide, Inc. Annual Report 2020

← All annual reports

FY2020 Annual Report · Kronos Worldwide, Inc.

Loading PDF…

Kronos Worldwide

2020

ANNUAL REPORT

KRONOS WORLDWIDE, INC. CORPORATE AND OTHER INFORMATION

Board of Directors

Loretta J. Feehan
Chair of the Board (non-executive)
Financial Consultant

Robert D. Graham
Vice Chairman, President and
Chief Executive Officer

John E. Harper (a)
Private Investor

Meredith W. Mendes (a)
Chief Operating Officer and Principal
Gresham Partners LLC

Cecil H. Moore, Jr. (a)(b)
Retired Partner
KPMG LLP

Gen. Thomas P. Stafford (ret.) (a)(b)
United States Air Force (retired)

Dr. R. Gerald Turner (a)(b)
President
Southern Methodist University

Board Committees

(a) Audit Committee
(b) Management Development

and Compensation Committee

Annual Meeting

The 2021 Annual Meeting of Stockholders
will be held at the Conference Center at
Three Lincoln Centre, 5430 LBJ Freeway,
Suite 350, Dallas, Texas 75240-2620, on
the date and time as set forth in the notice
of the meeting, proxy statement and form
of proxy that will be mailed to
stockholders in advance of the meeting.

Stock Exchange

Kronos’ common shares are listed on the
New York Stock Exchange under the
symbol “KRO.”

Corporate and
Operating Management

Robert D. Graham
Vice Chairman, President and
Chief Executive Officer

James M. Buch
Chief Operating Officer

Benjamin R. Corona
President, Global Sales Management

James W. Brown
Executive Vice President and
Chief Financial Officer

Brian W. Christian
Executive Vice President

Andrew B. Nace
Executive Vice President

Tim C. Hafer
Senior Vice President and Controller

Courtney J. Riley
Senior Vice President,
Environmental Affairs

John A. Sunny
Senior Vice President and
Chief Information Officer

Clarence B. Brown, III
Vice President, General Counsel
and Secretary

Steve S. Eaton
Vice President, Internal
Control over Financial Reporting

Bryan A. Hanley
Vice President and Treasurer

Janet G. Keckeisen
Vice President, Corporate Strategy
and Investor Relations

Patricia A. Kropp
Vice President,
Global Human Resources

Kristin B. McCoy
Vice President, Tax

Michael S. Simmons
Vice President, Finance

Product Information

Information about our products and
services is available online or by
contacting:

Kronos Worldwide, Inc.
Three Lincoln Centre
5430 LBJ Freeway, Suite 1700
Dallas, Texas 75240-2620
Phone: (972) 233-1700
Customer Service: 1-800-866-5600.
Email: kronos.marketing@kronosww.com

Transfer Agent

Computershare acts as transfer agent,
registrar and dividend paying agent for the
Company’s common stock.
Communications regarding stockholder
accounts, dividends and change of
address should be directed to:

Computershare Trust Company, N.A.
P.O. Box 505000
Louisville, Kentucky 40233-5000
Telephone: (877) 373-6374
http://www.computershare.com/investor

Visit us on the Web
http://www.kronostio2.com

Form 10-K Report

The Company’s Annual Report on Form
10-K for the year ended December 31,
2020, as filed with the Securities and
Exchange Commission is printed as part
of this Annual Report. Additional copies
are available without charge upon written
request to:

Janet G. Keckeisen
Vice President, Corporate Strategy and
Investor Relations
Kronos Worldwide, Inc.
Three Lincoln Centre
5430 LBJ Freeway, Suite 1700
Dallas, Texas 75240-2620

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-K

☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended December 31, 2020

OR
☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to
Commission file number 1-31763

KRONOS WORLDWIDE, INC.

(Exact name of Registrant as specified in its charter)

DELAWARE
(State or other jurisdiction
of incorporation or organization)

76-0294959
(IRS Employer
Identification No.)

5430 LBJ Freeway, Suite 1700
Dallas, Texas 75240-2620
(Address of principal executive offices)

Registrant’s telephone number, including area code: (972) 233-1700

Securities registered pursuant to Section 12(b) of the Act:

Title of each class
Common stock

Trading Symbol(s)
KRO

Name of each exchange on which registered
NYSE

No securities are registered pursuant to Section 12(g) of the Act.

Indicate by check mark:
If the Registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐ No ☒
If the Registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No ☒
Whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934
during the preceding 12 months and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405
of Regulation S-T during the preceding 12 months (or for such shorter period that the Registrant was required to submit such
files). Yes ☒ No ☐
Whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company or an
emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,”
and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer
Non-accelerated filer
Emerging growth company

Accelerated filer ☒
Smaller reporting company ☐

☐
☐
☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal
control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public
accounting firm that prepared or issued its audit report.

☒

Whether the Registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐ No ☒
The aggregate market value of the 22.2 million shares of voting stock held by nonaffiliates of Kronos Worldwide, Inc. as of
June 30, 2020 (the last business day of the Registrant’s most recently-completed second fiscal quarter) approximated
$231.1 million.
Number of shares of the registrant’s common stock, $.01 par value per share, outstanding on February 26, 2021: 115,542,717.

Documents incorporated by reference
The information required by Part III is incorporated by reference from the Registrant’s definitive proxy statement to be filed
with the Commission pursuant to Regulation 14A not later than 120 days after the end of the fiscal year covered by this report.

Forward-Looking Information

This Annual Report on Form 10-K contains forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995, as amended. Statements in this Annual Report that are not historical facts
are forward-looking in nature and represent management’s beliefs and assumptions based on currently available
information. In some cases, you can identify forward-looking statements by the use of words such as “believes,”
“intends,” “may,” “should,” “could,” “anticipates,” “expects” or comparable terminology, or by discussions of
strategies or trends. Although we believe the expectations reflected in forward-looking statements are reasonable,
we do not know if these expectations will be correct. Such statements by their nature involve substantial risks and
uncertainties that could significantly impact expected results. Actual future results could differ materially from
those predicted. The factors that could cause our actual future results to differ materially from those described
herein are the risks and uncertainties discussed in this Annual Report and those described from time to time in our
other filings with the SEC and include, but are not limited to, the following:

(cid:129)

Future supply and demand for our products

The extent of the dependence of certain of our businesses on certain market sectors

The cyclicality of our business

Customer and producer inventory levels

(cid:129) Unexpected or earlier-than-expected industry capacity expansion
(cid:129)

Changes in raw material and other operating costs (such as energy and ore costs)

(cid:129)

Changes in the availability of raw materials (such as ore)

(cid:129) General global economic and political conditions that harm the worldwide economy, disrupt our
supply chain, increase material costs or reduce demand or perceived demand for our TiO2 products or
impair our ability to operate our facilities (including changes in the level of gross domestic product in
various regions of the world, natural disasters, terrorist acts, global conflicts and public health crises
such as COVID-19)

(cid:129)

Competitive products and substitute products

Customer and competitor strategies

Potential consolidation of our competitors

Potential consolidation of our customers

The impact of pricing and production decisions

Competitive technology positions

Potential difficulties in upgrading or implementing accounting and manufacturing software systems

The introduction of trade barriers or trade disputes

Fluctuations in currency exchange rates (such as changes in the exchange rate between the U.S. dollar
and each of the euro, the Norwegian krone and the Canadian dollar and between the euro and the
Norwegian krone), or possible disruptions to our business resulting from uncertainties associated with
the euro or other currencies

(cid:129) Operating interruptions (including, but not limited to, labor disputes, leaks, natural disasters, fires,
explosions, unscheduled or unplanned downtime, transportation interruptions, cyber-attacks and public
health crises such as COVID-19)

(cid:129) Our ability to renew or refinance credit facilities
(cid:129) Our ability to maintain sufficient liquidity

(cid:129)

The ultimate outcome of income tax audits, tax settlement initiatives or other tax matters, including
future tax reform

(cid:129) Our ability to utilize income tax attributes, the benefits of which may or may not have been recognized

under the more-likely-than-not recognition criteria

(cid:129)

Environmental matters (such as those requiring compliance with emission and discharge standards for
existing and new facilities)

(cid:129) Government laws and regulations and possible changes therein including new environmental health

and safety regulations (such as those seeking to limit or classify TiO2 or its use)

(cid:129)

Possible future litigation.

Should one or more of these risks materialize (or the consequences of such a development worsen), or
should the underlying assumptions prove incorrect, actual results could differ materially from those forecasted or
expected. We disclaim any intention or obligation to update or revise any forward-looking statements whether as a
result of changes in information, future events or otherwise.

ITEM 1.

BUSINESS

General

PART I

Kronos Worldwide, Inc. (NYSE: KRO) (Kronos), incorporated in Delaware in 1989, is a leading global
producer and marketer of value-added titanium dioxide pigments, or TiO2, a base industrial product used in a wide
range of applications. We, along with our distributors and agents, sell and provide technical services for our
products to approximately 4,000 customers in 100 countries with the majority of our sales in Europe, North America
and the Asia Pacific region. We believe we have developed considerable expertise and efficiency in the
manufacture, sale, shipment and service of our products in domestic and international markets.

TiO2 is a white inorganic pigment used in a wide range of products for its exceptional durability and its
ability to impart whiteness, brightness and opacity. TiO2 is a critical component of everyday applications, such as
coatings, plastics and paper, as well as many specialty products such as inks, food and cosmetics. TiO2 is widely
considered to be superior to alternative white pigments in large part due to its hiding power (or opacity), which is the
ability to cover or mask other materials effectively and efficiently. TiO2 is designed, marketed and sold based on
specific end-use applications.

TiO2 is the largest commercially used whitening pigment because it has a high refractive rating, giving it
more hiding power than any other commercially produced white pigment. In addition, TiO2 has excellent resistance
to interaction with other chemicals, good thermal stability and resistance to ultraviolet degradation. Although there
are other white pigments on the market, we believe there are no effective substitutes for TiO2 because no other white
pigment has the physical properties for achieving comparable opacity and brightness or can be incorporated in as
cost-effective a manner. Pigment extenders such as kaolin clays, calcium carbonate and polymeric opacifiers are
used together with TiO2 in a number of end-use markets. However, these products are not able to duplicate the
opacity performance characteristics of TiO2 and we believe these products are unlikely to have a significant impact
on the use of TiO2.

TiO2 is considered a “quality-of-life” product. Demand for TiO2 has generally been driven by worldwide
gross domestic product and has generally increased with rising standards of living in various regions of the world.
According to industry estimates, TiO2 consumption has grown at a compound annual growth rate of approximately
2% since 2000. Per capita consumption of TiO2 in Western Europe and North America far exceeds that in other
areas of the world, and these regions are expected to continue to be the largest consumers of TiO2 on a per capita
basis for the foreseeable future. We believe that Western Europe and North America currently each account for
approximately 17% of global TiO2 consumption. Markets for TiO2 are generally increasing in South America,
Eastern Europe, the Asia Pacific region and China and we believe these are significant markets which will continue
to grow as economies in these regions continue to develop and quality-of-life products, including TiO2, experience
greater demand.

At December 31, 2020, approximately 50% of our common stock was owned by Valhi, Inc. (NYSE: VHI)
and approximately 30% was owned by a wholly-owned subsidiary of NL Industries, Inc. (NYSE: NL). Valhi also
owns approximately 83% of NL Industries’ outstanding common stock. A wholly-owned subsidiary of Contran
Corporation held approximately 92% of Valhi’s outstanding common stock. As discussed in Note 1 to our
Consolidated Financial Statements, Lisa K. Simmons and a trust established for the benefit of Ms. Simmons and her
late sister and their children (the “Family Trust”) may be deemed to control Contran, and therefore may be deemed
to indirectly control the wholly-owned subsidiary of Contran, Valhi, NL and us.

Products and end-use markets

Including our predecessors, we have produced and marketed TiO2 in North America and Europe, our
primary markets, for over 100 years. We believe we are the largest producer of TiO2 in Europe with 46% of our
2020 sales volumes attributable to markets in Europe. The table below shows our estimated market share for our
significant markets, Europe and North America, for the last three years.

Europe
North America

2018

2019

2020

13%
17%

18%
19%

17%
18%

We believe we are the leading seller of TiO2 in several countries, including Germany, with an estimated 9%

share of worldwide TiO2 sales volume in 2020. Overall, we are one of the top five producers of TiO2 in the world.

We offer our customers a broad portfolio of products that include over 40 different TiO2 pigment grades
under the KRONOS® trademark, which provide a variety of performance properties to meet customers’ specific
requirements. Our major customers include domestic and international paint, plastics, decorative laminate and paper
manufacturers. We ship TiO2 to our customers in either a powder or slurry form via rail, truck and/or ocean carrier.
Sales of our core TiO2 pigments represented approximately 93% of our net sales in 2020. We and our agents and
distributors primarily sell our products in three major end-use markets: coatings, plastics and paper.

The following tables show our approximate TiO2 sales volume by geographic region and end-use for the

year ended December 31, 2020:

Sales volume percentages
by geographic region

Sales volume percentages
by end-use

Europe
North America
Asia Pacific
Rest of World

46%
36%
11%
7%

Coatings
Plastics
Paper
Other

58%
30%
6%
6%

Some of the principal applications for our products include the following:

TiO2 for coatings – Our TiO2 is used to provide opacity, durability, tinting strength and brightness in
industrial coatings, as well as coatings for commercial and residential interiors and exteriors, automobiles, aircraft,
machines, appliances, traffic paint and other special purpose coatings. The amount of TiO2 used in coatings varies
widely depending on the opacity, color and quality desired. In general, the higher the opacity requirement of the
coating, the greater the TiO2 content.

TiO2 for plastics – We produce TiO2 pigments that improve the optical and physical properties of plastics,
including whiteness and opacity. TiO2 is used to provide opacity to items such as containers and packaging
materials, and vinyl products such as windows, door profiles and siding. TiO2 also generally provides hiding power,
neutral undertone, brightness and surface durability for housewares, appliances, toys, computer cases and food
packages. TiO2’s high brightness along with its opacity, is used in some engineering plastics to help mask their
undesirable natural color. TiO2 is also used in masterbatch, which is a concentrate of TiO2 and other additives and is
one of the largest uses for TiO2 in the plastics end-use market. In masterbatch, the TiO2 is dispersed at high
concentrations into a plastic resin and is then used by manufacturers of plastic containers, bottles, packaging and
agricultural films.

TiO2 for paper – Our TiO2 is used in the production of several types of paper, including laminate
(decorative) paper, filled paper and coated paper to provide whiteness, brightness, opacity and color stability.
Although we sell our TiO2 to all segments of the paper end-use market, our primary focus is on the TiO2 grades used
in paper laminates, where several layers of paper are laminated together using melamine resin under high
temperature and pressure. The top layer of paper contains TiO2 and plastic resin and is the layer that is printed with
decorative patterns. Paper laminates are used to replace materials such as wood and tile for such applications as

counter tops, furniture and wallboard. TiO2 is beneficial in these applications because it assists in preventing the
material from fading or changing color after prolonged exposure to sunlight and other weathering agents.

TiO2 for other applications – We produce TiO2 to improve the opacity and hiding power of printing inks.
TiO2 allows inks to achieve very high print quality while not interfering with the technical requirements of printing
machinery, including low abrasion, high printing speed and high temperatures. Our TiO2 is also used in textile
applications where TiO2 functions as an opacifying and delustering agent. In man-made fibers such as rayon and
polyester, TiO2 corrects an otherwise undesirable glossy and translucent appearance. Without the presence of TiO2,
these materials would be unsuitable for use in many textile applications.

We produce high-purity sulfate process anatase TiO2 used to provide opacity, whiteness and brightness in a
variety of cosmetic and personal care products, such as skin cream, lipstick, eye shadow and toothpaste. Our TiO2 is
also found in food products, such as candy and confectionaries, and in pet foods where it is used to obtain
uniformity of color and appearance. In pharmaceuticals, our TiO2 is used commonly as a colorant in tablet and
capsule coatings as well as in liquid medicines to provide uniformity of color and appearance. KRONOS® purified
anatase grades meet the applicable requirements of the CTFA (Cosmetics, Toiletries and Fragrances Association),
USP and BP (United States Pharmacopoeia and British Pharmacopoeia) and the FDA (United States Food and Drug
Administration).

Our TiO2 business is enhanced by the following three complementary businesses, which comprised

approximately 7% of our net sales in 2020:

(cid:129) We own and operate two ilmenite mines in Norway pursuant to a governmental concession with an
unlimited term. Ilmenite is a raw material used directly as a feedstock by some sulfate-process TiO2
plants. We supply ilmenite to our sulfate plants in Europe. We also sell ilmenite ore to third parties,
some of whom are our competitors, and we sell an ilmenite-based specialty product to the oil and gas
industry. The mines have estimated ilmenite reserves that are expected to last at least 50 years.

(cid:129) We manufacture and sell iron-based chemicals, which are co-products and processed co-products of
sulfate and chloride process TiO2 pigment production. These co-product chemicals are marketed
through our Ecochem division and are primarily used as treatment and conditioning agents for
industrial effluents and municipal wastewater as well as in the manufacture of iron pigments, cement
and agricultural products.

(cid:129) We manufacture and sell titanium oxychloride and titanyl sulfate, which are side-stream specialty
products from the production of TiO2. Titanium oxychloride is used in specialty applications in the
formulation of pearlescent pigments, production of electroceramic capacitors for cell phones and other
electronic devices. Titanyl sulfate products are used in pearlescent pigments, natural gas pipe and
other specialty applications.

Manufacturing, operations and properties

We produce TiO2 in two crystalline forms: rutile and anatase. Rutile TiO2 is manufactured using both a
chloride production process and a sulfate production process, whereas anatase TiO2 is only produced using a sulfate
production process. Manufacturers of many end-use applications can use either form, especially during periods of
tight supply for TiO2. The chloride process is the preferred form for use in coatings and plastics, the two largest
end-use markets. Due to environmental factors and customer considerations, the proportion of TiO2 industry sales
represented by chloride process pigments has remained stable relative to sulfate process pigments, and in 2020,
chloride process production facilities represented approximately 45% of industry capacity. The sulfate process is
preferred for use in selected paper products, ceramics, rubber tires, man-made fibers, food products, pharmaceuticals
and cosmetics. Once an intermediate TiO2 pigment has been produced by either the chloride or sulfate process, it is
“finished” into products with specific performance characteristics for particular end-use applications through
proprietary processes involving various chemical surface treatments and intensive micronizing (milling).

(cid:129)

Chloride process – The chloride process is a continuous process in which chlorine is used to extract
rutile TiO2. The chloride process produces less waste than the sulfate process because much of the
chlorine is recycled and feedstock bearing higher titanium content is used. The chloride process also
has lower energy requirements and is less labor-intensive than the sulfate process, although the

chloride process requires a higher-skilled labor force. The chloride process produces an intermediate
base pigment with a wide range of properties.

(cid:129)

Sulfate process – The sulfate process is a batch process in which sulfuric acid is used to extract the
TiO2 from ilmenite or titanium slag. After separation from the impurities in the ore (mainly iron), the
TiO2 is precipitated and calcined to form an intermediate base pigment ready for sale or can be
upgraded through finishing treatments.

We produced 536,000 metric tons of TiO2 in 2018, 546,000 metric tons of TiO2 in 2019 and 517,000 metric
tons of TiO2 in 2020. Our production volumes include our share of the output produced by our TiO2 manufacturing
joint venture discussed below in “TiO2 manufacturing joint venture.” Our average production capacity utilization
rates were 95% in 2018, 98% in 2019 and 92% in 2020. Our production rates in 2018 were impacted by
maintenance activities at certain facilities and by the first quarter implementation of a productivity-enhancing
improvement project at our Belgium facility. Our production rates in 2020 were impacted by the COVID-19
pandemic as we decreased production levels early in the third quarter to correspond with a temporary decline in
market demand.

We operate facilities throughout North America and Europe, including the only sulfate process plant in
North America and four TiO2 plants in Europe (one in each of Leverkusen, Germany; Nordenham, Germany;
Langerbrugge, Belgium; and Fredrikstad, Norway). In North America, we have a TiO2 plant in Varennes, Quebec,
Canada and, through the manufacturing joint venture described below in “TiO2 manufacturing joint venture,” a 50%
interest in a TiO2 plant near Lake Charles, Louisiana.

Our production capacity has increased by approximately 5% over the past ten years due to debottlenecking
programs, incurring only moderate capital expenditures. We expect to operate our TiO2 plants at near full practical
capacity levels in 2021.

The following table presents the division of our expected 2021 manufacturing capacity by plant location

and type of manufacturing process:

Facility

Leverkusen, Germany (1)
Nordenham, Germany
Langerbrugge, Belgium

Fredrikstad, Norway (2)
Varennes, Canada

Description

TiO2 production, chloride process, co-products
TiO2 production, sulfate process, co-products
TiO2 production, chloride process, co-products,

titanium chemicals products

TiO2 production, sulfate process, co-products
TiO2 production, chloride and sulfate process,
slurry facility, titanium chemicals products

Lake Charles, LA, US (3)

TiO2 production, chloride process

Total

% of capacity by TiO2
manufacturing process
Chloride
31%
-

Sulfate

17
-

17
14
79%

-
7

3
-
21%

(1)

(2)

(3)

The Leverkusen facility is located within an extensive manufacturing complex owned by Bayer AG. We
own the Leverkusen facility, which represents about one-third of our current TiO2 production capacity, but
we lease the land under the facility from Bayer under a long-term agreement which expires in 2050. Lease
payments are periodically negotiated with Bayer for periods of at least two years at a time. A majority-
owned subsidiary of Bayer provides some raw materials including chlorine, auxiliary and operating
materials, utilities and services necessary to operate the Leverkusen facility under separate supplies and
services agreements. In conjunction with our long-term strategy to increase chloride process production,
we phased-out sulfate production at the Leverkusen facility during 2020.

The Fredrikstad facility is located on public land and is leased until 2063.

We operate the facility near Lake Charles through a joint venture with Venator Investments LLC (Venator
Investments), a wholly-owned subsidiary of Venator Group, of which Venator Materials PLC (Venator)
owns 100% and the amount indicated in the table above represents the share of TiO2 produced by the joint

venture to which we are entitled. See Note 5 to our Consolidated Financial Statements and “TiO2
manufacturing joint venture.” The joint venture owns the land and facility.

We own the land underlying all of our principal production facilities unless otherwise indicated in the table

above.

We also operate two ilmenite mines in Norway pursuant to a governmental concession with an unlimited
term. In addition, we operate a rutile slurry manufacturing plant near Lake Charles, Louisiana, which converts dry
pigment primarily manufactured for us at the Lake Charles TiO2 facility into a slurry form that is then shipped to
customers.

We have corporate and administrative offices located in the U.S., Germany, Norway, Canada, Belgium,

France and the United Kingdom and various sales offices located in North America.

TiO2 manufacturing joint venture

Kronos Louisiana, Inc., one of our subsidiaries, and Venator Investments each own a 50% interest in a
manufacturing joint venture, Louisiana Pigment Company, L.P. (LPC). LPC owns and operates a chloride-process
TiO2 plant located near Lake Charles, Louisiana. We and Venator share production from the plant equally pursuant
to separate offtake agreements, unless we and Venator otherwise agree.

A supervisory committee directs the business and affairs of the joint venture, including production and
output decisions. This committee is composed of four members, two of whom we appoint and two of whom
Venator appoints. Two general managers manage the operations of the joint venture acting under the direction of
the supervisory committee. We appoint one general manager and Venator appoints the other.

We do not consolidate LPC because we do not control it. We account for our interest in the joint venture
by the equity method. The joint venture operates on a break-even basis and therefore we do not have any equity in
earnings of the joint venture. We are required to purchase one half of the TiO2 produced by the joint venture. All
costs and capital expenditures are shared equally with Venator with the exception of feedstock (purchased natural
rutile ore or chlorine slag) and packaging costs for the pigment grades produced. Our share of net costs is reported
as cost of sales as the TiO2 is sold. See Notes 5 and 14 to our Consolidated Financial Statements.

Raw materials

The primary raw materials used in chloride process TiO2 are titanium-containing feedstock (purchased
natural rutile ore or chlorine slag), chlorine and petroleum coke. Chlorine is available from a number of suppliers,
while petroleum coke is available from a limited number of suppliers. Titanium-containing feedstock suitable for
use in the chloride process is available from a limited but increasing number of suppliers principally in Australia,
South Africa, Canada, India and the United States. We purchase chloride process grade slag from Rio Tinto Iron
and Titanium Limited under a long-term supply contract which automatically renewed at the end of 2020 and
extends through December 31, 2023. The contract automatically renews bi-annually, but can be terminated if
written notice is given at least twelve months prior to the current contract end date. We also purchase upgraded slag
from Rio Tinto Iron and Titanium Limited under a long-term supply contract that automatically renewed at the end
of 2020 and extends through December 31, 2022. The contract automatically renews annually, but can be
terminated if written notice is given at least twelve months prior to the contract end date. We purchase rutile ore
primarily from Sierra Rutile Limited under a contract that expires in 2022 and Base Titanium Limited under a
contract that expires at the end of 2022. In the past we have been, and we expect that we will continue to be,
successful in obtaining short-term and long-term extensions to these and other existing supply contracts prior to their
expiration. We expect the raw materials purchased under these contracts, and contracts that we may enter into, will
meet our chloride process feedstock requirements over the next several years.

The primary raw materials used in sulfate process TiO2 are titanium-containing feedstock, primarily
ilmenite or purchased sulfate grade slag, and sulfuric acid. Sulfuric acid is available from a number of suppliers.
Titanium-containing feedstock suitable for use in the sulfate process is available from a limited number of suppliers
principally in Norway, Canada, Australia, India and South Africa. As one of the few vertically-integrated producers

of sulfate process TiO2, we operate two rock ilmenite mines in Norway, which provided all of the feedstock for our
European sulfate process TiO2 plants in 2020. We expect ilmenite production from our mines to meet our European
sulfate process feedstock requirements for the foreseeable future. For our Canadian sulfate process plant, we
purchase sulfate grade slag primarily from Rio Tinto Fer et Titane Inc. under a supply contract that renews annually,
subject to termination upon twelve months written notice. We expect the raw materials purchased under this
contract, and contracts that we may enter into, to meet our sulfate process feedstock requirements over the next
several years.

Many of our raw material contracts contain fixed quantities we are required to purchase or specify a range
of quantities within which we are required to purchase. The pricing under these agreements is generally negotiated
quarterly or semi-annually.

The following table summarizes our raw materials purchased or mined in 2020.

Production process/raw material

Chloride process plants -

Purchased slag or rutile ore

Sulfate process plants:

Ilmenite ore mined and used internally
Purchased slag

Raw materials
procured or mined
(In thousands
of metric tons)

478

294
23

Sales and marketing

Our marketing strategy is aimed at developing and maintaining strong relationships with new and existing
customers. Because TiO2 represents a significant input cost for our customers, the purchasing decisions are often
made by our customers’ senior management. We work to maintain close relationships with the key decision makers
through in-depth and frequent contact. We endeavor to extend these commercial and technical relationships to
multiple levels within our customers’ organizations using our direct sales force and technical service group to
accomplish this objective. We believe this has helped build customer loyalty to Kronos and strengthened our
competitive position. Close cooperation and strong customer relationships enable us to stay closely attuned to trends
in our customers’ businesses. Where appropriate, we work in conjunction with our customers to solve formulation
or application problems by modifying specific product properties or developing new pigment grades. We also focus
our sales and marketing efforts on those geographic and end-use market segments where we believe we can realize
higher selling prices. This focus includes continuously reviewing and optimizing our customer and product
portfolios.

We also work directly with our customers to monitor the success of our products in their end-use
applications, evaluate the need for improvements in our product and process technology and identify opportunities
to develop new product solutions for our customers. Our marketing staff closely coordinates with our sales force
and technical specialists to ensure the needs of our customers are met, and to help develop and commercialize new
grades where appropriate.

We sell a majority of our products through our direct sales force operating in Europe and North America.
We also utilize sales agents and distributors who are authorized to sell our products in specific geographic areas. In
Europe, our sales efforts are conducted primarily through our direct sales force and our sales agents. Our agents do
not sell any TiO2 products other than KRONOS® brand products. In North America, our sales are made primarily
through our direct sales force and supported by a network of distributors. In export markets, where we have
increased our marketing efforts over the last several years, our sales are made through our direct sales force, sales
agents and distributors. In addition to our direct sales force and sales agents, many of our sales agents also act as
distributors to service our customers in all regions. We offer customer and technical service to customers who
purchase our products through distributors as well as to our larger customers serviced by our direct sales force.

We sell to a diverse customer base with only one customer representing 10% or more of our net sales in
2020 (Behr Process Corporation - 10%). Our largest ten customers accounted for approximately 34% of net sales in
2020.

Neither our business as a whole nor any of our principal product groups is seasonal to any significant
extent. However, TiO2 sales are generally higher in the second and third quarters of the year, due in part to the
increase in coatings production in the spring to meet demand during the spring and summer painting seasons. With
certain exceptions such as the COVID-19 pandemic, we have historically operated our production facilities at near
full capacity rates throughout the entire year, which among other things helps to minimize our per-unit production
costs. As a result, we normally will build inventories during the first and fourth quarters of each year in order to
maximize our product availability during the higher demand periods normally experienced in the second and third
quarters.

Competition

The TiO2 industry is highly competitive. We compete primarily on the basis of price, product quality,
technical service and the availability of high performance pigment grades. Since TiO2 is not traded through a
commodity market, its pricing is largely a product of negotiation between suppliers and their respective customers.
Price and availability are the most significant competitive factors along with quality and customer service for the
majority of our product grades. Increasingly, we are focused on providing pigments that are differentiated to meet
specific customer requests and specialty grades that are differentiated from our competitors’ products. During 2020,
we had an estimated 9% share of worldwide TiO2 sales volume, and based on sales volume, we believe we are the
leading seller of TiO2 in several countries, including Germany.

Our principal competitors are The Chemours Company, Tronox Incorporated, Lomon Billions and Venator

Materials PLC. The top five TiO2 producers (i.e. we and our four principal competitors) account for approximately
52% of the world’s production capacity.

The following chart shows our estimate of worldwide production capacity in 2020:

Worldwide production capacity - 2020

Chemours
Tronox
Lomon Billions
Venator
Kronos
Other

15%
13%
9%
8%
7%
48%

Chemours has approximately one-half of total North American TiO2 production capacity and is our
principal North American competitor. In the second quarter of 2019, Tronox acquired certain of the TiO2 assets of
Cristal Global. Lomon Billions added approximately 200,000 tons of chloride capacity in 2019 and 2020 and has
announced plans to add an additional 200,000 tons by 2023.

Over the past ten years, we and our competitors increased industry capacity through debottlenecking
projects, which in part compensated for the shut-down of various TiO2 plants throughout the world. Although
overall industry demand is expected to increase in 2021, we do not expect any significant efforts will be undertaken
by us or our principal competitors to further increase capacity for the foreseeable future, other than through
debottlenecking projects and the Lomon Billions expansion mentioned above. If actual developments differ from
our expectations, the TiO2 industry’s and our performance could be unfavorably affected.

The TiO2 industry is characterized by high barriers to entry consisting of high capital costs, proprietary
technology and significant lead times required to construct new facilities or to expand existing capacity. We believe
it is unlikely any new TiO2 plants will be constructed in Europe or North America in the foreseeable future.

Research and development

We employ scientists, chemists, process engineers and technicians who are engaged in research and
development, process technology and quality assurance activities in Leverkusen, Germany. These individuals have
the responsibility for improving our chloride and sulfate production processes, improving product quality and
strengthening our competitive position by developing new products and applications. Our expenditures for these
activities were approximately $16 million in 2018, $17 million in 2019 and $16 million in 2020. We expect to
spend approximately $17 million on research and development in 2021.

We continually seek to improve the quality of our grades and have been successful in developing new
grades for existing and new applications to meet the needs of our customers and increase product life cycles. Since
the beginning of 2016, we have added ten new grades for pigments and other applications.

Patents, trademarks, trade secrets and other intellectual property rights

We have a comprehensive intellectual property protection strategy that includes obtaining, maintaining and
enforcing our patents, primarily in the United States, Canada and Europe. We also protect our trademark and trade
secret rights and have entered into license agreements with third parties concerning various intellectual property
matters. We have also from time to time been involved in disputes over intellectual property.

Patents – We have obtained patents and have numerous patent applications pending that cover our products
and the technology used in the manufacture of our products. Our patent strategy is important to us and our
continuing business activities. In addition to maintaining our patent portfolio, we seek patent protection for our
technical developments, principally in the United States, Canada and Europe. U.S. patents are generally in effect for
20 years from the date of filing. Our U.S. patent portfolio includes patents having remaining terms ranging from
three years to 20 years.

Trademarks and trade secrets – Our trademarks, including KRONOS®, are covered by issued and/or
pending registrations, including in Canada and the United States. We protect the trademarks that we use in
connection with the products we manufacture and sell and have developed goodwill in connection with our long-
term use of our trademarks. We conduct research activities in secret and we protect the confidentiality of our trade
secrets through reasonable measures, including confidentiality agreements and security procedures, including data
security. We rely upon unpatented proprietary knowledge and continuing technological innovation and other trade
secrets to develop and maintain our competitive position. Our proprietary chloride production process is an
important part of our technology and our business could be harmed if we fail to maintain confidentiality of our trade
secrets used in this technology.

Human capital resources

Employees – Our operating results depend in part on our ability to successfully manage our human capital
resources, including attracting, identifying, and retaining key talent. We have a well-trained labor force with a
substantial number of long-tenured employees. We provide competitive compensation and benefits to our employees,
some of which are offered under collective bargaining agreements. In addition to salaries, these programs, which
vary by country/region, can include annual bonuses, a defined benefit pension plan, a defined contribution plan with
employer matching opportunities, healthcare and insurance benefits, health savings and flexible spending accounts,
paid time off, family leave, family care resources, employee assistance programs, and tuition assistance.

As of December 31, 2020, we employed the following number of people:

Europe
Canada
United States (1)
Total

1,839
350
53
2,242

(1)

Excludes employees of our LPC joint venture.

Certain employees at each of our production facilities are organized by labor unions. We strive to maintain
good relationships with all our employees, including the unions and workers’ councils representing those
employees. In Europe, our union employees are covered by master collective bargaining agreements for the
chemical industry that are generally renewed annually. In Canada, our union employees are covered by a collective
bargaining agreement that expires in June 2021. At December 31, 2020, approximately 86% of our worldwide
workforce is organized under collective bargaining agreements. We did not experience any work stoppages during
2020, although it is possible that there could be future work stoppages or other labor disruptions that could
materially and adversely affect our business, results of operations, financial position or liquidity.

Health and safety – Protecting the health and safety of our employees, our customers, our business partners
and the natural environment is one of our core values. We are committed to conducting our business in ways that
provide all personnel with a safe and healthy work environment and have established safety and environmental
programs and goals to achieve such results. We expect our manufacturing facilities to produce our products safely
and in compliance with local permits and policies intended to protect the environment and have established global
policies designed to promote such compliance. We require our employees to comply with legal and regulatory
requirements and our policies, standards and practices.

Diversity and inclusion – We recognize that everyone deserves respect and equal treatment. As a global
company, we embrace diversity and collaboration in our workforce and our business initiatives. We are an equal
opportunity employer and we base employment decisions on merit, competence and qualifications, without regard to
race, color, national origin, gender, age, religion, disability, sex, sexual orientation or other characteristics protected
by applicable law in the jurisdictions in which we operate. We promote a respectful, diverse, and inclusive
workplace in which all individuals are treated with respect and dignity.

Environmental, Social and Governance (“ESG”)

We seek to operate our business in line with sound ESG principles that include corporate governance,
social responsibility, sustainability and cybersecurity. At our facilities, we undertake various environmental
sustainability programs and promote social responsibility and volunteerism through programs designed to support
and give back to the local communities in which we operate. At a corporate level, we engage in periodic reviews of
our cybersecurity program, including cybersecurity risk and threats, and have established stock ownership guidelines
for our non-employee directors. In addition, we publish a Sustainability Report on our website every two years to
provide our customers, stockholders and other stakeholders with additional information on our approach to
sustainability.

Regulatory and environmental matters

Our operations and properties are governed by various environmental laws and regulations which are
complex, change frequently and have tended to become stricter over time. These environmental laws govern,
among other things, the generation, storage, handling, use and transportation of hazardous materials; the emission
and discharge of hazardous materials into the ground, air or water; and the health and safety of our employees.
Certain of our operations are, or have been, engaged in the generation, storage, handling, manufacture or use of
substances or compounds that may be considered toxic or hazardous within the meaning of applicable environmental
laws and regulations. As with other companies engaged in similar businesses, certain of our past and current
operations and products have the potential to cause environmental or other damage. We have implemented and
continue to implement various policies and programs in an effort to minimize these risks. Our policy is to comply
with applicable environmental laws and regulations at all our facilities and to strive to improve our environmental
performance and overall sustainability. We update our Kronos Sustainability Report biennially (available on our
website at www.kronostio2.com), which highlights our focus on sustainability of our manufacturing operations, as
well as our environmental, social and governance strategy. It is possible that future developments, such as stricter
requirements in environmental laws and enforcement policies, could adversely affect our operations, including
production, handling, use, storage, transportation, sale or disposal of hazardous or toxic substances or require us to
make capital and other expenditures to comply, and could adversely affect our consolidated financial position and
results of operations or liquidity.

Our U.S. manufacturing operations are governed by federal, state and local environmental and worker
health and safety laws and regulations. These include the Resource Conservation and Recovery Act, or RCRA, the

Occupational Safety and Health Act, the Clean Air Act, the Clean Water Act, the Safe Drinking Water Act, the
Toxic Substances Control Act and the Comprehensive Environmental Response, Compensation and Liability Act, as
amended by the Superfund Amendments and Reauthorization Act, or CERCLA, as well as the state counterparts of
these statutes. Some of these laws hold current or previous owners or operators of real property liable for the costs
of cleaning up contamination, even if these owners or operators did not know of, and were not responsible for, such
contamination. These laws also assess liability on any person who arranges for the disposal or treatment of
hazardous substances, regardless of whether the affected site is owned or operated by such person. Although we
have not incurred and do not currently anticipate any material liabilities in connection with such environmental laws,
we may be required to make expenditures for environmental remediation in the future.

While the laws regulating operations of industrial facilities in Europe vary from country to country, a
common regulatory framework is provided by the European Union, or the EU. Germany and Belgium are members
of the EU and follow its initiatives. Norway is not a member but generally patterns its environmental regulatory
actions after those of the EU.

At our sulfate plant facility in Germany, we recycle spent sulfuric acid either through contracts with third
parties or at our own facility. In addition, at our German sulfate-process location we have a contract with a third-
party to treat certain sulfate-process effluents. At our Norwegian plant, we ship spent acid to a third-party location
where it is used as a neutralization agent. These contracts may be terminated by either party after giving three or
four years advance notice, depending on the contract.

From time to time, our facilities may be subject to environmental regulatory enforcement under U.S. and
non-U.S. statutes. Typically, we establish compliance programs to resolve these matters. Occasionally, we may pay
penalties. To date, such penalties have not involved amounts having a material adverse effect on our consolidated
financial position, results of operations or liquidity. We believe all of our facilities are in substantial compliance
with applicable environmental laws.

From time to time, new environmental, health and safety regulations are passed or proposed in the
countries in which we operate or sell our products, seeking to regulate our operations or to restrict, limit or classify
TiO2. We believe that we are in substantial compliance with laws applicable to the regulation of TiO2. However,
increased regulatory scrutiny could affect consumer perception of TiO2 or limit the marketability and demand for
TiO2 or products containing TiO2 and increase our regulatory and compliance costs.

On February 18, 2020 the European Union published a regulation classifying TiO2 powder and powder
mixtures containing TiO2 as a suspected carcinogen via inhalation under its EU Regulation No. 1272/2008 on
classification, labeling and packing of substances and mixtures. The regulation will enter into force on October 1,
2021 at which time hazard labels will be required on certain TiO2 powder products and certain powder mixtures
containing TiO2 in the EU. This classification of TiO2 is based on scientifically questioned animal test data.
Separate studies of TiO2 workers conducted by the TiO2 industry have shown no TiO2 specific links to cancer. We
intend to comply with the new requirements including working with customers and other stakeholders on
compliance matters as appropriate.

Our capital expenditures related to ongoing environmental compliance, protection and improvement
programs, including capital expenditures which are primarily focused on increasing operating efficiency but also
result in improved environmental protection such as lower emissions from our manufacturing facilities, were
$21.8 million in 2020 and are currently expected to be approximately $23 million in 2021.

Website and other available information

Our fiscal year ends December 31. Our annual reports on Form 10-K, quarterly reports on Form 10-Q,
current reports on Form 8-K and any amendments to those reports are available on our website at kronostio2.com.
These reports are available on the website, without charge, as soon as is reasonably practicable after we file or
furnish them electronically with the Securities and Exchange Commission, or SEC. Additional information
regarding us, including our Audit Committee charter, Code of Business Conduct and Ethics and our Corporate
Governance Guidelines, can also be found at this website. Information contained on our website is not part of this

report. We will also provide free copies of such documents upon written request. Such requests should be directed
to the Corporate Secretary at our address on the cover page of this Form 10-K.

We are an electronic filer and the SEC maintains an internet website that contains reports, proxy and
information statements and other information regarding issuers that file electronically with the SEC at www.sec.gov.

ITEM 1A.

RISK FACTORS

Below are certain risk factors associated with our business. See also certain risk factors discussed in Item
7- “Management’s Discussion and Analysis of Financial Condition and Results of Operations – Critical Accounting
Policies and Estimates.” In addition to the potential effect of these risk factors, any risk factor which could result in
reduced earnings or operating losses, or reduced liquidity, could in turn adversely affect our ability to service our
liabilities or pay dividends on our common stock or adversely affect the quoted market prices for our securities.

Operational Risk Factors

Demand for, and prices of, certain of our products are influenced by changing market conditions for our
products, which may result in reduced earnings or in operating losses.

Our sales and profitability are largely dependent on the TiO2 industry. In 2020, 93% of our sales were
attributable to sales of TiO2. TiO2 is used in many “quality of life” products for which demand historically has been
linked to global, regional and local gross domestic product and discretionary spending, which can be negatively
impacted by regional and world events or economic conditions. Such events are likely to cause a decrease in
demand for our products and, as a result, may have an adverse effect on our results of operations and financial
condition.

Pricing within the global TiO2 industry over the long term is cyclical and changes in economic conditions
worldwide can significantly impact our earnings and operating cash flows. Historically, the markets for many of our
products have experienced alternating periods of increasing and decreasing demand. Relative changes in the selling
prices for our products are one of the main factors that affect the level of our profitability. In periods of increasing
demand, our selling prices and profit margins generally will tend to increase, while in periods of decreasing demand
our selling prices and profit margins generally tend to decrease. In addition, pricing may affect customer inventory
levels as customers may from time to time accelerate purchases of TiO2 in advance of anticipated price increases or
defer purchases of TiO2 in advance of anticipated price decreases. Our ability to further increase capacity without
additional investment in greenfield or brownfield capacity may be limited and as a result, our profitability may
become even more dependent upon the selling prices of our products.

The TiO2 industry is concentrated and highly competitive and we face price pressures in the markets in which we
operate, which may result in reduced earnings or operating losses.

The global market in which we operate our business is concentrated, with the top five TiO2 producers
accounting for approximately 52% of the world’s production capacity, and is highly competitive. Competition is
based on a number of factors, such as price, product quality and service. Some of our competitors may be able to
drive down prices for our products if their costs are lower than our costs. In addition, some of our competitors’
financial, technological and other resources may be greater than our resources and such competitors may be better
able to withstand changes in market conditions. Our competitors may be able to respond more quickly than we can
to new or emerging technologies and changes in customer requirements. Further, consolidation of our competitors
or customers may result in reduced demand for our products or make it more difficult for us to compete with our
competitors. The occurrence of any of these events could result in reduced earnings or operating losses.

Higher costs or limited availability of our raw materials may reduce our earnings and decrease our liquidity. In
addition, many of our raw material contracts contain fixed quantities we are required to purchase.

The number of sources for and availability of certain raw materials is specific to the particular geographical
region in which a facility is located. For example, titanium-containing feedstocks suitable for use in our TiO2
facilities are available from a limited number of suppliers around the world. Political and economic instability in the
countries from which we purchase our raw materials could adversely affect their availability. If our worldwide

vendors were unable to meet their contractual obligations and we were unable to obtain necessary raw materials, we
could incur higher costs for raw materials or may be required to reduce production levels. We experienced increases
in our feedstock costs in 2019 and during the first half of 2020, before they moderated in the second half of 2020.
We expect our feedstock costs in 2021 to remain relatively consistent with average 2020 costs. We may also
experience higher operating costs such as energy costs, which could affect our profitability. We may not always be
able to increase our selling prices to offset the impact of any higher costs or reduced production levels, which could
reduce our earnings and decrease our liquidity.

We have long-term supply contracts that provide for our TiO2 feedstock requirements that currently expire
through 2023. While we believe we will be able to renew these contracts, there can be no assurance we will be
successful in renewing them or in obtaining long-term extensions to them prior to expiration. Our current
agreements (including those entered into through January 2021) require us to purchase certain minimum quantities
of feedstock with minimum purchase commitments aggregating approximately $1.2 billion beginning in 2021. In
addition, we have other long-term supply and service contracts that provide for various raw materials and services.
These agreements require us to purchase certain minimum quantities or services with minimum purchase
commitments aggregating approximately $86 million at December 31, 2020. Our commitments under these
contracts could adversely affect our financial results if we significantly reduce our production and were unable to
modify the contractual commitments.

COVID-19 has affected our operations and may continue to affect our operations during 2021.

Our results of operations during 2020 were significantly impacted by the COVID-19 pandemic, primarily
in the second and third quarters, specifically through reduced demand for many of our products resulting from the
rapid contraction of the global economy. The extent of the impact of the COVID-19 pandemic on our future
operations will depend on the time period and degree to which the COVID-19 pandemic persists in the global
economy, including the timing and extent to which our customers’ operations continue to be impacted, our
customers’ perception as to when consumer demand for their products will return to pre-pandemic levels and on any
future disruptions in our operations or our suppliers’ operations, all of which are difficult to predict.

We have 2,242 employees and operate facilities throughout North America and Europe. With the onset of
COVID-19, within each facility we enhanced cleaning and sanitization procedures, mandated social distancing and
implemented other health and safety protocols. We are designated an essential business in the countries where we
operate and are therefore permitted to fully operate during the pandemic. It is possible we may have temporary
closures at one or more of our facilities for the health and safety of our workforce before the end of the pandemic if
conditions warrant.

Financial Risk Factors

Our leverage may impair our financial condition or limit our ability to operate our businesses.

As of December 31, 2020, our total consolidated debt was approximately $487 million, substantially all of
which relates to our Senior Secured Notes issued in September 2017. Our level of debt could have important
consequences to our stockholders and creditors, including:

(cid:129) making it more difficult for us to satisfy our obligations with respect to our liabilities;
(cid:129)

increasing our vulnerability to adverse general economic and industry conditions;

(cid:129)

requiring that a portion of our cash flows from operations be used for the payment of interest on our
debt, which reduces our ability to use our cash flow to fund working capital, capital expenditures,
dividends on our common stock, acquisitions or general corporate requirements;

limiting the ability of our subsidiaries to pay dividends to us;

limiting our ability to obtain additional financing to fund future working capital, capital expenditures,
acquisitions or general corporate requirements;

limiting our flexibility in planning for, or reacting to, changes in our business and the industry in which
we operate; and

(cid:129)

placing us at a competitive disadvantage relative to other less leveraged competitors.

Indebtedness outstanding under our revolving North American and European credit facilities accrues
interest at variable rates. To the extent market interest rates rise, the cost of our debt could increase, adversely
affecting our financial condition, results of operations and cash flows.

In addition to our indebtedness, we are party to various lease and other agreements (including feedstock
purchase contracts and other long-term supply and service contracts, as discussed above) pursuant to which, along
with our indebtedness, we are committed to pay approximately $591 million in 2021. Our ability to make payments
on and refinance our debt and to fund planned capital expenditures depends on our future ability to generate cash
flow. To some extent, this is subject to general economic, financial, competitive, legislative, regulatory and other
factors that are beyond our control. In addition, our ability to borrow funds under our revolving credit facilities in
the future will, in some instances, depend in part on our ability to maintain specified financial ratios and satisfy
certain financial covenants contained in the applicable credit agreement.

Our business may not generate cash flows from operating activities sufficient to enable us to pay our debts
when they become due and to fund our other liquidity needs. As a result, we may need to refinance all or a portion
of our debt before maturity. We may not be able to refinance any of our debt in a timely manner on favorable terms,
if at all, in the current credit markets. Any inability to generate sufficient cash flows or to refinance our debt on
favorable terms could have a material adverse effect on our financial condition.

Changes in currency exchange rates and interest rates can adversely affect our net sales, profits and cash flows.

We operate our businesses in several different countries and sell our products worldwide. For example,
during 2020, 46% of our sales volumes were sold into European markets. The majority (but not all) of our sales
from our operations outside the United States are denominated in currencies other than the United States dollar,
primarily the euro, other major European currencies and the Canadian dollar. Therefore, we are exposed to risks
related to the need to convert currencies we receive from the sale of our products into the currencies required to pay
for certain of our operating costs and expenses and other liabilities (including indebtedness), all of which could
result in future losses depending on fluctuations in currency exchange rates and affect the comparability of our
results of operations between periods.

Legal, Compliance and Regulatory Risk Factors

We may be subject to litigation, the disposition of which could have a material adverse effect on our results of
operations.

The nature of our operations exposes us to possible litigation claims, including disputes with customers and
suppliers and matters relating to, among other things, antitrust, product liability, intellectual property, employment
and environmental claims. It is possible that judgments could be rendered against us in these or other types of cases
for which we could be uninsured or not covered by indemnity, or which may be beyond the amounts that we
currently have reserved or anticipate incurring for such matters. Some of the lawsuits may seek fines or penalties
and damages in large amounts or seek to restrict our business activities. Because of the uncertain nature of litigation
and coverage decisions, we cannot predict the outcome of these matters or whether insurance claims may mitigate
any damages ultimately determined to be owed by us. Any liability we might incur in the future could be material.
In addition, litigation is very costly, and the costs associated with defending litigation matters could have a material
adverse effect on our results of operations.

If our intellectual property were to be declared invalid, or copied by or become known to competitors, or if our
competitors were to develop similar or superior intellectual property or technology, our ability to compete could
be adversely impacted.

Protection of our intellectual property rights, including patents, trade secrets, confidential information,
trademarks and tradenames, is important to our business and our competitive position. We endeavor to protect our
intellectual property rights in key jurisdictions in which our products are produced or used and in jurisdictions into
which our products are imported. However, we may be unable to obtain protection for our intellectual property in
key jurisdictions. Although we own and have applied for numerous patents and trademarks throughout the world,

we may have to rely on judicial enforcement of our patents and other proprietary rights. Our patents and other
intellectual property rights may be challenged, invalidated, circumvented, and rendered unenforceable or otherwise
compromised. A failure to protect, defend or enforce our intellectual property could have an adverse effect on our
financial condition and results of operations. Similarly, third parties may assert claims against us and our customers
and distributors alleging our products infringe upon third-party intellectual property rights.

Although it is our practice to enter into confidentiality agreements with our employees and third parties to
protect our proprietary expertise and other trade secrets, these agreements may not provide sufficient protection for
our trade secrets or proprietary know-how, or adequate remedies for breaches of such agreements may not be
available in the event of an unauthorized use or disclosure of such trade secrets and know-how. We also may not be
able to readily detect breaches of such agreements. The failure of our patents or confidentiality agreements to
protect our proprietary technology, know-how or trade secrets could result in a material loss of our competitive
position, which could lead to significantly lower revenues, reduced profit margins or loss of market share.

If we must take legal action to protect, defend or enforce our intellectual property rights, any suits or
proceedings could result in significant costs and diversion of resources and management’s attention, and we may not
prevail in any such suits or proceedings. A failure to protect, defend or enforce our intellectual property rights could
have an adverse effect on our financial condition and results of operations.

Environmental, health and safety laws and regulations may result in increased regulatory scrutiny which could
decrease demand for our products, increase our manufacturing and compliance costs or obligations and result in
unanticipated losses which could negatively impact our financial results or limit our ability to operate our
business.

From time to time, new environmental, health and safety regulations are passed or proposed in the
countries in which we operate or sell our products, seeking to regulate our operations or to restrict, limit or classify
TiO2, or its use (such as the classification of TiO2 powder as a suspected carcinogen in the EU). Increased
regulatory scrutiny could affect consumer perception of TiO2 or limit the marketability and demand for TiO2 or
products containing TiO2 and
increase our manufacturing and regulatory compliance obligations and
costs. Increased compliance obligations and costs or restrictions on certain TiO2 applications could negatively
impact our future financial results through increased costs of production, or reduced sales which may decrease our
liquidity, operating income and results of operations.

Global climate change legislation could negatively impact our financial results or limit our ability to operate our
businesses.

We operate production facilities in several countries. In many of the countries in which we operate,
legislation has been passed, or proposed legislation is being considered, to limit greenhouse gases through various
means, including emissions permits and/or energy taxes. In several of our production facilities, we consume large
amounts of energy, primarily electricity and natural gas. To date, the permit system in effect in the various countries
in which we operate has not had a material adverse effect on our financial results. However, if further greenhouse
gas legislation were to be enacted in one or more countries, it could negatively impact our future results from
operations through increased costs of production, particularly as it relates to our energy requirements or our need to
obtain emissions permits. If such increased costs of production were to materialize, we may be unable to pass on
price increases to our customers to compensate for increased production costs, which may decrease our liquidity,
operating income and results of operations.

General Risk Factors

Operating as a global business presents risks associated with global and regional economic, political and
regulatory environments.

We have significant international operations which, along with our customers and suppliers, could be
substantially affected by a number of risks arising from operating a multi-national business, including trade barriers,
tariffs, exchange controls, global and regional economic downturns, terrorism, natural disasters, health crises (such
as COVID-19) and political conditions. We may encounter difficulties enforcing agreements or other legal rights
and our effective tax rate may fluctuate based on the variability of geographic earnings and statutory tax rates,

including costs associated with the repatriation of non-U.S. earnings. These risks, individually or in the aggregate,
could have an adverse effect on our results of operations and financial condition.

Technology failures or cyber security breaches could have a material adverse effect on our operations.

We rely on integrated information technology systems to manage, process and analyze data, including to
facilitate the manufacture and distribution of our products to and from our plants, receive, process and ship orders,
manage the billing of and collections from our customers and manage payments to our vendors. Although we have
systems and procedures in place to protect our information technology systems, there can be no assurance that such
systems and procedures would be sufficiently effective. Therefore, any of our information technology systems may
be susceptible to outages, disruptions or destruction as well as cyber security breaches or attacks, resulting in a
disruption of our business operations, injury to people, harm to the environment or our assets, and/or the inability to
access our information technology systems. If any of these events were to occur, our results of operations and
financial condition could be adversely affected.

ITEM 1B.

UNRESOLVED STAFF COMMENTS

None

ITEM 2.

PROPERTIES

Information on our properties is incorporated by reference to Item 1: Manufacturing, Operations and
Properties above. Our corporate headquarters is located in Dallas, Texas. See Notes 1 and 7 to our Consolidated
Financial Statements for information on our leases.

ITEM 3.

LEGAL PROCEEDINGS

We are involved in various environmental, contractual, intellectual property, product liability and other
claims and disputes incidental to our business. Information required for this Item is incorporated by reference to
Note 15 to our Consolidated Financial Statements.

ITEM 4.

MINE SAFETY DISCLOSURES

Not applicable

PART II

ITEM 5.

MARKET FOR COMMON EQUITY AND RELATED STOCKHOLDER MATTERS

Our common stock is listed and traded on the New York Stock Exchange (symbol: KRO). As of

February 26, 2021, there were approximately 1,800 holders of record of our common stock.

In December 2010, our board of directors authorized the repurchase of up to 2.0 million shares of our
common stock in open market transactions, including block purchases, or in privately-negotiated transactions at
unspecified prices and over an unspecified period of time. In 2020 we repurchased 122,489 shares, and we have
1,563,519 shares available for repurchase under the stock repurchase program at December 31, 2020. See Note 13
to our Consolidated Financial Statements.

Performance graph

Set forth below is a table and line graph comparing the yearly change in our cumulative total stockholder
return on our common stock against the cumulative total return of the S&P 500 Composite Stock Index and an index
of a self-selected peer group of companies. In 2018, as more of our peers became publicly traded, we began using a
peer group metric which we believe provides a more meaningful comparison to our performance. The peer group
index is comprised of The Chemours Company, Venator Materials PLC and Tronox Ltd. The Chemours Company
is included from the date the company began trading on the New York Stock Exchange in August 2017. The graph
shows the value at December 31 of each year, assuming an original investment of $100 at December 31, 2015 and
reinvestment of cash dividends and other distributions to stockholders.

Kronos common stock
S&P 500 Composite Stock Index
Peer Group

2015

2016

2017

2018

2019

2020

100
100
100

230
112
374

512
136
828

238
130
395

292
171
323

346
203
441

$900

$800

$700

$600

$500

$400

$300

$200

$100

2015

2016

2017

2018

2019

2020

Kronos Worldwide Inc

S&P 500 Index

Peer Group

The information contained in the performance graph shall not be deemed “soliciting material” or “filed”
with the SEC, or subject to the liabilities of Section 18 of the Securities Exchange Act, except to the extent we
specifically request that the material be treated as soliciting material or specifically incorporate this performance
graph by reference into a document filed under the Securities Act or the Securities Exchange Act.

Equity compensation plan information

We have an equity compensation plan, which was approved by our stockholders, pursuant to which an
aggregate of 200,000 shares of our common stock can be awarded to members of our board of directors. At
December 31, 2020, 127,400 shares are available for awards under this plan. See Note 13 to our Consolidated
Financial Statements.

ITEM 6.

SELECTED FINANCIAL DATA

The following selected financial data should be read in conjunction with our Consolidated Financial
Statements and Item 7 - “Management’s Discussion and Analysis of Financial Condition and Results of
Operations.”

Years ended December 31,
2016
2020
2018
(In millions, except per share data and TiO2 operating statistics)

2019

2017

STATEMENTS OF OPERATIONS DATA:

Net sales
Gross margin (1)
Income from operations (1)
Net income
Net income per share
Cash dividends per share

BALANCE SHEET DATA (at year end):

Total assets (2)
Notes payable and long-term debt
including current maturities
Common stockholders' equity

STATEMENTS OF CASH FLOW DATA:

Net cash provided by (used in):

$ 1,364.3
264.7
92.9
43.3
.37
.60

$ 1,729.0
569.7
347.8
354.5
3.06
.60

$ 1,661.9
562.2
330.1
205.0
1.77
.68

$ 1,731.1
386.2
145.8
87.1
.75
.72

$ 1,638.8
351.2
116.2
63.9
.55
.72

$ 1,179.6

$ 1,824.4

$ 1,898.1

$ 1,965.8

$ 2,036.7

339.0
395.0

474.5
754.3

456.6
839.8

445.5
816.1

487.4
796.5

Operating activities
Investing activities
Financing activities

89.6
$
(53.0)
(73.3)

276.1
$
(77.9)
58.8

188.5
$
(42.7)
(80.4)

160.3
$
(52.5)
(87.9)

102.5
(61.3)
(85.3)

TiO2 OPERATING STATISTICS:

Sales volumes (3)
Production volumes (3)
Production capacity at beginning of year (3)
Production rate as a percentage of capacity

559
546
555

98%

586
576
555
100%

491
536
565

566
546
560

95%

98%

531
517
560
92%

(1)

Prior period amounts have been reclassified to reflect the adoption on January 1, 2018 of ASU 2017-07,
Compensation – Retirement Benefits (Topic 715) Improving the Presentation of Net Periodic Pension Cost
and Net Periodic Postretirement Benefit Cost. As a result, gross margin increased by $7.7 million in 2016 and
$10.8 million in 2017. Income from operations increased by $11.8 million and $17.4 million in 2016 and
2017, respectively. There was no impact to net income in any period as a result of this reclassification.

(2) On January 1, 2019 we adopted ASU 2016-02, Leases (Topic 842). Our total assets include $29.0 million and
$26.1 million of right-of-use lease assets as of December 31, 2019 and 2020, respectively. Prior periods were
not restated.

(3) Metric tons in thousands

ITEM 7.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
RESULTS OF OPERATIONS

RESULTS OF OPERATIONS

Business overview

We are a leading global producer and marketer of value-added TiO2. TiO2 is used for a variety of
manufacturing applications, including plastics, paints, paper and other industrial and specialty products. During
2020, 46% of our sales volumes were sold into European markets. We believe we are the largest producer of TiO2
in Europe with an estimated 17% share of European TiO2 sales volumes in 2020. In addition, we estimate we have
an 18% share of North American TiO2 sales volumes in 2020. Our production facilities are located in Europe and
North America.

We consider TiO2 to be a “quality of life” product, with demand affected by gross domestic product, or
GDP, and overall economic conditions in our markets located in various regions of the world. Over the long-term,
we expect demand for TiO2 will grow by 2% to 3% per year, consistent with our expectations for the long-term
growth in GDP. However, even if we and our competitors maintain consistent shares of the worldwide market,
demand for TiO2 in any interim or annual period may not change in the same proportion as the change in GDP, in
part due to relative changes in the TiO2 inventory levels of our customers. We believe our customers’ inventory
levels are influenced in part by their expectation for future changes in TiO2 selling prices as well as their expectation
for future availability of product. Although certain of our TiO2 grades are considered specialty pigments, the
majority of our grades and substantially all of our production are considered commodity pigment products with price
and availability being the most significant competitive factors along with product quality, and customer and
technical support services.

The factors having the most impact on our reported operating results are:

(cid:129)

TiO2 selling prices,

(cid:129) Our TiO2 sales and production volumes,
(cid:129) Manufacturing costs, particularly raw materials such as third-party feedstock, maintenance and energy-

related expenses, and

(cid:129)

Currency exchange rates (particularly the exchange rate for the U.S. dollar relative to the euro, the
Norwegian krone and the Canadian dollar and the euro relative to the Norwegian krone).

Our key performance indicators are our TiO2 average selling prices, our level of TiO2 sales and production
volumes and the cost of our third-party feedstock ore. TiO2 selling prices generally follow industry trends and
selling prices will increase or decrease generally as a result of competitive market pressures.

Executive summary

We reported net income of $63.9 million, or $.55 per share, in 2020 compared to $87.1 million, or $.75 per
share in 2019. We reported lower net income in 2020 as compared to 2019 primarily due to lower income from
operations resulting from the effects of lower sales volumes, lower average TiO2 selling prices and higher raw
materials and other production costs. Our results of operations for the year ended December 31, 2020 were
significantly impacted by the COVID-19 pandemic, specifically through sharply reduced demand for certain of our
products resulting from the rapid contraction across the global economy occurring in the second quarter, with
demand continuing to strengthen throughout the second half of 2020.

We reported net income of $87.1 million, or $.75 per share, in 2019 compared to $205.0 million, or $1.77
per share for 2018. We reported lower net income in 2019 as compared to 2018 primarily due to lower income from
operations resulting from the effects of lower average TiO2 selling prices and higher raw materials and other
production costs partially offset by higher sales volumes.

Our net income in 2020 includes the first quarter recognition of a pre-tax insurance settlement gain of $1.5

million ($1.2 million, or $.01 per share, net of income tax expense) related to a property damage claim.

Our net income in 2019 includes:

(cid:129)

the fourth quarter recognition of a non-cash deferred income tax expense of $5.5 million ($.05 per
share) primarily related to the revaluation of our net deferred income tax asset in Germany as a result
of a decrease in the German trade tax rate,

the fourth quarter recognition of an income tax benefit of $3.0 million ($.03 per share) related to the
favorable settlement of a prior year tax matter in Germany, and

the fourth quarter recognition of a pre-tax insurance settlement gain of $2.6 million ($2.0 million, or
$.02 per share, net of income tax expense) related to a property damage claim.

Our net income in 2018 includes:

(cid:129)

the fourth quarter recognition of a $3.7 million ($.03 per share) current cash income tax expense
related to tax on global intangible low-tax income (GILTI), and

an aggregate $2.1 million ($.02 per share) non-cash income tax expense related to an increase in our
reserve for uncertain tax positions, recognized in the first and fourth quarters.

Comparison of 2020 to 2019 Results of Operations

Net sales
Cost of sales

Gross margin

Selling, general and administrative expense
Other operating income (expense):
Currency transactions, net
Other operating expense, net
Income from operations

TiO2 operating statistics:
Sales volumes*
Production volumes*
Percentage change in net sales:

TiO2 product pricing
TiO2 sales volumes
TiO2 product mix/other
Changes in currency exchange rates

Total

* Thousands of metric tons

2019

1,731.1
1,344.9
386.2
228.2

2.0
(14.2)
145.8

Years ended December 31,

(Dollars in millions)

2020

100 % $
78
22
13

-
(1)
8 % $

1,638.8
1,287.6
351.2
218.6

(4.0)
(12.4)
116.2

100 %
79
21
13

-
(1)
7 %

% Change

566
546

531
517

(6)%
(5)%

(2)%
(6)
2
1
(5)%

Industry conditions and 2020 overview – We started 2020 with average TiO2 selling prices 1% lower than
at the beginning of 2019. At the end of 2020, our average TiO2 selling prices were comparable to the end of the
third quarter of 2020 and 3% lower than at the beginning of the year. We experienced lower sales volumes in all
major markets in 2020 as compared to sales volumes in 2019, primarily due to demand contraction related to the
COVID-19 pandemic, which mainly impacted the second and third quarters.

The following table shows our capacity utilization rates during 2019 and 2020. Our production rates in
2020 were impacted by the COVID-19 pandemic as we decreased production levels early in the third quarter to
correspond with a temporary decline in market demand, then increased production levels later in the third quarter
and into the fourth quarter to align with improved demand and our market expectations for the near term.

First Quarter
Second Quarter
Third Quarter
Fourth Quarter
Overall

2019

2020

97%
97%
97%
100%
98%

95%
96%
86%
92%
92%

Net sales – Our net sales decreased $92.3 million, or 5%, in 2020 compared to 2019, primarily due to a 6%
decrease in sales volumes (which decreased net sales by approximately $104 million) and a 2% decrease in average
TiO2 selling prices (which decreased net sales by approximately $35 million). In addition to the impact of lower
sales volumes and lower average selling prices, we estimate that changes in currency exchange rates (primarily the
euro) increased our net sales by approximately $9 million, or 1%, as compared to 2019. TiO2 selling prices will
increase or decrease generally as a result of competitive market pressures, changes in the relative level of supply and
demand as well as changes in raw material and other manufacturing costs.

Our sales volumes decreased 6% in 2020 as compared to the sales volumes of 2019 due to lower sales
volumes in all major markets, with the European and export markets experiencing the most significant reductions.
A significant portion of the sales volume decrease occurred in the second and third quarters as a result of the
demand contraction related to the COVID-19 pandemic.

Cost of sales and gross margin – Cost of sales decreased $57.3 million, or 4%, in 2020 compared to 2019
due to the net effect of a 6% decrease in sales volumes, higher raw materials and other production costs of
approximately $6 million (including higher cost for third-party feedstock and other raw materials) and currency
exchange rate fluctuations. Our cost of sales per metric ton of TiO2 sold in 2020 was higher as compared to 2019
(excluding the effect of changes in currency exchange rates) primarily due to a moderate rise in the cost of third-
party feedstock we procured in 2019 and the first half of 2020. Our cost of sales as a percentage of net sales
increased to 79% in 2020 compared to 78% in 2019 primarily due to the unfavorable effects of lower average TiO2
selling prices and higher raw materials and other production costs, as discussed above, partially offset by improved
sales and production volumes from our ilmenite mine operations.

Gross margin as a percentage of net sales decreased to 21% in 2020 compared to 22% in 2019. As
discussed and quantified above, our gross margin as a percentage of net sales decreased primarily due to the net
effect of lower sales volumes, lower average TiO2 selling prices, higher raw materials and other production costs
and higher sales from our ilmenite mine operations.

Selling, general and administrative expense – Selling, general and administrative expenses decreased $9.6
million, or 4%, in 2020 compared to 2019 primarily due to variable costs related to lower overall sales volumes.
Selling, general and administrative expenses were approximately 13% of net sales in each of 2019 and 2020.

Income from operations – Income from operations decreased by $29.6 million, from $145.8 million in 2019
to $116.2 million in 2020. Income from operations as a percentage of net sales was 7% in 2020 compared to 8% in
2019. This decrease was driven by the lower gross margin discussed above for the comparable periods. We
estimate that changes in currency exchange rates increased income from operations by approximately $6 million in
2020 as compared to 2019 as discussed in the Effects of currency exchange rates section below.

Our income from operations was also minimally impacted by the effects of Hurricane Laura which
temporarily halted production at LPC on August 24, 2020. Although storm damage to core manufacturing facilities
was not severe, a variety of factors, including loss of utilities, limited availability of employees to return to work and
restrictions on the facility’s access to raw materials, prevented the resumption of operations until September 25,
2020. LPC believes insurance (subject to applicable deductibles) will cover a majority of its losses, including those
related to property damage and the disruption of its operations. The Kronos warehouse and slurry facilities located
near LPC’s facility were also temporarily closed due to the hurricane, but property damage to these facilities was not
significant. Our 2020 income from operations includes immaterial costs related to Hurricane Laura, primarily costs
to relocate inventory and modify shipping schedules in order to maintain service levels to our customers following
the hurricane. We believe insurance (subject to applicable deductibles) will cover a majority of our losses from the
hurricane, including property damage, business interruption losses related to our share of LPC’s lost production and
other costs resulting from the disruption of operations, but no insurance recoveries have yet been recognized as the
allowable damage claim amounts are not presently determinable. On October 9, 2020 Hurricane Delta caused an
additional temporary halt to production at the LPC facility. Damages resulting from Hurricane Delta were not as
severe and production activities were resumed within five days from the time of initial shutdown prior to landfall of
the hurricane. Similar to Hurricane Laura, losses determined to be incurred by LPC and us as a result of Hurricane
Delta are expected to be recoverable from insurance (subject to applicable deductibles).

Other non-operating income (expense) – We recognized a loss of $1.1 million in 2020 and $.1 million in
2019 on the change in value of our marketable equity securities. See Note 6 to our Consolidated Financial
Statements. Other components of net periodic pension and postretirement benefits other than pensions, or OPEB,
cost in 2020 increased $4.2 million compared to 2019 primarily due to increased amortization costs from previously
unrecognized actuarial losses as a result of lower discount rates and lower expected returns on plan assets. See Note
10 to our Consolidated Financial Statements. Interest expense in 2020 was comparable to 2019.

Income tax expense – We recognized income tax expense of $16.1 million in 2020 compared to income tax
expense of $34.0 million in 2019. The decrease is primarily due to lower earnings in 2020 and the jurisdictional mix
of such earnings. In addition, our income tax expense in 2019 includes an income tax benefit recognized in the
fourth quarter of $3.0 million related to the favorable settlement of a prior year tax matter in Germany, with $1.5
million recognized as a current cash tax benefit and $1.5 million recognized as a non-cash deferred income tax
benefit related to an increase to our German net operating loss carryforward. In addition, in the fourth quarter of
2019, we recognized a non-cash deferred income tax expense of $5.5 million primarily related to the revaluation of
our net deferred income tax asset in Germany resulting from a decrease in the German trade tax rate.

Our earnings are subject to income tax in various U.S. and non-U.S. jurisdictions. Generally, our
consolidated effective income tax rate is higher than the U.S. federal statutory tax rate of 21% primarily because the
income tax rates applicable to the pre-tax earnings (losses) of our non-U.S. operations are generally higher than the
income tax rates applicable to our U.S. operations. However, in 2020 our consolidated effective income tax rate is
lower than the U.S. federal statutory rate of 21% due to the effect of lower earnings and tax benefits associated with
losses incurred in certain high tax jurisdictions. See Note 12 to our Consolidated Financial Statements for a tabular
reconciliation of our statutory income tax provision to our actual tax provision.

Our consolidated effective income tax rate in 2021 is expected to be higher than the U.S. federal statutory
rate of 21% because the income tax rates applicable to the earnings (losses) of our non-U.S. operations will be
higher than the income tax rates applicable to our U.S. operations and due to the expected mix of earnings.

Comparison of 2019 to 2018 Results of Operations

Net sales
Cost of sales

Gross margin

Selling, general and administrative expense
Other operating income (expense):
Currency transactions, net
Other operating expense, net
Income from operations

TiO2 operating statistics:
Sales volumes*
Production volumes*
Percentage change in net sales:

TiO2 product pricing
TiO2 sales volumes
TiO2 product mix/other
Changes in currency exchange rates

Total

* Thousands of metric tons

2018

1,661.9
1,099.7
562.2
228.3

10.1
(13.9)
330.1

Years ended December 31,

(Dollars in millions)

2019

100 % $
66
34
14

1
(1)
20 % $

1,731.1
1,344.9
386.2
228.2

2.0
(14.2)
145.8

100 %
78
22
13

-
(1)
8 %

% Change

491
536

566
546

15 %
2 %

(6 )%
15
(2)
(3)
4 %

Net sales – Our net sales increased $69.2 million, or 4%, in 2019 compared to 2018, primarily due to the
net effect of a 6% decrease in average TiO2 selling prices (which decreased net sales by approximately $100
million), a 15% increase in sales volumes (which increased net sales by approximately $249 million) and changes in
currency exchange rates. TiO2 selling prices will increase or decrease generally as a result of competitive market
pressures, changes in the relative level of supply and demand as well as changes in raw material and other
manufacturing costs.

Our sales volumes increased 15% in 2019 as compared to the sales volumes of 2018 primarily due to
strength in the European, North American and export markets in 2019 as compared to 2018. In addition to the
impact of changes in average TiO2 selling prices and sales volumes, we estimate that changes in currency exchange
rates decreased our net sales by approximately $49 million, or 3%, as compared to 2018.

Cost of sales and gross margin – Cost of sales increased $245.2 million, or 22%, in 2019 compared to 2018
primarily due to the net impact of a 15% increase in sales volumes, higher raw materials and other production costs
of approximately $122 million (including higher cost for third-party feedstock, energy and other raw materials) and
currency fluctuations (primarily the euro). Our cost of sales as a percentage of net sales increased to 78% in 2019
compared to 66% in 2018 primarily due to the unfavorable effects of lower average selling prices and higher raw
materials and other production costs, as discussed above.

Gross margin as a percentage of net sales decreased to 22% in 2019 compared to 34% in 2018. As
discussed and quantified above, our gross margin decreased primarily due to the net effect of lower average TiO2
selling prices, higher sales volumes and higher raw materials and other production costs.

Selling, general and administrative expense – Selling, general and administrative expenses were $228.2

million in 2019, which were comparable to such expenses in 2018.

Income from operations – Income from operations decreased by $184.3 million, from $330.1 million in
2018 to $145.8 million in 2019. Income from operations as a percentage of net sales was 8% in 2019 compared to
20% in 2018. This decrease was driven by the decrease in gross margin discussed above for the comparable periods.
We estimate that changes in currency exchange rates decreased income from operations by approximately $3 million
in 2019 as compared to 2018.

Other non-operating income (expense) – We recognized a loss of $.1 million in 2019 and $7.3 million in
2018 on the change in value of our marketable equity securities. See Note 6 to our Consolidated Financial
Statements. Other components of net periodic pension and OPEB cost in 2019 was comparable to 2018. See Note
10 to our Consolidated Financial Statements. Interest expense in 2019 was comparable to 2018.

Income tax expense – We recognized income tax expense of $34.0 million in 2019 compared to income tax
expense of $88.8 million in 2018. The decrease is primarily due to lower earnings in 2019. In addition, our income
tax expense in 2019 includes an income tax benefit recognized in the fourth quarter of $3.0 million related to the
favorable settlement of a prior year tax matter in Germany, with $1.5 million recognized as a current cash tax benefit
and $1.5 million recognized as a non-cash deferred income tax benefit related to an increase to our German net
operating loss carryforward. In addition, in the fourth quarter of 2019, we recognized a non-cash deferred income
tax expense of $5.5 million primarily related to the revaluation of our net deferred income tax asset in Germany
resulting from a decrease in the German trade tax rate.

Effects of currency exchange rates

We have substantial operations and assets located outside the United States (primarily in Germany,
Belgium, Norway and Canada). The majority of our sales from non-U.S. operations are denominated in currencies
other than the U.S. dollar, principally the euro, other major European currencies and the Canadian dollar. A portion
of our sales generated from our non-U.S. operations is denominated in the U.S. dollar (and consequently our non-
U.S. operations will generally hold U.S. dollars from time to time). Certain raw materials used in all our production
facilities, primarily titanium-containing feedstocks, are purchased primarily in U.S. dollars, while labor and other
production and administrative costs are incurred primarily in local currencies. Consequently, the translated U.S.
dollar value of our non-U.S. sales and operating results are subject to currency exchange rate fluctuations which may
favorably or unfavorably impact reported earnings and may affect the comparability of period-to-period operating
results. In addition to the impact of the translation of sales and expenses over time, our non-U.S. operations also
generate currency transaction gains and losses which primarily relate to (i) the difference between the currency
exchange rates in effect when non-local currency sales or operating costs (primarily U.S. dollar denominated) are
initially accrued and when such amounts are settled with the non-local currency and (ii) changes in currency
exchange rates during time periods when our non-U.S. operations are holding non-local currency (primarily U.S.
dollars).

Overall, we estimate that fluctuations in currency exchange rates had the following effects on our sales and

income from operations for the periods indicated.

Impact of changes in currency exchange rates - 2020 vs. 2019

Transaction gains/(losses) recognized

Translation
gains -
impact of

2019

2020

Change rate changes
(In millions)

Total currency
impact
2020 vs. 2019

- $
2

- $
(4)

- $
(6)

9
12

9
6

Impact on:
Net sales
Income from operations

The $9 million increase in net sales (translation gain) was caused primarily by a weakening of the U.S.
dollar relative to the euro, as our euro-denominated sales were translated into more U.S. dollars in 2020 as compared
to 2019. The strengthening of the U.S. dollar relative to the Canadian dollar and the Norwegian krone in 2020 did
not have a significant effect on the reported amount of our net sales, as a substantial portion of the sales generated
by our Canadian and Norwegian operations are denominated in the U.S. dollar.

The $6 million increase in income from operations was comprised of the following:

(cid:129)

Lower net currency transaction gains of approximately $6 million primarily caused by relative changes
in currency exchange rates at each applicable balance sheet date between the U.S. dollar and the euro,
Canadian dollar and the Norwegian krone, and between the euro and the Norwegian krone, which
causes increases or decreases, as applicable, in U.S. dollar-denominated receivables and payables and
U.S. dollar currency held by our non-U.S. operations, and in Norwegian krone denominated
receivables and payables held by our non-U.S. operations, and

(cid:129) Approximately $12 million from net currency translation gains primarily caused by a strengthening of
the U.S. dollar relative to the Canadian dollar and Norwegian krone, as local currency-denominated
operating costs were translated into fewer U.S. dollars in 2020 as compared to 2019, and such
translation, as it related to the U.S. dollar relative to the euro, had a nominal effect on income from
operations in 2020 as compared to 2019.

Impact of changes in currency exchange rates - 2019 vs. 2018

Transaction gains/(losses) recognized

Translation
gains/(losses)
impact of

2018

2019

Change rate changes
(In millions)

Total currency
impact
2019 vs. 2018

- $
10

- $
2

- $
(8)

(49) $
5

(49)
(3)

Impact on:
Net sales
Income from operations

The $49 million decrease in net sales (translation loss) was caused primarily by a strengthening of the U.S.
dollar relative to the euro, as our euro-denominated sales were translated into fewer U.S. dollars in 2019 as
compared to 2018. The strengthening of the U.S. dollar relative to the Canadian dollar and the Norwegian krone in
2019 did not have a significant effect on the reported amount of our net sales, as a substantial portion of the sales
generated by our Canadian and Norwegian operations are denominated in the U.S. dollar.

The $3 million decrease in income from operations was comprised of the following:

(cid:129)

Lower net currency transaction gains of approximately $8 million primarily caused by relative changes
in currency exchange rates at each applicable balance sheet date between the U.S. dollar and the euro,
Canadian dollar and the Norwegian krone, which causes increases or decreases, as applicable, in U.S.
dollar-denominated receivables and payables and U.S. dollar currency held by our non-U.S.
operations, and

(cid:129) Approximately $5 million from net currency translation gains primarily caused by the strengthening of
the U.S. dollar relative to the Canadian dollar and Norwegian krone, as its local currency-denominated
operating costs were translated into fewer U.S. dollars in 2019 as compared to 2018, partially offset by
the strengthening of the U.S. dollar relative to the euro as the reduction in net sales caused by such
strengthening of the stronger U.S. dollar on euro-denominated sales more than offset the favorable
effect of euro-denominated operating costs being translated into fewer U.S. dollars in 2019 as
compared to 2018.

Outlook

In the second half of 2020 our sales volumes increased from the reduced levels we experienced during the
first half of the year, primarily during the second quarter. However, the COVID-19 pandemic, including the

measures employed to mitigate its spread, continued to impact our operations through reduced demand for our
products and resulted in lower sales and earnings in 2020 than otherwise would have been expected. Our
manufacturing facilities operated at near planned production rates in the first half of 2020, however, early in the
third quarter we decreased our production levels to align with demand and our market expectations for the near term,
and late in the third quarter and into the fourth quarter we began increasing production levels as demand improved.

The advance of the COVID-19 pandemic and the global efforts to mitigate its spread have resulted in sharp
contractions of vast areas of the global economy and are expected to continue to challenge workers, businesses and
governments for the foreseeable future. Government actions in various regions have generally permitted the
resumption of commercial activities following various regional shutdowns, but further government action restricting
economic activity is possible in an effort to mitigate increases in COVID-19 in certain regions. As a result, we
expect U.S. and worldwide gross domestic product to be significantly impacted for an indeterminate period of time.
While many of our products are used by our customers in end-products that thus far have remained in demand across
the world economy, we believe overall demand for our products and our customers’ products will continue to be
impacted by reduced economic activity.

Despite negative impacts and continued uncertainty on worldwide gross domestic product from COVID-19,
we have experienced increasing demand for our products in the second half of 2020 and expect these demand levels
to continue into 2021. As such, we expect our 2021 sales and income from operations to be higher than in 2020,
principally as a result of higher average TiO2 selling prices and higher sales volumes. We also expect our
production volumes in 2021 to be slightly higher as compared to 2020 production volumes, in line with expected
increased demand for our products. The full extent of the COVID-19 impact on our operations will depend on
numerous factors, including customer demand for our products, any future disruption in our operations or our
suppliers’ operations and the timing and effectiveness of measures deployed to fight COVID-19, all of which are
uncertain and cannot be predicted. We will continue to monitor current and anticipated near-term customer demand
throughout the year and further align our production and inventory levels accordingly.

We experienced increases in our feedstock costs in 2019 and during the first half of 2020 before the costs
moderated in the second half of 2020. We expect our feedstock costs to remain relatively consistent in 2021 as
compared to the average 2020 costs. To-date, the availability of raw materials has not been adversely impacted by
the COVID-19 pandemic.

At the beginning of 2020, our average TiO2 selling prices were 1% lower than at the beginning of 2019 and
average TiO2 selling prices decreased 3% during 2020. Due to increasing customer demand experienced in the
second half of 2020, we expect prices to rise slightly in 2021.

Our manufacturing and administrative facilities are generally located in densely populated regions of
Europe and North America which have experienced substantial outbreaks of COVID-19 and are in varying stages of
outbreak and recovery. We continue to employ a variety of methods to protect the health and well-being of our
workforce and our customers, including the implementation of contact tracing, deep cleaning and disinfecting of
facilities, work-from-home strategies and staggered shift deployment, among other health and safety protocols. To-
date, we have had limited cases of COVID-19 among our workforce and all of our facilities have remained open and
operational. We commend our employees for their continuing efforts and support in these challenging times as we
work together to foster their physical and economic health as well as that of the company.

Operations outside the United States

As discussed above, we have substantial operations located outside the United States for which the
functional currency is not the U.S. dollar. As a result, the reported amount of our assets and liabilities related to our
non-U.S. operations, and therefore our consolidated net assets, will fluctuate based upon changes in currency
exchange rates. At December 31, 2020, we had substantial net assets denominated in the euro, Canadian dollar and
Norwegian krone.

Critical accounting policies and estimates

Our significant accounting policies are more fully described in Note 1 to our Consolidated Financial
Statements. Our Consolidated Financial Statements have been prepared in accordance with accounting principles

generally accepted in the United States of America, or GAAP which requires management to make estimates,
judgments and assumptions that we believe are reasonable based on our historical experience, observance of known
trends in our Company and industry as a whole and information available from outside sources. Our estimates affect
the reported amounts of assets and liabilities and related disclosures of contingent assets and liabilities at the date of
the financial statements and the reported amounts of revenue and expense during the reporting period. Actual
results may differ significantly from those initial estimates.

We believe the most critical accounting policies and estimates involving significant judgment primarily

relate to long-lived assets, defined benefit pension plans and income taxes.

(cid:129)

Long-lived assets – The net book value of our property and equipment totaled $524.6 million at
December 31, 2020. We recognize an impairment charge associated with our long-lived assets,
including property and equipment, whenever we determine that recovery of such long-lived asset is not
probable. Such determination is based upon, among other things, estimates of the amount of future net
cash flows to be generated by the long-lived asset and estimates of the current fair value of the asset.
Significant judgment is required in estimating such cash flows. Adverse changes in such estimates of
future net cash flows or estimates of fair value could result in an inability to recover the carrying value
of the long-lived asset, thereby possibly requiring an impairment charge to be recognized in the future.
We do not assess our property and equipment for impairment unless certain impairment indicators are
present. We did not evaluate any long-lived assets for impairment during 2020 because no such
impairment indicators were present.

(cid:129) Defined benefit pension plans – We maintain various defined benefit pension plans in the U.S., Europe
and Canada. See Note 10 to our Consolidated Financial Statements. We recognized consolidated
defined benefit pension plan expense of $26.6 million in 2018, $28.0 million in 2019 and $32.7 million
in 2020. The funding requirements for these defined benefit pension plans are generally based upon
applicable regulations (such as ERISA in the U.S.) and will generally differ from pension expense for
financial reporting purposes. We made contributions to all of our plans which aggregated $17.1
million in 2018, $16.2 million in 2019 and $16.6 million in 2020.

Under defined benefit pension plan accounting, defined benefit pension plan expense, pension assets
and accrued pension costs are each recognized based on certain actuarial assumptions. These
assumptions are principally the assumed discount rate, the assumed long-term rate of return on plan
assets, the fair value of plan assets and the assumed increase in future compensation levels. We
recognize the full funded status of our defined benefit pension plans as either an asset (for overfunded
plans) or a liability (for underfunded plans) on our Consolidated Balance Sheets.

The discount rates we use for determining defined benefit pension expense and the related pension
obligations are based on current interest rates earned on long-term bonds that receive one of the two
highest ratings given by recognized rating agencies in the applicable country where the defined benefit
pension benefits are being paid. In addition, we receive third-party advice about appropriate discount
rates and these advisors may in some cases use their own market indices. We adjust these discount
rates as of each December 31 valuation date to reflect then-current interest rates on such long-term
bonds. We use these discount rates to determine the actuarial present value of the pension obligations
as of December 31 of that year. We also use these discount rates to determine the interest component
of defined benefit pension expense for the following year.

At December 31, 2020, approximately 74%, 14%, 6% and 2% of the projected benefit obligations
related to our plans in Germany, Canada, Norway and the U.S., respectively. We use several different
discount rate assumptions in determining our consolidated defined benefit pension plan obligation and
expense. This is because we maintain defined benefit pension plans in several different countries in
Europe and North America and the interest rate environment differs from country to country.

We used the following discount rates for our defined benefit pension plans:

Obligations
at December 31, 2018
and expense in 2019
1.8%
3.5%
2.5%
4.1%

Discount rates used for:
Obligations
at December 31, 2019
and expense in 2020
1.0%
3.0%
2.3%
3.1%

Obligations
at December 31, 2020
and expense in 2021
.7%
2.4%
1.7%
2.2%

Germany
Canada
Norway
U.S.

The assumed long-term rate of return on plan assets represents the estimated average rate of earnings
expected to be earned on the funds invested or to be invested in the plans’ assets provided to fund the
benefit payments inherent in the projected benefit obligations. Unlike the discount rate, which is
adjusted each year based on changes in current long-term interest rates, the assumed long-term rate of
return on plan assets will not necessarily change based upon the actual short-term performance of the
plan assets in any given year. Defined benefit pension expense each year is based upon the assumed
long-term rate of return on plan assets for each plan, the actual fair value of the plan assets as of the
beginning of the year and an estimate of the amount of contributions to and distributions from the plan
during the year. Differences between the expected return on plan assets for a given year and the actual
return are deferred and amortized over future periods based either upon the expected average
remaining service life of the active plan participants (for plans for which benefits are still being earned
by active employees) or the average remaining life expectancy of the inactive participants (for plans
for which benefits are not still being earned by active employees).

At December 31, 2020, approximately 59%, 23%, 11% and 3% of the plan assets related to our plans
in Germany, Canada, Norway and the U.S., respectively. We use several different long-term rates of
return on plan asset assumptions in determining our consolidated defined benefit pension plan expense.
This is because the plan assets in different countries are invested in a different mix of investments and
the long-term rates of return for different investments differ from country to country.

In determining the expected long-term rate of return on plan asset assumptions, we consider the long-
term asset mix (e.g. equity vs. fixed income) for the assets for each of our plans and the expected long-
term rates of return for such asset components. In addition, we receive third-party advice about
appropriate long-term rates of return. We regularly review our actual asset allocation for each of our
U.S. and non-U.S. plans and will periodically rebalance the investments in each plan to more
accurately reflect the targeted allocation when considered appropriate.

Our assumed long-term rates of return on plan assets for 2018, 2019 and 2020 were as follows:

Germany
Canada
Norway
U.S.

2018

2019

2020

2.0%
4.2%
4.0%
7.5%

2.3%
4.0%
4.0%
5.5%

1.0%
3.5%
4.0%
4.5%

Our long-term rate of return on plan asset assumptions in 2021 used for purposes of determining our
2021 defined benefit pension plan expense for Germany, Canada, Norway and the U.S. are 2.0%,
3.1%, 2.8% and 4.0%, respectively.

We follow ASC Topic 820, Fair Value Measurements and Disclosures, in determining the fair value
of plan assets within our defined benefit pension plans. While we believe the valuation methods used
to determine the fair value of plan assets are appropriate, the use of different methodologies or
assumptions to determine the fair value of certain financial instruments could result in a different
estimate of fair value at the reporting date.

To the extent that a plan’s particular pension benefit formula calculates the pension benefit in whole or
in part based upon future compensation levels, the projected benefit obligations and the pension
expense will be based in part upon expected increases in future compensation levels. For all of our
plans for which the benefit formula is so calculated, we generally base the assumed expected increase
in future compensation levels upon average long-term inflation rates for the applicable country.

In addition to the actuarial assumptions discussed above, the amount of recognized defined benefit
pension expense and the amount of net pension asset and net pension liability will vary based upon
relative changes in currency exchange rates. See Note 10 to our Consolidated Financial Statements for
additional discussion of actuarial assumptions used in determining defined benefit pension assets,
liabilities and expenses.

Based on the actuarial assumptions described above and our current expectation for what actual
average currency exchange rates will be during 2021, we expect our defined benefit pension expense
will approximate $31 million in 2021. In comparison, we expect to be required to contribute
approximately $17 million to such plans during 2021.

As noted above, defined benefit pension expense and the amounts recognized as accrued pension costs
are based upon the actuarial assumptions discussed above. We believe all of the actuarial assumptions
used are reasonable and appropriate. However, if we had lowered the assumed discount rate by 25
basis points for all plans as of December 31, 2020, our aggregate projected benefit obligations would
have increased by approximately $41 million at that date and our defined benefit pension expense
would be expected to increase by approximately $2.2 million during 2021. Similarly, if we lowered
the assumed long-term rate of return on plan assets by 25 basis points for all of our plans, our defined
benefit pension expense would be expected to increase by approximately $1.2 million during 2021.

(cid:129)

Income taxes – We operate globally and the calculation of our provision for income taxes and our
deferred tax assets and liabilities involves the interpretation and application of complex tax laws and
regulations in a multitude of jurisdictions across our global operations. Our effective tax rate is highly
dependent upon the geographic distribution of our earnings or losses and the effects of tax laws and
regulations in each tax-paying jurisdiction in which we operate. Significant judgments and estimates
are required in determining our consolidated provision for income taxes due to the global nature of our
operations. Our provision for income taxes and deferred tax assets and liabilities reflect our best
assessment of estimated current and future taxes to be paid, including the recognition and measurement
of deferred tax assets and liabilities.

We recognize deferred taxes for future tax effects of temporary differences between financial and
income tax reporting. Deferred income tax assets and liabilities for each tax-paying jurisdiction in
which we operate are netted and presented as either a noncurrent deferred income tax asset or liability,
as applicable. We record a valuation allowance to reduce our deferred income tax assets to the amount
that is believed to be realized under the more-likely-than-not recognition criteria. While we have
considered future taxable income and ongoing prudent and feasible tax planning strategies in assessing
the need for a valuation allowance, it is possible that we may change our estimate of the amount of the
deferred income tax assets that would more-likely-than-not be realized in the future, resulting in an
adjustment to the deferred income tax asset valuation allowance that would either increase or decrease,
as applicable, reported net income in the period such change in estimate was made.

For example, at December 31, 2020 we have substantial net operating loss carryforwards in Germany
(the equivalent of $531 million for German corporate tax purposes) and Belgium (the equivalent of
$20 million for Belgian corporate tax purposes). At December 31, 2020, we have concluded that no
deferred income tax asset valuation allowance is required to be recognized with respect to such
carryforwards, principally because (i) such carryforwards have an indefinite carryforward period, (ii)
we have utilized a portion of such carryforwards during the most recent three-year period and (iii) we
currently expect to utilize the remainder of such carryforwards over the long term. However, prior to
the complete utilization of such carryforwards, if we were to generate additional losses in our German
or Belgian operations for an extended period of time, or if applicable law were to change such that the

carryforward period was no longer indefinite, it is possible that we might conclude the benefit of such
carryforwards would no longer meet the more-likely-than-not recognition criteria, at which point we
would be required to recognize a valuation allowance against some or all of the then-remaining tax
benefit associated with the carryforwards.

LIQUIDITY AND CAPITAL RESOURCES

Consolidated cash flows

Operating activities

Trends in cash flows as a result of our operating activities (excluding the impact of significant asset
dispositions and relative changes in assets and liabilities) are generally similar to trends in our earnings. In addition
to the impact of the operating, investing and financing cash flows discussed below, changes in the amount of cash,
cash equivalents and restricted cash we report from year to year can be impacted by changes in currency exchange
rates, since a portion of our cash, cash equivalents and restricted cash is held by our non-U.S. subsidiaries. For
example, during 2020, relative changes in currency exchange rates resulted in a $13.8 million increase in the
reported amount of our cash, cash equivalents and restricted cash compared to a $2.3 million decrease in 2019 and a
$14.4 million decrease in 2018.

Cash provided by operating activities was $102.5 million in 2020 compared to $160.3 million in 2019.

This $57.8 million decrease in the amount of cash provided was primarily due to the net effect of the following:

(cid:129)

lower income from operations in 2020 of $29.6 million,

higher amount of net cash used associated with relative changes in our inventories, receivables,
payables and accruals in 2020 of $45.8 million as compared to 2019,

lower cash paid for taxes in 2020 of $20.5 million due to decreased earnings in 2020, and

higher contributions to our TiO2 manufacturing joint venture in 2020 of $3.5 million.

Cash provided by operating activities was $160.3 million in 2019 compared to $188.5 million in 2018.

This $28.2 million decrease in the amount of cash provided was primarily due to the net effect of the following:

(cid:129)

lower income from operations in 2019 of $184.3 million,

lower amount of net cash used associated with relative changes in our inventories, receivables,
payables and accruals in 2019 of $129.4 million as compared to 2018,

lower cash paid for taxes in 2019 of $32.1 million due to the net effects of decreased profits in 2019
and the timing of tax payments, and

net contributions of $9.3 million in 2019 compared to net distributions of $4.0 million in 2018 from
our TiO2 manufacturing joint venture.

Changes in working capital are affected by accounts receivable and inventory changes. As shown below:
(cid:129) Our average days sales outstanding, or DSO, decreased from December 31, 2019 to December 31,

2020, primarily due to relative changes in the timing of collections, and

(cid:129) Our average days sales in inventory, or DSI, decreased from December 31, 2019 to December 31,
2020, primarily due to lower inventory volumes attributable to sales volumes outpacing production
volumes in the fourth quarter of 2020, which was not the case in the fourth quarter of 2019.

For comparative purposes, we have provided prior year numbers below.

Days sales outstanding
Days sales in inventory

December 31,
2018
76 days
113 days

December 31,
2019
71 days
83 days

December 31,
2020
68 days
74 days

Investing activities

Our capital expenditures were $62.8 million in 2020 compared to $55.1 million in 2019 and $56.3 million
in 2018. Capital expenditures are primarily incurred to maintain and improve the cost effectiveness of our
manufacturing facilities. Our capital expenditures during the past three years include an aggregate of $58.9 million
(including $21.8 million in 2020) for our ongoing environmental protection and compliance programs.

During 2020, we had no loans or collections under our unsecured revolving demand promissory note with
Valhi. In 2019, we loaned $16.6 million and subsequently collected $16.6 million and in 2018, we loaned $2.6
million and collected $16.2 million under such facility.

In addition, we received $1.5 million and $2.6 million in 2020 and 2019, respectively, from an insurance

settlement related to a property damage claim.

Financing activities

During 2020, we:

(cid:129)

paid quarterly dividends of $.18 per share to stockholders aggregating $83.2 million, and

acquired 122,489 shares of our common stock in market transactions for an aggregate purchase price
of $1.0 million.

During 2019, we:

(cid:129)

paid quarterly dividends of $.18 per share to stockholders aggregating $83.4 million, and

acquired 264,992 shares of our common stock in market transactions for an aggregate purchase price
of $3.0 million.

During 2018, we paid quarterly dividends of $.17 per share to stockholders aggregating $78.8 million.

In February 2021, our board of directors declared a first quarter 2021 regular quarterly dividend of $.18 per

share, payable March 18, 2021 to stockholders of record as of March 9, 2021.

Outstanding debt obligations and borrowing availability

At December 31, 2020, our consolidated debt comprised:

(cid:129)

€400 million aggregate outstanding on our Kronos International, Inc. (KII) 3.75% Senior Secured
Notes ($485.7 million carrying amount, net of unamortized debt issuance costs) due in September 2025,
and

approximately $1.7 million of other indebtedness.

Our North American and European revolvers and our Senior Secured Notes contain a number of covenants
and restrictions which, among other things, restrict our ability to incur or guarantee additional debt, incur liens, pay
dividends or make other restricted payments, or merge or consolidate with, or sell or transfer substantially all of our
assets to, another entity, and contain other provisions and restrictive covenants customary in lending transactions of
this type. Certain of our credit agreements contain provisions which could result in the acceleration of indebtedness
prior to their stated maturity for reasons other than defaults for failure to comply with typical financial or payment
covenants. For example, certain credit agreements allow the lender to accelerate the maturity of the indebtedness
upon a change of control (as defined in the agreement) of the borrower. In addition, certain credit agreements could
result in the acceleration of all or a portion of the indebtedness following a sale of assets outside the ordinary course
of business. Our European revolving credit facility also requires the maintenance of certain financial ratios, and one
of such requirements is based on the ratio of net debt to the last twelve months earnings before interest, income tax,
depreciation and amortization expense (EBITDA) of the borrowers. The terms of all of our debt instruments
(including revolving lines of credit for which we have no outstanding borrowings at December 31, 2020) are
discussed in Note 8 to our Consolidated Financial Statements. We are in compliance with all of our debt covenants at

December 31, 2020. We believe that we will be able to continue to comply with the financial covenants contained in
our credit facilities through their maturity.

In addition to the outstanding indebtedness indicated above, at December 31, 2020 we had $107.6 million
available for borrowing under our North American revolving credit facility. At December 31, 2020, based upon the
last twelve months EBITDA and the net debt to EBITDA financial test for our European revolving credit facility, the
full €90 million amount of the credit facility ($110.3 million) was available for borrowing. We could borrow all
available amounts under each of our credit facilities without violating our existing debt covenants.

Our assets consist primarily of investments in operating subsidiaries, and our ability to service our
obligations, including the Senior Secured Notes, depends in part upon the distribution of earnings of our
subsidiaries, whether in the form of dividends, advances or payments on account of intercompany obligations or
otherwise. Our Senior Secured Notes are collateralized by, among other things, a first priority lien on (i) 100% of
the common stock or other ownership interests of each existing and future direct domestic subsidiary of KII and the
guarantors, and (ii) 65% of the voting common stock or other ownership interests and 100% of the non-voting
common stock or other ownership interests of each non-U.S. subsidiary that is directly owned by KII or any
guarantor. Our North American revolving credit facility is collateralized by, among other things, a first priority lien
on the borrower’s trade receivables and inventories. Our European revolving credit facility is collateralized by,
among other things, the accounts receivable and inventories of the borrowers plus a limited pledge of all the other
assets of the Belgian borrower. See Note 8 to our Consolidated Financial Statements.

Future cash requirements

Liquidity

Our primary source of liquidity on an ongoing basis is cash flows from operating activities which is
generally used to (i) fund capital expenditures, (ii) repay any short-term indebtedness incurred for working capital
purposes and (iii) provide for the payment of dividends. From time-to-time we will incur indebtedness, generally to
(i) fund short-term working capital needs, (ii) refinance existing indebtedness or (iii) fund major capital expenditures
or the acquisition of other assets outside the ordinary course of business. We will also from time-to-time sell assets
outside the ordinary course of business and use the proceeds to (i) repay existing indebtedness, (ii) make
investments in marketable and other securities, (iii) fund major capital expenditures or the acquisition of other assets
outside the ordinary course of business or (iv) pay dividends.

The TiO2 industry is cyclical, and changes in industry economic conditions significantly impact earnings
and operating cash flows. Changes in TiO2 pricing, production volumes and customer demand, among other things,
could significantly affect our liquidity.

We routinely evaluate our liquidity requirements, alternative uses of capital, capital needs and availability
of resources in view of, among other things, our dividend policy, our debt service, our capital expenditure
requirements and estimated future operating cash flows. As a result of this process, we have in the past and may in
the future seek to reduce, refinance, repurchase or restructure indebtedness, raise additional capital, repurchase
shares of our common stock, modify our dividend policy, restructure ownership interests, sell interests in our
subsidiaries or other assets, or take a combination of these steps or other steps to manage our liquidity and capital
resources. Such activities have in the past and may in the future involve related companies. In the normal course of
our business, we may investigate, evaluate, discuss and engage in acquisition, joint venture, strategic relationship
and other business combination opportunities in the TiO2 industry. In the event of any future acquisition or joint
venture opportunity, we may consider using then-available liquidity, issuing our equity securities or incurring
additional indebtedness.

Based upon our expectation for the TiO2 industry and anticipated demands on cash resources, we expect to
have sufficient liquidity to meet our short term obligations (defined as the twelve-month period ending
December 31, 2021) and our long-term obligations (defined as the five-year period ending December 31, 2025, our
time period for long-term budgeting). If actual developments differ from our expectations, our liquidity could be
adversely affected.

Cash, cash equivalents, restricted cash and marketable securities

At December 31, 2020 we had:

Cash and cash equivalents
Current restricted cash
Noncurrent restricted cash
Noncurrent marketable securities

Held by

U.S.
entities

199.6
-
-
2.2

Non-U.S.
entities
(In millions)
155.7
$
2.0
4.7
-

Total

355.3
2.0
4.7
2.2

Following implementation of a territorial tax system under the 2017 Tax Act, repatriation of any cash and
cash equivalents held by our non-U.S. subsidiaries would not be expected to result in any material income tax
liability as a result of such repatriation.

Stock repurchase program

At December 31, 2020, we have 1,563,519 shares available for repurchase under a stock repurchase

program authorized by our board of directors. See Note 13 to our Consolidated Financial Statements.

Capital expenditures

We intend to spend approximately $85 million on capital expenditures during 2021, primarily to maintain
and improve our existing facilities, including approximately $23 million in environmental compliance, protection
and improvement programs which are primarily focused on increasing operating efficiency but also result in
improved environmental protection, such as lower emissions from our manufacturing plants. Capital spending for
2021 is expected to be funded through cash on hand or borrowing under existing credit facilities. It is possible we
will delay planned capital projects based on market conditions.

Off-balance sheet financing

Neither we nor any of our subsidiaries or affiliates are parties to any off-balance sheet financing

arrangements.

Commitments and contingencies

See Notes 12 and 15 to our Consolidated Financial Statements for a description of certain income tax

contingencies, certain legal proceedings and other commitments.

As more fully described in the Notes to the Consolidated Financial Statements, we are a party to various
debt, lease and other agreements which contractually and unconditionally commit us to pay certain amounts in the
future. See Notes 7, 8, 14 and 15 to our Consolidated Financial Statements. The timing and amount shown for our
commitments in the table below are based upon the contractual payment amount and the contractual payment date
for such commitments. The following table summarizes such contractual commitments of ours and our consolidated
subsidiaries as of December 31, 2020.

Contractual commitment

Indebtedness:

Principal (1)
Interest payments (2)

Operating leases
Long-term supply contracts for the purchase
of TiO2 feedstock (3)
Long-term service and other supply contracts (4)
Fixed asset acquisitions
Estimated tax obligations (5)

2021

2022/
2023

Payment due date
2024/
2025
(In millions)

2026
and after

Total

.7 $
18.4
7.4

1.0 $
36.8
6.8

490.4 $
31.5
3.1

- $
-
20.1

492.1
86.7
37.4

483.5
33.6
22.9
24.3
590.8 $

690.1
36.7
-
17.1
788.5 $

-
12.5
-
33.5
571.0 $

- 1,173.6
86.1
22.9
74.9
23.4 $ 1,973.7

3.3
-
-

(1)

(2)

(3)

(4)

(5)

At December 31, 2020, a significant portion of the amount shown for indebtedness relates to our 3.75%
Senior Secured Notes due 2025 ($490.4 million at December 31, 2020 exclusive of $4.7 million
unamortized debt issuance costs). Such indebtedness is denominated in the euro. See Item 7A -
“Quantitative and Qualitative Disclosures About Market Risk” and Note 8 to the Consolidated Financial
Statements.

The amounts shown for interest payments relate to outstanding fixed-rate indebtedness. Interest payments
assume that fixed-rate indebtedness remains outstanding until maturity.

Our contracts for the purchase of TiO2 feedstock contain fixed quantities of ore that we are required to
purchase or specify a range of quantities within which we are required to purchase based on our feedstock
requirements. The pricing under these agreements is generally negotiated quarterly or semi-annually. The
timing and amount shown for our commitments related to the supply contracts for TiO2 feedstock are based
upon our current estimate of the quantity of material that will be purchased in each time period shown, the
payment that would be due based upon such estimated purchased quantity and an estimate of the prices for
the various suppliers which is primarily based on first half 2021 pricing. The actual amount of material
purchased and the actual amount that would be payable by us, may vary from such estimated amounts. Our
obligation for the purchase of TiO2 feedstock is more fully described in Note 15 to our Consolidated
Financial Statements and above in “Business – Raw materials.” The amounts shown in the table above
include the feedstock requirements from contracts we entered into through January 2021.

The amounts shown for the long-term service and other supply contracts primarily pertain to agreements
we have entered into with various providers of products or services which help to run our plant facilities
(electricity, natural gas, etc.), utilizing December 31, 2020 exchange rates. See Note 15 to our
Consolidated Financial Statements.

The amount shown for estimated tax obligations in 2021 is the consolidated amount of income taxes
payable at December 31, 2020, including an amount related to the Transition Tax which is assumed to be
paid during 2021. The amounts shown for estimated tax obligations in 2022 and thereafter relate to the
Transition Tax which will be paid in the years indicated above. See Note 12 to our Consolidated Financial
Statements.

The above table does not reflect:
(cid:129) Any amounts we might pay to fund our defined benefit pension plans, as the timing and amount of any
such future fundings are unknown and dependent on, among other things, the future performance of
defined benefit pension plan assets, interest rate assumptions and actual future retiree medical costs.
We expect to be required to contribute an aggregate of approximately $17 million to our defined
benefit pension plans during 2021. Such defined benefit pension plans are discussed above in greater
detail and in Note 10 to our Consolidated Financial Statements.

(cid:129) Any amounts we might pay to settle any of our uncertain tax positions classified as a noncurrent
liability, as the timing and amount of any such future settlements are unknown and dependent on,
among other things, the timing of tax audits. See Note 12 to our Consolidated Financial Statements.
(cid:129) Any amounts we might pay to acquire TiO2 from our TiO2 manufacturing joint venture, as the timing
and amount of such purchases are unknown and dependent on, among other things, the amount of TiO2
produced by the joint venture in the future and the joint venture’s future cost of producing such TiO2.
However, the table does include amounts related to our share of the joint venture’s ore requirements
necessary to produce TiO2 for us. See Item 1, “Business” and Note 5 to our Consolidated Financial
Statements.

We occasionally enter into raw material supply arrangements to mitigate the short-term impact of future
increases in raw material costs. While these arrangements do not necessarily commit us to a minimum volume of
purchase, they generally provide for stated unit prices based upon achievement of specified volume purchase levels.
This allows us to stabilize raw material purchase prices to a certain extent, provided the specified minimum monthly
purchase quantities are met.

Recent accounting pronouncements

See Note 17 to our Consolidated Financial Statements.

ITEM 7A.

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

General

We are exposed to market risk from changes in interest rates, currency exchange rates, equity security and

raw materials prices.

Interest rates

At December 31, 2019 and 2020, our fixed-rate, euro-denominated Senior Secured Notes comprised the
majority of our aggregate indebtedness. The fixed-rate debt instrument minimizes earnings volatility that would
result from changes in interest rates. The following table presents principal amounts and weighted average interest
rates for our aggregate outstanding indebtedness at December 31, 2019 and 2020. Information shown below for our
euro-denominated Senior Secured Notes is presented in its U.S. dollar equivalent at December 31, 2019 and 2020
(net of unamortized debt issuance costs of $5.3 million and $4.7 million, respectively) using an exchange rate of
U.S. $1.120 per euro and $1.226 per euro, respectively. See Note 8 to our Consolidated Financial Statements.

December 31, 2020
Fixed-rate Senior Secured Notes
December 31, 2019
Fixed-rate Senior Secured Notes

Indebtedness amount
Carrying
amount

Fair
value

Year-end
interest
rate

Maturity
date

(In millions)

485.7 $

499.9

3.75 %

2025

442.6 $

457.0

3.75%

2025

Currency exchange rates

We are exposed to market risk arising from changes in currency exchange rates as a result of manufacturing
and selling our products worldwide. Earnings are primarily affected by fluctuations in the value of the U.S. dollar
relative to the euro, the Canadian dollar, the Norwegian krone and to a lesser extent the United Kingdom pound
sterling and the value of the euro relative to the Norwegian krone.

The majority of our sales from non-U.S. operations are denominated in currencies other than the U.S.
dollar, principally the euro, other major European currencies and the Canadian dollar. A portion of our sales
generated from our non-U.S. operations is denominated in the U.S. dollar (and consequently our non-U.S. operations
will generally hold U.S. dollars from time to time). Certain raw materials used in all our production facilities,
primarily titanium-containing feedstocks, are purchased primarily in U.S. dollars, while labor and other production
and administrative costs are incurred primarily in local currencies. Consequently, the translated U.S. dollar value of
our non-U.S. sales and operating results are subject to currency exchange rate fluctuations which may favorably or
unfavorably impact reported earnings. In addition to the impact of the translation of sales and expenses over time,
our non-U.S. operations also generate currency transaction gains and losses which primarily relate to (i) the
difference between the currency exchange rates in effect when non-local currency sales or operating costs (primarily
U.S. dollar denominated) are initially accrued and when such amounts are settled with the non-local currency and
(ii) changes in currency exchange rates during time periods when our non-U.S. operations are holding non-local
currency (primarily U.S. dollars).

Also, we are subject to currency exchange rate risk associated with our Senior Secured Notes, as such
indebtedness is denominated in the euro. At December 31, 2019 and 2020, we had the equivalent of $447.9 million
and $490.4 million, respectively, outstanding under our euro-denominated Senior Secured Notes (exclusive of
unamortized debt issuance costs.) The potential increase in the U.S. dollar equivalent of such indebtedness resulting
from a hypothetical 10% adverse change in exchange rates at such dates would be approximately $45 million and
$49 million, respectively.

Raw materials

We are exposed to market risk from changes in commodity prices relating to our raw materials. As
discussed in Item 1 we generally enter into long-term supply agreements for certain of our raw material
requirements. Many of our raw material contracts contain fixed quantities we are required to purchase or specify a
range of quantities within which we are required to purchase. Raw material pricing under these agreements is
generally negotiated quarterly or semi-annually depending upon the suppliers. For certain raw material
requirements we do not have long-term supply agreements either because we have assessed the risk of the
unavailability of those raw materials and/or the risk of a significant change in the cost of those raw materials to be
low, or because long-term supply agreements for those raw materials are generally not available.

Other

We believe there may be a certain amount of incompleteness in the sensitivity analyses presented above.
For example, the hypothetical effect of changes in exchange rates discussed above ignores the potential effect on
other variables which affect our results of operations and cash flows, such as demand for our products, sales
volumes and selling prices and operating expenses. Accordingly, the amounts presented above are not necessarily
an accurate reflection of the potential losses we would incur assuming the hypothetical changes in exchange rates
were actually to occur.

The above discussion and estimated sensitivity analysis amounts include forward-looking statements of
market risk which assume hypothetical changes in currency exchange rates. Actual future market conditions will
likely differ materially from such assumptions. Accordingly, such forward-looking statements should not be
considered to be projections by us of future events, gains or losses.

ITEM 8.

FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

The information called for by this Item is contained in a separate section of this Annual Report. See “Index

of Financial Statements” (page F-1).

ITEM 9.

CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND
FINANCIAL DISCLOSURE

None

ITEM 9A.

CONTROLS AND PROCEDURES

Evaluation of disclosure controls and procedures

We maintain disclosure controls and procedures which, as defined in Exchange Act Rule 13a-15(e), means
controls and other procedures that are designed to ensure that information required to be disclosed in the reports that
we file or submit to the SEC under the Securities Exchange Act of 1934, as amended (the Act), is recorded,
processed, summarized and reported, within the time periods specified in the SEC’s rules and forms. Disclosure
controls and procedures include, without limitation, controls and procedures designed to ensure that information we
are required to disclose in the reports we file or submit to the SEC under the Act is accumulated and communicated
to our management, including our principal executive officer and our principal financial officer, or persons
performing similar functions, as appropriate to allow timely decisions to be made regarding required disclosure.
Each of Robert D. Graham, our Vice Chairman of the Board, President and Chief Executive Officer and James W.
Brown, our Executive Vice President and Chief Financial Officer, have evaluated the design and effectiveness of
our disclosure controls and procedures as of December 31, 2020. Based upon their evaluation, these executive
officers have concluded that our disclosure controls and procedures are effective as of the date of such evaluation.

Management’s report on internal control over financial reporting

Our management is responsible for establishing and maintaining adequate internal control over financial
reporting which, as defined by Exchange Act Rule 13a-15(f) means a process designed by, or under the supervision
of, our principal executive and principal financial officers, or persons performing similar functions, and effected by
the board of directors, management and other personnel, to provide reasonable assurance regarding the reliability of
financial reporting and the preparation of financial statements for external purposes in accordance with generally
accepted accounting principles, and includes those policies and procedures that:

(cid:129)

Pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the
transactions and dispositions of our assets,

Provide reasonable assurance that transactions are recorded as necessary to permit preparation of
financial statements in accordance with GAAP, and that receipts and expenditures are being made only
in accordance with authorizations of management and directors and

Provide reasonable assurance regarding prevention or timely detection of an unauthorized acquisition,
use or disposition of assets that could have a material effect on our Consolidated Financial Statements.

Our evaluation of the effectiveness of internal control over financial reporting is based upon the criteria
established in Internal Control – Integrated Framework issued by the Committee of Sponsoring Organizations of
the Treadway Commission in 2013 (commonly referred to as the “2013 COSO” framework). Based on our
evaluation under that framework, we have concluded that our internal control over financial reporting was effective
as of December 31, 2020.

PricewaterhouseCoopers LLP, the independent registered public accounting firm that has audited our
consolidated financial statements included in this Annual Report, has audited the effectiveness of our internal
control over financial reporting as of December 31, 2020, as stated in their report, which is included in this Annual
Report on Form 10-K.

Other

As permitted by the SEC, our assessment of internal control over financial reporting excludes (i) internal
control over financial reporting of equity method investees and (ii) internal control over the preparation of any
financial statement schedules which would be required by Article 12 of Regulation S-X. However, our assessment
of internal control over financial reporting with respect to equity method investees did include controls over the
recording of amounts related to our investment that are recorded in the consolidated financial statements, including

controls over the selection of accounting methods for our investments, the recognition of equity method earnings
and losses and the determination, valuation and recording of our investment account balances.

Changes in internal control over financial reporting

There has been no change to our internal control over financial reporting during the quarter ended
December 31, 2020 that has materially affected, or is reasonably likely to materially affect, our internal control over
financial reporting.

Certifications

Our chief executive officer is required to annually file a certification with the New York Stock Exchange,
or NYSE, certifying our compliance with the corporate governance listing standards of the NYSE. During 2020, our
chief executive officer filed such annual certification with the NYSE. The 2020 certification was unqualified.

Our chief executive officer and chief financial officer are also required to, among other things, file
quarterly certifications with the SEC regarding the quality of our public disclosures, as required by Section 302 of
the Sarbanes-Oxley Act of 2002. The certifications for the quarter ended December 31, 2020 have been filed as
Exhibits 31.1 and 31.2 to this Annual Report on Form 10-K.

ITEM 9B.

OTHER INFORMATION

Not applicable

PART III

ITEM 10.

DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

The information required by this Item is incorporated by reference to our 2021 definitive proxy statement
to be filed with the SEC pursuant to Regulation 14A within 120 days after the end of the fiscal year covered by this
report.

ITEM 11.

EXECUTIVE COMPENSATION

The information required by this Item is incorporated by reference to our 2021 proxy statement.

ITEM 12.

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
AND RELATED STOCKHOLDER MATTERS

The information required by this Item is incorporated by reference to our 2021 proxy statement.

ITEM 13.

CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR
INDEPENDENCE

The information required by this Item is incorporated by reference to our 2021 proxy statement. See also

Note 14 to our Consolidated Financial Statements.

ITEM 14.

PRINCIPAL ACCOUNTING FEES AND SERVICES

The information required by this Item is incorporated by reference to our 2021 proxy statement.

PART IV

ITEM 15.

EXHIBITS AND FINANCIAL STATEMENT SCHEDULES

(a) and (c) Financial Statements

The Registrant

The consolidated financial statements of the Registrant listed on the accompanying Index of Financial
Statements (see page F-1) are filed as part of this Annual Report.

50%-or-less owned persons

We are not required to provide any consolidated financial statements pursuant to Rule 3-09 of
Regulation S-X.

(b)

Exhibits

Included as exhibits are the items listed in the Exhibit Index. We will furnish a copy of any of the
exhibits listed below upon payment of $4.00 per exhibit to cover our costs to furnish the exhibits.
Pursuant to Item 601(b)(4)(iii) of Regulation S-K, any instrument defining the rights of holders of long-
term debt issues and other agreements related to indebtedness which do not exceed 10% of consolidated
total assets as of December 31, 2020 will be furnished to the Commission upon request.

Item No.

3.1+

3.2

4.1

10.1

10.2

10.3*

10.4

10.5

Exhibit Index

Restated First Amended and Restated Certificate of Incorporation of Kronos Worldwide, Inc., as
amended on May 12, 2011 – incorporated by reference to Exhibit 3.1 of the Registrant’s Current Report
on Form 8-K (File No. 001-31763) filed on May 12, 2011.

Amended and Restated Bylaws of Kronos Worldwide, Inc. as of February 24, 2021 – incorporated by
reference to Exhibit 3.1 of the Registrant’s Current Report on Form 8-K (File No. 001-31763) filed
with the U.S. Securities and Exchange Commission on February 24, 2021.

Description of the Registrant’s Capital Stock – incorporated by reference to Exhibit 4.1 to the
Registrant’s Annual Report on Form 10-K (File No. 001-31763) for the year ended December 31, 2019.

Tax Agreement between Valhi, Inc. and Kronos Worldwide, Inc. dated as of January 1, 2020 –
incorporated by reference to Exhibit 10.1 to the Registrant’s Annual Report on Form 10-K (File No.
001-31763) for the year ended December 31, 2019.

Intercorporate Services Agreement by and between Contran Corporation and Kronos Worldwide, Inc.,
effective as of January 1, 2004 – incorporated by reference to Exhibit 10.1 to the Quarterly Report on
Form 10-Q of the Registrant (File No. 001-31763) for the quarter ended March 31, 2004.

Kronos Worldwide, Inc. 2012 Director Stock Plan – incorporated by reference to Exhibit 4.4 of the
Registration statement on Form S-8 of the Registrant (File No. 333-113425).

Lease Contract, dated June 21, 1952, between Farbenfabriken Bayer Aktiengesellschaft and
Titangesellschaft mit beschrankter Haftung (German language version and English translation thereof)-
incorporated by reference to Exhibit 10.14 to the Annual Report on Form 10-K (File No. 001-00640) of
NL Industries, Inc. for the year ended December 31, 1985. (P)

Master Technology Exchange Agreement, dated as of October 18, 1993, among Kronos Worldwide,
Inc. (f/k/a Kronos, Inc.), Kronos Louisiana, Inc., Kronos International, Inc., Tioxide Group Limited and
Tioxide Group Services Limited – incorporated by reference to Exhibit 10.8 to the Quarterly Report on
Form 10-Q (File No. 001-00640) of NL Industries, Inc. for the quarter ended September 30, 1993. (P)

Item No.

10.6

10.7

10.8

10.9

10.10

10.11

10.12

10.13

10.14

10.15

10.16

10.17**

10.18

Exhibit Index

Form of Assignment and Assumption Agreement, dated as of January 1, 1999, between Kronos Inc.
(formerly known as Kronos (USA), Inc.) and Kronos International, Inc. – incorporated by reference to
Exhibit 10.9 to Kronos International, Inc.’s Registration Statement on Form S-4 (File No. 333-100047).
(P)

Form of Cross License Agreement, effective as of January 1, 1999, between Kronos Inc. (formerly
known as Kronos (USA), Inc.) and Kronos International, Inc. – incorporated by reference to Exhibit to
Kronos International, Inc.’s Registration Statement on Form S-4 (File No. 333-100047). (P)

Formation Agreement dated as of October 18, 1993 among Tioxide Americas Inc., Kronos Louisiana,
Inc. and Louisiana Pigment Company, L.P. – incorporated by reference to Exhibit 10.2 to NL
Industries, Inc.’s Quarterly Report on Form 10-Q (File No. 001-00640) for the quarter ended
September 30, 1993. (P)

Joint Venture Agreement dated as of October 18, 1993 between Tioxide Americas Inc. and Kronos
Louisiana, Inc. – incorporated by reference to Exhibit 10.3 to NL Industries, Inc.’s Quarterly Report on
Form 10-Q (File No. 001-00640) for the quarter ended September 30, 1993. (P)

Kronos Offtake Agreement dated as of October 18, 1993 between Kronos Louisiana, Inc. and Louisiana
Pigment Company, L.P. – incorporated by reference to Exhibit 10.4 to NL Industries, Inc.’s Quarterly
Report on Form 10-Q (File No. 001-00640) for the quarter ended September 30, 1993. (P)

Amendment No. 1 to Kronos Offtake Agreement dated as of December 20, 1995 between Kronos
Louisiana, Inc. and Louisiana Pigment Company, L.P. – incorporated by reference to Exhibit 10.22 to
NL Industries, Inc.’s Annual Report on Form 10-K (File No. 001-00640) for the year ended
December 31, 1995. (P)

Tioxide Americas Offtake Agreement dated as of October 18, 1993 between Tioxide Americas Inc. and
Louisiana Pigment Company, L.P. – incorporated by reference to Exhibit 10.5 to NL Industries, Inc.’s
Quarterly Report on Form 10-Q (File No. 001-00640) for the quarter ended September 30, 1993. (P)

Amendment No. 1 to Tioxide Americas Offtake Agreement dated as of December 20, 1995 between
Tioxide Americas Inc. and Louisiana Pigment Company, L.P. – incorporated by reference to Exhibit
10.24 to NL Industries, Inc.’s Annual Report on Form 10-K (File No. 001-00640) for the year ended
December 31, 1995. (P)

Parents’ Undertaking dated as of October 18, 1993 between ICI American Holdings Inc. and Kronos
Worldwide, Inc. (f/k/a Kronos, Inc.) – incorporated by reference to Exhibit 10.9 to NL Industries, Inc.’s
Quarterly Report on Form 10-Q (File No. 001-00640) for the quarter ended September 30, 1993. (P)

Allocation Agreement dated as of October 18, 1993 between Tioxide Americas Inc., ICI American
Holdings, Inc., Kronos Worldwide, Inc. (f/k/a Kronos, Inc.) and Kronos Louisiana, Inc. – incorporated
by reference to Exhibit 10.10 to NL Industries, Inc.’s Quarterly Report on Form 10-Q (File No. 001-
00640) for the quarter ended September 30, 1993. (P)

Second Amended and Restated Agreement Regarding Shared Insurance among CompX International
Inc., Contran Corporation, Kronos Worldwide, Inc., NL Industries, Inc., and Valhi, Inc. dated January
25, 2019 – incorporated by reference to Exhibit 10.16 to the Registrant’s Annual Report on Form 10-K
(File No. 001-31763) for the year ended December 31, 2018.

Unsecured Revolving Demand Promissory Note dated December 31, 2020 in the principal amount of
$40.0 million executed by Valhi, Inc. and payable to the order of Kronos Worldwide, Inc.

Restated and Amended Agreement by and between Richards Bay Titanium (Proprietary) Limited
(acting through its sales agent Rio Tinto Iron & Titanium Limited) and Kronos (US), Inc. effective
January 1, 2016 – incorporated by reference to Exhibit 10.26 to the Registrant’s Annual Report on
Form 10-K (File No. 001-31763) for the year ended December 31, 2015.

Item No.

10.19

10.20

Exhibit Index

Indenture, dated as of September 13, 2017, among Kronos International, Inc., the guarantors named
therein, and Deutsche Bank Trust Company Americas, as trustee, collateral agent, paying agent,
transfer agent and registrar – incorporated by reference to Exhibit 4.1 to the Current Report on Form 8-
K (File No. 001-31763) dated September 13, 2017 and filed by the registrant on September 13, 2017.

Pledge Agreement, dated as of September 13, 2017, among Kronos International, Inc., the guarantors
named therein and Deutsche Bank Trust Company Americas, as collateral agent – incorporated by
reference to Exhibit 4.2 to the Current Report on Form 8-K (File No. 001-31763) dated September 13,
2017 and filed by the registrant on September 13, 2017.

21.1**

Subsidiaries.

23.1**

Consent of PricewaterhouseCoopers LLP.

31.1**

Certification.

31.2**

Certification.

32.1**

Certification.

101.INS** Inline XBRL Instance - the instance document does not appear in the Interactive Data File because its

XBRL tags are embedded within the Inline XBRL document.

101.SCH** Inline XBRL Taxonomy Extension Schema

101.CAL** Inline XBRL Taxonomy Extension Calculation Linkbase

101.DEF** Inline XBRL Taxonomy Extension Definition Linkbase

101.LAB** Inline XBRL Taxonomy Extension Label Linkbase

101.PRE** Inline XBRL Taxonomy Extension Presentation Linkbase

104

(P)

Cover page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

Exhibit 3.1 is restated for the purposes of the disclosure requirements of Item 601 of Regulation S-K
promulgated by the U.S. Securities and Exchange Commission and does not represent a restated certificate of
incorporation that has been filed with the Delaware Secretary of State.

Management contract, compensatory plan or arrangement

Filed herewith

Paper exhibits

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant

has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

SIGNATURES

Kronos Worldwide, Inc.
(Registrant)

By:

/s/ Robert D. Graham
Robert D. Graham, March 10, 2021
(Vice Chairman, President and Chief Executive Officer)

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by

the following persons on behalf of the Registrant and in the capacities and on the dates indicated:

/s/ Loretta J. Feehan
Loretta J. Feehan, March 10, 2021
(Chair of the Board (non-executive))

/s/ John E. Harper
John E. Harper, March 10, 2021
(Director)

/s/ Robert D. Graham
Robert D. Graham, March 10, 2021
(Vice Chairman, President and Chief Executive Officer)

/s/ Meredith W. Mendes
Meredith W. Mendes, March 10, 2021
(Director)

/s/ James W. Brown
James W. Brown, March 10, 2021
(Executive Vice President and Chief Financial Officer,
Principal Financial Officer)

/s/ Cecil H. Moore, Jr.
Cecil H. Moore, Jr., March 10, 2021
(Director)

/s/ Tim C. Hafer
Tim C. Hafer, March 10, 2021
(Senior Vice President and Controller,
Principal Accounting Officer)

/s/ Thomas P. Stafford
Thomas P. Stafford, March 10, 2021
(Director)

/s/ R. Gerald Turner
R. Gerald Turner, March 10, 2021
(Director)

KRONOS WORLDWIDE, INC.

Annual Report on Form 10-K

Items 8, 15(a) and 15(c)

Index of Financial Statements

Financial Statements

Report of Independent Registered Public Accounting Firm

Consolidated Balance Sheets – December 31, 2019 and 2020

Consolidated Statements of Income –

Years ended December 31, 2018, 2019 and 2020

Consolidated Statements of Comprehensive Income –
Years ended December 31, 2018, 2019 and 2020

Consolidated Statements of Stockholders’ Equity –
Years ended December 31, 2018, 2019 and 2020

Consolidated Statements of Cash Flows –

Years ended December 31, 2018, 2019 and 2020

Notes to Consolidated Financial Statements

Page

F-2

F-5

F-7

F-8

F-9

F-10

F-12

All financial statement schedules have been omitted either because they are not applicable or required, or the
information that would be required to be included is disclosed in the Notes to the Consolidated Financial Statements.

F-1

Report of Independent Registered Public Accounting Firm

To the Board of Directors and Stockholders of Kronos Worldwide, Inc.

Opinions on the Financial Statements and Internal Control over Financial
Reporting

We have audited the accompanying consolidated balance sheets of Kronos Worldwide, Inc. and
its subsidiaries (the “Company”) as of December 31, 2020 and 2019, and the related consolidated
statements of income, of comprehensive income, of stockholders’ equity and of cash flows for
each of the three years in the period ended December 31, 2020, including the related notes
(collectively referred to as the “consolidated financial statements”). We also have audited the
Company's internal control over financial reporting as of December 31, 2020, based on criteria
established in Internal Control - Integrated Framework (2013) issued by the Committee of
Sponsoring Organizations of the Treadway Commission (COSO).

In our opinion, the consolidated financial statements referred to above present fairly, in all
material respects, the financial position of the Company as of December 31, 2020 and 2019, and
the results of its operations and its cash flows for each of the three years in the period ended
December 31, 2020 in conformity with accounting principles generally accepted in the United
States of America. Also in our opinion, the Company maintained, in all material respects, effective
internal control over financial reporting as of December 31, 2020, based on criteria established in
Internal Control - Integrated Framework (2013) issued by the COSO.

Basis for Opinions

The Company's management is responsible for these consolidated financial statements, for
maintaining effective internal control over financial reporting, and for its assessment of the
effectiveness of internal control over financial reporting, included in Management’s report on
internal control over financial reporting appearing under Item 9A. Our responsibility is to express
opinions on the Company’s consolidated financial statements and on the Company's internal
control over financial reporting based on our audits. We are a public accounting firm registered
with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required
to be independent with respect to the Company in accordance with the U.S. federal securities laws
and the applicable rules and regulations of the Securities and Exchange Commission and the
PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards
require that we plan and perform the audits to obtain reasonable assurance about whether the
consolidated financial statements are free of material misstatement, whether due to error or
fraud, and whether effective internal control over financial reporting was maintained in all
material respects.

Our audits of the consolidated financial statements included performing procedures to assess the
risks of material misstatement of the consolidated financial statements, whether due to error or
fraud, and performing procedures that respond to those risks. Such procedures included
examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated
financial statements. Our audits also included evaluating the accounting principles used and
significant estimates made by management, as well as evaluating the overall presentation of the
consolidated financial statements. Our audit of internal control over financial reporting included
obtaining an understanding of internal control over financial reporting, assessing the risk that a
material weakness exists, and testing and evaluating the design and operating effectiveness of
internal control based on the assessed risk. Our audits also included performing such other
procedures as we considered necessary in the circumstances. We believe that our audits provide a
reasonable basis for our opinions.

F-2

Definition and Limitations of Internal Control over Financial Reporting

A company’s internal control over financial reporting is a process designed to provide reasonable
assurance regarding the reliability of financial reporting and the preparation of financial
statements for external purposes in accordance with generally accepted accounting principles. A
company’s internal control over financial reporting includes those policies and procedures that
(i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect
the transactions and dispositions of the assets of the company; (ii) provide reasonable assurance
that transactions are recorded as necessary to permit preparation of financial statements in
accordance with generally accepted accounting principles, and that receipts and expenditures of
the company are being made only in accordance with authorizations of management and
directors of the company; and (iii) provide reasonable assurance regarding prevention or timely
detection of unauthorized acquisition, use, or disposition of the company’s assets that could have
a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or
detect misstatements. Also, projections of any evaluation of effectiveness to future periods are
subject to the risk that controls may become inadequate because of changes in conditions, or that
the degree of compliance with the policies or procedures may deteriorate.

Critical Audit Matters

The critical audit matter communicated below is a matter arising from the current period audit of
the consolidated financial statements that was communicated or required to be communicated to
the audit committee and that (i) relates to accounts or disclosures that are material to the
consolidated financial statements and (ii) involved our especially challenging, subjective, or
complex judgments. The communication of critical audit matters does not alter in any way our
opinion on the consolidated financial statements, taken as a whole, and we are not, by
communicating the critical audit matter below, providing a separate opinion on the critical audit
matter or on the accounts or disclosures to which it relates.

Income Taxes

As described in Note 12 to the consolidated financial statements, the Company recorded a
provision for income taxes of $16.1 million and recorded noncurrent deferred tax asset and
deferred tax liability amounts of $151.0 million and $24.6 million, respectively, for the year ended
December 31, 2020. As disclosed by management, the Company operates globally and the
calculation of the Company's provision for income taxes and its deferred tax assets and liabilities
involves the interpretation and application of complex tax laws and regulations in a multitude of
jurisdictions across the Company's global operations. The Company’s effective tax rate is highly
dependent upon the geographic distribution of its earnings or losses and the effects of tax laws
and regulations in each tax-paying jurisdiction in which the Company operates. Significant
judgments and estimates are required by management in determining the consolidated provision
for income taxes due to the global nature of the Company’s operations. The Company's provision
for income taxes and deferred tax assets and liabilities reflect management's best assessment of
estimated current and future taxes to be paid, including the recognition and measurement of
deferred tax assets and liabilities.

The principal considerations for our determination that performing procedures relating to income
taxes is a critical audit matter are the significant judgment by management when developing the
estimate of current and future taxes to be paid, including the recognition and measurement of
deferred tax assets and liabilities. This in turn led to a high degree of auditor judgment,

F-3

subjectivity, and effort in performing procedures and evaluating evidence related to the
recognition and measurement of deferred tax assets and liabilities and management's assessment
of the estimated current and future taxes to be paid, including evaluating management’s
interpretation of tax laws and regulations.

Addressing the matter involved performing procedures and evaluating audit evidence in
connection with forming our overall opinion on the consolidated financial statements. These
procedures included testing the effectiveness of controls relating to accounting for income taxes,
including controls over the identification, completeness, and recognition of permanent and
temporary differences within jurisdictions, the recognition and measurement of deferred tax
assets and liabilities, the application of tax laws and regulations in the various jurisdictions in
which the Company operates, the rate reconciliation and the provision to tax return
reconciliation. These procedures also included, among others, (i) evaluating the provision for
income taxes, including the accuracy of the underlying information used in the calculation by
jurisdiction, as well as the reasonableness of management's judgments and estimates in the
application of tax laws and regulations; (ii) testing the current and deferred income tax provision,
including evaluating permanent and temporary differences within certain jurisdictions and
management's assessment of the technical merits of the differences; (iii) performing procedures
over the Company's rate reconciliation; and (iv) testing the reconciliation of the provision to the
tax returns.

Dallas, Texas
March 10, 2021

We have served as the Company’s auditor since 1997.

F-4

KRONOS WORLDWIDE, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(In millions, except per share data)

ASSETS

Current assets:

Cash and cash equivalents
Restricted cash
Accounts and other receivables, net
Receivables from affiliates
Inventories, net
Prepaid expenses and other

Total current assets

Other assets:

Investment in TiO2 manufacturing joint venture
Restricted cash
Marketable securities
Operating lease right-of-use assets
Deferred income taxes
Other

Total other assets

Property and equipment:

Land
Buildings
Equipment
Mining properties
Construction in progress

Less accumulated depreciation and amortization

Net property and equipment

December 31,

2019

2020

390.8 $
1.5
302.5
6.9
503.0
15.0

355.3
2.0
319.5
3.5
519.0
19.0

1,219.7

1,218.3

90.2
-
3.3
29.0
127.7
5.3

255.5

40.4
211.4
1,113.1
116.2
54.9
1,536.0
1,045.4

490.6

103.3
4.7
2.2
26.1
151.0
6.5

293.8

44.1
233.9
1,173.7
127.8
56.1
1,635.6
1,111.0

524.6

Total assets

1,965.8 $

2,036.7

F-5

KRONOS WORLDWIDE, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS (CONTINUED)

(In millions, except per share data)

LIABILITIES AND STOCKHOLDERS' EQUITY

Current liabilities:

Current maturities of long-term debt
Accounts payable and accrued liabilities
Payables to affiliates
Income taxes

Total current liabilities

Noncurrent liabilities:
Long-term debt
Accrued pension costs
Payable to affiliate - income taxes
Operating lease liabilities
Deferred income taxes
Other

Total noncurrent liabilities

Stockholders' equity:

December 31,

2019

2020

1.5 $

237.7
21.3
10.1

270.6

444.0
307.4
56.6
22.2
20.7
28.2

879.1

.7
215.9
27.9
15.7

260.2

486.7
372.6
50.6
18.8
24.6
26.7

980.0

Common stock, $.01 par value; 240.0 shares authorized;
115.7 and 115.5 shares issued and outstanding
Additional paid-in capital
Retained deficit
Accumulated other comprehensive loss

1.2
1,396.2
(132.5)
(448.8)

1.2
1,395.3
(151.8)
(448.2)

Total stockholders' equity

816.1

796.5

Total liabilities and stockholders' equity

1,965.8 $

2,036.7

Commitments and contingencies (Notes 12 and 15)

See accompanying Notes to Consolidated Financial Statements.

F-6

KRONOS WORLDWIDE, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF INCOME

(In millions, except per share data)

Years ended December 31,
2019

2020

2018

Net sales
Cost of sales

Gross margin

Selling, general and administrative expense
Other operating income (expense):
Currency transactions, net
Disposition of property and equipment
Other income, net
Corporate expense

1,661.9 $
1,099.7

1,731.1 $
1,344.9

1,638.8
1,287.6

562.2

386.2

351.2

228.3

228.2

218.6

10.1
(.2)
.8
(14.5)

2.0
(.2)
1.1
(15.1)

(4.0)
(.2)
1.6
(13.8)

Income from operations

330.1

145.8

116.2

Other income (expense):

Interest and dividend income
Insurance settlement gain
Marketable equity securities
Other components of net periodic pension and OPEB cost
Interest expense

Income before income taxes

Income tax expense

Net income

Net income per basic and diluted share

5.5
-
(7.3)
(15.0)
(19.5)

6.7
2.6
(.1)
(15.2)
(18.7)

293.8

121.1

88.8

34.0

205.0 $

87.1 $

1.8
1.5
(1.1)
(19.4)
(19.0)

80.0

16.1

63.9

1.77 $

.75 $

.55

Weighted average shares used in the calculation of net
income per share

115.9

115.8

115.6

See accompanying Notes to Consolidated Financial Statements.

F-7

KRONOS WORLDWIDE, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(In millions)

Net income

Other comprehensive income (loss), net of tax:

Currency translation
Defined benefit pension plans
Other postretirement benefit plans

Total other comprehensive income (loss), net

Years ended December 31,
2019

2020

2018

205.0 $

87.1 $

63.9

(33.1)
(7.2)
(.5)

(40.8)

(1.8)
(22.2)
(.5)

(24.5)

13.4
(12.3)
(.5)

Comprehensive income

164.2 $

62.6 $

64.5

See accompanying Notes to Consolidated Financial Statements.

F-8

l
a
t
o
T

k
c
o
t
s

s
s
o
l

y
r
u
s
a
e
r
T

e
v
i
s
n
e
h
e
r
p
m
o
c

d
e
n

i
a
t
e
R

t
i
c
i
f
e
d

d
e
t
a
l
u
m
u
c
c
A

r
e
h
t
o

)
s
n
o
i
l
l
i

m
n
I
(

l
a
n
o
i
t
i
d
d
A

i
-
d

i
a
p

l
a
t
i
p
a
c

n
o
m
m
o
C

k
c
o
t
s

S
E
I
R
A
I
D
I
S
B
U
S
D
N
A

C
N
I

E
D
I
W
D
L
R
O
W
S
O
N
O
R
K

Y
T
I
U
Q
E

’
S
R
E
D
L
O
H
K
C
O
T
S
F
O
S
T
N
E
M
E
T
A
T
S
D
E
T
A
D
I
L
O
S
N
O
C

0
2
0
2
d
n
a

9
1
0
2

,
8
1
0
2

,
1
3
r
e
b
m
e
c
e
D
d
e
d
n
e

s
r
a
e
Y

3
.
4
5
7

)
8
.
0
4
(

0
.
5
0
2

1
.

)
8
.
8
7
(

8
.
9
3
8

1
.

1
.
7
8

)
5
.
4
2
(

)
0
.
3
(

)
4
.
3
8
(

1
.
6
1
8

6
.

1
.

9
.
3
6

)
0
.
1
(

)
2
.
3
8
(

)
0
.
3
(

0
.
3

)
0
.
1
(

0
.
1

)
8
.
4
(

)
5
.
3
8
3
(

)
8
.
0
4
(

8
.
4

)
4
.
2
6
2
(

0
.
5
0
2

)
8
.
8
7
(

1
.

0
.
9
9
3
,
1

)
7
.
8
7
3
(

)
2
.
7
6
2
(

0
.
9
9
3
,
1

2
.
1

1
0
-
6
1
0
2
U
S
A

e
l
p
i
c
n
i
r
p

g
n
i
t
n
u
o
c
c
a

n
i

e
g
n
a
h
C

d
e
t
s
u
j
d
a

s
a

,
8
1
0
2

,
1

y
r
a
u
n
a
J

t
a

e
c
n
a
l
a
B

7
1
0
2

,
1
3
r
e
b
m
e
c
e
D

t
a

e
c
n
a
l
a
B

x
a
t

f
o

t
e
n

,
s
s
o
l

e
v
i
s
n
e
h
e
r
p
m
o
c

r
e
h
t
O

e
r
a
h
s

r
e
p

8
6
.
$

d
i
a
p

s
d
n
e
d
i
v
i
D

k
c
o
t
s

n
o
m
m
o
c

f
o

e
c
n
a
u
s
s
I

e
m
o
c
n
i

t
e
N

)
3
.
4
2
4
(

)
2
.
6
3
1
(

1
.
9
9
3
,
1

2
.
1

8
1
0
2

,
1
3
r
e
b
m
e
c
e
D

t
a

e
c
n
a
l
a
B

)
5
.
4
2
(

1
.
7
8

)
4
.
3
8
(

1
.

)
0
.
3
(

x
a
t

f
o

t
e
n

,
s
s
o
l

e
v
i
s
n
e
h
e
r
p
m
o
c

r
e
h
t
O

e
r
a
h
s

r
e
p

2
7
.
$

d
i
a
p

s
d
n
e
d
i
v
i
D

k
c
o
t
s

n
o
m
m
o
c

f
o

e
c
n
a
u
s
s
I

d
e
r
i
u
q
c
a

k
c
o
t
s

y
r
u
s
a
e
r
T

d
e
r
i
t
e
r

k
c
o
t
s

y
r
u
s
a
e
r
T

e
m
o
c
n
i

t
e
N

F-9

)
8
.
8
4
4
(

)
5
.
2
3
1
(

2
.
6
9
3
,
1

2
.
1

9
1
0
2

,
1
3
r
e
b
m
e
c
e
D

t
a

e
c
n
a
l
a
B

6
.

9
.
3
6

)
2
.
3
8
(

1
.

)
0
.
1
(

x
a
t

f
o

t
e
n

,
e
m
o
c
n
i

e
v
i
s
n
e
h
e
r
p
m
o
c

r
e
h
t
O

e
m
o
c
n
i

t
e
N

e
r
a
h
s

r
e
p

2
7
.
$

d
i
a
p

s
d
n
e
d
i
v
i
D

k
c
o
t
s

n
o
m
m
o
c

f
o

e
c
n
a
u
s
s
I

d
e
r
i
u
q
c
a

k
c
o
t
s

y
r
u
s
a
e
r
T

d
e
r
i
t
e
r

k
c
o
t
s

y
r
u
s
a
e
r
T

.
s
t
n
e
m
e
t
a
t
S

l
a
i
c
n
a
n
i

F
d
e
t
a
d
i
l
o
s
n
o
C
o
t

s
e
t
o
N
g
n
i
y
n
a
p
m
o
c
c
a

e
e
S

5
.
6
9
7

)
2
.
8
4
4
(

)
8
.
1
5
1
(

3
.
5
9
3
,
1

2
.
1

0
2
0
2

,
1
3
r
e
b
m
e
c
e
D

t
a

e
c
n
a
l
a
B

KRONOS WORLDWIDE, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In millions)

Years ended December 31,
2019

2020

2018

Cash flows from operating activities:

Net income
Depreciation
Amortization of operating lease right-of-use assets
Deferred income taxes
Benefit plan expense greater than cash funding
Marketable equity securities
Distributions from (contributions to) TiO2 manufacturing
joint venture, net
Other, net
Change in assets and liabilities:

Accounts and other receivables, net
Inventories, net
Prepaid expenses
Accounts payable and accrued liabilities
Income taxes
Accounts with affiliates
Other noncurrent assets
Other noncurrent liabilities

205.0 $
49.7
-
27.3
8.4
7.3

4.0
2.8

8.7
(135.5)
(5.3)
16.4
(16.4)
15.4
1.5
(.8)

87.1 $
48.1
6.8
6.5
11.1
.1

(9.3)
2.5

(6.8)
(7.1)
.3
24.6
(3.1)
(.7)
-
.2

63.9
58.1
6.5
(3.2)
15.7
1.1

(12.8)
.9

(4.7)
13.3
(3.0)
(33.2)
6.6
(4.3)
(4.6)
2.2

Net cash provided by operating activities

188.5

160.3

102.5

Cash flows from investing activities:

Capital expenditures
Loan to Valhi:
Loans
Collections

Proceeds from insurance settlement

(56.3)

(55.1)

(62.8)

(2.6)
16.2
-

(16.6)
16.6
2.6

-
-
1.5

Net cash used in investing activities

(42.7)

(52.5)

(61.3)

Cash flows from financing activities:
Payments on long-term debt
Deferred financing fees
Dividends paid
Treasury stock acquired

(1.5)
(.1)
(78.8)
-

(1.5)
-
(83.4)
(3.0)

(1.1)
-
(83.2)
(1.0)

Net cash used in financing activities

(80.4)

(87.9)

(85.3)

F-10

KRONOS WORLDWIDE, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS (CONTINUED)

(In millions)

Years ended December 31,
2019

2020

2018

Cash, cash equivalents and restricted cash - net change from:

Operating, investing and financing activities
Effect of currency exchange rate changes on cash

65.4 $
(14.4)

19.9 $
(2.3)

(44.1)
13.8

Net change for the year

51.0

17.6

(30.3)

Balance at beginning of year

323.7

374.7

392.3

Balance at end of year

374.7 $

392.3 $

362.0

Supplemental disclosures:

Cash paid for:

Interest, net of amounts capitalized
Income taxes

Accrual for capital expenditures

18.5 $
67.9
6.3

17.4 $
35.8
9.1

18.0
15.3
5.8

See accompanying Notes to Consolidated Financial Statements.

F-11

KRONOS WORLDWIDE, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

December 31, 2020

Note 1 – Summary of significant accounting policies:

Organization and basis of presentation – At December 31, 2020, Valhi, Inc. (NYSE: VHI) held
approximately 50% of our outstanding common stock and a wholly-owned subsidiary of NL Industries, Inc. (NYSE:
NL) held approximately 30% of our common stock. Valhi owned approximately 83% of NL’s outstanding common
stock and a wholly-owned subsidiary of Contran Corporation held approximately 92% of Valhi’s outstanding
common stock. A majority of Contran’s outstanding voting stock is held directly by Lisa K. Simmons and various
family trusts established for the benefit of Ms. Simmons, Thomas C. Connelly (the husband of Ms. Simmons’ late
sister) and their children and for which Ms. Simmons or Mr. Connelly, as applicable, serve as trustee (collectively,
the “Other Trusts”). With respect to the Other Trusts for which Mr. Connelly serves as trustee, he is required to vote
the shares of Contran voting stock held in such trusts in the same manner as Ms. Simmons. Such voting rights of
Ms. Simmons last through April 22, 2030 and are personal to Ms. Simmons. The remainder of Contran’s
outstanding voting stock is held by another trust (the “Family Trust”), which was established for the benefit of Ms.
Simmons and her late sister and their children and for which a third-party financial institution serves as trustee.
Consequently, at December 31, 2020, Ms. Simmons and the Family Trust may be deemed to control Contran, and
therefore may be deemed to indirectly control the wholly-owned subsidiary of Contran, Valhi, NL and us.

Our results of operations in 2020 were significantly impacted by the COVID-19 pandemic, primarily in the
second and third quarters, specifically through reduced demand for many of our products resulting from the rapid
contraction of vast areas of the global economy. The extent of the impact of the COVID-19 pandemic on our future
operations will depend on the time period and degree to which the COVID-19 pandemic persists in the global
economy, including the timing and extent to which our customers’ operations continue to be impacted, our
customers’ perception as to when consumer demand for their products will return to pre-pandemic levels and on any
future disruptions in our operations or our suppliers’ operations, all of which are difficult to predict.

Unless otherwise indicated, references in this report to “we,” “us” or “our” refer to Kronos Worldwide, Inc.

and its subsidiaries, taken as a whole.

Management’s estimates – In preparing our financial statements in conformity with accounting principles
generally accepted in the United States of America (GAAP) we are required to make estimates and assumptions that
affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of
the financial statements, and the reported amount of revenues and expenses during the reporting period. Actual
results may differ significantly from previously-estimated amounts under different assumptions or conditions.

Principles of consolidation – The consolidated financial statements include our accounts and those of our

majority-owned subsidiaries. We have eliminated all material intercompany accounts and balances.

Translation of currencies – We translate the assets and liabilities of our subsidiaries whose functional
currency is other than the U.S. dollar at year-end exchange rates, while we translate our revenues and expenses at
average exchange rates prevailing during the year. We accumulate the resulting translation adjustments in
stockholders’ equity as part of accumulated other comprehensive loss, net of related deferred income taxes. We
recognize currency transaction gains and losses in income currently.

Cash and cash equivalents – We classify bank time deposits and highly-liquid investments with original

maturities of three months or less as cash equivalents.

F-12

Restricted cash – We classify cash that has been segregated or is otherwise limited in use as restricted.
Such restrictions or limitations relate primarily to financial assurance for landfill closure obligations at our Belgium
facility and certain Norwegian payroll tax and employee benefit obligations. To the extent the restricted amount
relates to a recognized liability, we classify such restricted amount as either a current or noncurrent asset to
correspond with the classification of the liability. To the extent the restricted amount does not relate to a recognized
liability, we classify restricted cash as a current asset. Restricted cash classified as a current asset and restricted cash
classified as a noncurrent asset are presented separately on our Consolidated Balance Sheets.

Marketable securities and securities transactions – We carry marketable securities at fair value.
Accounting Standard Codification (ASC) Topic 820, Fair Value Measurements and Disclosures, establishes a
consistent framework for measuring fair value and (with certain exceptions) this framework is generally applied to
all financial statement items required to be measured at fair value. The standard requires fair value measurements to
be classified and disclosed in one of the following three categories:

(cid:3)

Level 1 – Unadjusted quoted prices in active markets that are accessible at the measurement date for
identical, unrestricted assets or liabilities;

Level 2 – Quoted prices in markets that are not active, or inputs which are observable, either directly or
indirectly, for substantially the full term of the assets or liability; and

Level 3 – Prices or valuation techniques that require inputs that are both significant to the fair value
measurement and unobservable.

We classify all of our marketable securities as available-for-sale. Unrealized gains or losses on the
securities are recognized in Other income (expense) - Marketable equity securities on our Consolidated Statements
of Income. We base realized gains and losses upon the specific identification of the securities sold.

See Notes 6 and 10.

Accounts receivable – We provide an allowance for doubtful accounts for known and estimated potential

losses arising from sales to customers based on a periodic review of these accounts. See Note 3.

Inventories and cost of sales – We state inventories at the lower of cost or net realizable value, net of
allowance for obsolete and slow-moving inventories. We generally base inventory costs for all inventory categories
on average cost that approximates the first-in, first-out method. Inventories include the costs for raw materials, the
cost to manufacture the raw materials into finished goods and overhead. Depending on the inventory’s stage of
completion, our manufacturing costs can include the costs of packing and finishing, utilities, maintenance,
depreciation, and salaries and benefits associated with our manufacturing process. We allocate fixed manufacturing
overhead costs based on normal production capacity. Unallocated overhead costs resulting from periods with
abnormally low production levels are charged to expense as incurred. As inventory is sold to third parties, we
recognize the cost of sales in the same period that the sale occurs. We periodically review our inventory for
estimated obsolescence or instances when inventory is no longer marketable for its intended use, and we record any
write-down equal to the difference between the cost of inventory and its estimated net realizable value based on
assumptions about alternative uses, market conditions and other factors. See Note 4.

Investment in TiO2 manufacturing joint venture – We account for our investment in a 50%-owned
manufacturing joint venture by the equity method. Distributions received from such investee are classified for
statement of cash flow purposes using the “nature of distribution” approach under ASC Topic 320. See Note 5.

Leases – We enter into various arrangements (or leases) that convey the rights to use and control identified
underlying assets for a period of time in exchange for consideration. We lease various manufacturing facilities, land
and equipment. From time to time, we may also enter into an arrangement in which the right to use and control an
identified underlying asset is embedded in another type of contract.

We determine if an arrangement is a lease (including leases embedded in another type of contract) at
inception. All of our leases are classified as operating leases. Operating leases are included in operating lease right-
of-use assets, current operating lease liabilities and noncurrent operating lease liabilities on our Consolidated
Balance Sheets. See Note 9. As permitted by ASC Topic 842, Leases, we elected the practical expedients related to

F-13

nonlease components (in which nonlease components associated with a lease and paid by us to the lessor, such as
property taxes, insurance and maintenance, are treated as a lease component and considered part of minimum lease
rental payments), and short-term leases (in which leases with an original maturity of 12 months or less are excluded
from the recognition requirements of ASC 842).

Right-of-use assets represent our right to use an underlying asset for the lease term and operating lease
liabilities represent our obligation to make lease payments arising from the lease. The right-of-use operating lease
assets and liabilities are recognized based on the estimated present value of lease payments over the lease term as of
the respective lease commencement dates.

We use an estimated incremental borrowing rate to determine the present value of lease payments (unless
we can determine the rate implicit in the lease, which is generally not the case). Our incremental borrowing rate for
each of our leases is derived from available information, including our current debt and credit facilities and U.S. and
European yield curves as well as publicly available data for instruments with similar characteristics, adjusted for
factors such as collateralization and term.

Our leases generally do not include termination or purchase options. Certain of our leases include an
option to renew the lease after expiration of the initial lease term, but we have not included such renewal periods in
our lease term because it is not reasonably certain that we would exercise the renewal option. Our leases generally
have fixed lease payments, with no contingent or incentive payments. Certain of our leases include variable lease
payments that depend on a specified index or rate. Our lease agreements do not contain any residual value
guarantees.

Property and equipment and depreciation – We state property and equipment at cost, including capitalized
interest on borrowings during the actual construction period of major capital projects. Capitalized interest costs
were $.8 million in 2018, $.6 million in 2019 and $.5 million in 2020. We compute depreciation of property and
equipment for financial reporting purposes (including mining equipment) principally by the straight-line method
over the estimated useful lives of the assets as follows:

Asset
Buildings and improvements
Machinery and equipment
Mine development costs

Useful lives
10 to 40 years
3 to 20 years
units-of-production

We use accelerated depreciation methods for income tax purposes, as permitted. Upon the sale or
retirement of an asset, we remove the related cost and accumulated depreciation from the accounts and recognize
any gain or loss in income currently.

We expense costs incurred for maintenance, repairs and minor renewals (including planned major

maintenance) while we capitalize expenditures for major improvements.

We have a governmental concession with an unlimited term to operate our ilmenite mines in Norway.
Mining properties consist of buildings and equipment used in our Norwegian ilmenite mining operations. While we
own the land and ilmenite reserves associated with the mining operations, such land and reserves were acquired for
nominal value and we have no material asset recognized for the land and reserves related to our mining operations.

We perform impairment tests when events or changes in circumstances indicate the carrying value may not
be recoverable. We consider all relevant factors. We perform the impairment test by comparing the estimated
future undiscounted cash flows (exclusive of interest expense) associated with the asset to the asset’s net carrying
value to determine if a write-down to fair value is required.

Long-term debt – We state long-term debt net of any unamortized original issue premium, discount or
deferred financing costs (other than deferred financing costs associated with revolving credit facilities, which are
recognized as an asset). We classify amortization of all deferred financing costs and any premium or discount
associated with the issuance of indebtedness as interest expense and compute such amortization by either the interest
method or the straight-line method over the term of the applicable issue. See Note 8.

F-14

Employee benefit plans – Accounting and funding policies for our defined benefit pension and defined
contribution retirement plans are described in Note 10. We also provide certain postretirement benefits other than
pensions (OPEB), consisting of health care and life insurance benefits, to certain U.S. and Canadian retired
employees, which are not material. See Note 11.

Income taxes – We, Valhi and our qualifying subsidiaries are members of Contran’s consolidated U.S.
federal income tax group (the Contran Tax Group) and we and certain of our qualifying subsidiaries also file
consolidated income tax returns with Contran in various U.S. state jurisdictions. As a member of the Contran Tax
Group, we are jointly and severally liable for the federal income tax liability of Contran and the other companies
included in the Contran Tax Group for all periods in which we are included in the Contran Tax Group. See Note 15.
As a member of the Contran Tax Group, we are a party to a tax sharing agreement which provides that we compute
our provision for U.S. income taxes on a separate-company basis using the tax elections made by Contran. Pursuant
to the tax sharing agreement, we make payments to or receive payments from Valhi in amounts we would have paid
to or received from the U.S. Internal Revenue Service or the applicable state tax authority had we not been a
member of the Contran Tax Group. We received net refunds of income taxes from Valhi of $1.9 million in 2018
and made net payments of income taxes to Valhi of $10.7 million and $6.6 million in 2019 and 2020, respectively.

We recognize deferred income tax assets and liabilities for the expected future tax consequences of
temporary differences between the income tax and financial reporting carrying amounts of assets and liabilities,
including investments in our subsidiaries and affiliates who are not members of the Contran Tax Group and
undistributed earnings of non-U.S. subsidiaries which are not deemed to be permanently reinvested. At December
31, 2020, we continue to assert indefinite reinvestment as it relates to our outside basis difference attributable to our
investments in our non-U.S. subsidiaries, other than post-1986 undistributed earnings of our European subsidiaries
and all undistributed earnings of our Canadian subsidiary, which are not subject to permanent reinvestment plans. It
is not practical for us to determine the amount of the unrecognized deferred income tax liability related to our
investments in our non-U.S. subsidiaries which are permanently reinvested due to the complexities associated with
our organizational structure, changes in the Tax Cuts and Jobs Act (2017 Tax Act), and the U.S. taxation of such
investments in the states in which we operate. Deferred income tax assets and liabilities for each tax-paying
jurisdiction in which we operate are netted and presented as either a noncurrent deferred income tax asset or
liability, as applicable. We periodically evaluate our deferred tax assets in the various taxing jurisdictions in which
we operate and adjust any related valuation allowance based on the estimate of the amount of such deferred tax
assets that we believe does not meet the more-likely-than-not recognition criteria.

The 2017 Tax Act imposed a tax on global intangible low-tax income (GILTI). We record GILTI tax as a
current-period expense when incurred under the period cost method. While our future global operations depend on a
number of different factors, we do expect to have future U.S. inclusions in taxable income related to GILTI.

We account for the tax effects of a change in tax law as a component of the income tax provision related to
continuing operations in the period of enactment, including the tax effects of any deferred income taxes originally
established through a financial statement component other than continuing operations (i.e. other comprehensive
income). Changes in applicable income tax rates over time as a result of changes in tax law, or times in which a
deferred income tax asset valuation allowance is initially recognized in one year and subsequently reversed in a later
year, can give rise to “stranded” tax effects in accumulated other comprehensive income in which the net
accumulated income tax (benefit) remaining in accumulated other comprehensive income does not correspond to the
then-applicable income tax rate applied to the pre-tax amount which resides in accumulated other comprehensive
income. As permitted by GAAP, our accounting policy is to remove any such stranded tax effect remaining in
accumulated other comprehensive income by recognizing an offset to our provision for income taxes related to
continuing operations, only at the time when there is no remaining pre-tax amount in accumulated other
comprehensive income. For accumulated other comprehensive income related to currency translation, this would
occur only upon the sale or complete liquidation of one of our non-U.S. subsidiaries. For defined pension benefit
plans and OPEB plans, this would occur whenever one of our subsidiaries which previously sponsored a defined
benefit pension or OPEB plan had terminated such a plan and had no future obligation or plan asset associated with
such a plan.

We record a reserve for uncertain tax positions for tax positions where we believe that it is more-likely-
than-not our position will not prevail with the applicable tax authorities. The amount of the benefit associated with

F-15

our uncertain tax positions that we recognize is limited to the largest amount for which we believe the likelihood of
realization is greater than 50%. We accrue penalties and interest on the difference between tax positions taken on
our tax returns and the amount of benefit recognized for financial reporting purposes. We classify our reserves for
uncertain tax positions in a separate current or noncurrent liability, depending on the nature of the tax position. See
Note 12.

Net sales – Our sales involve single performance obligations to ship our products pursuant to customer
purchase orders. In some cases, the purchase order is supported by an underlying master sales agreement, but our
purchase order acceptance generally evidences the contract with our customer by specifying the key terms of
product and quantity ordered, price and delivery and payment terms. In accordance with Revenues from Contracts
with Customers, (ASC 606), we record revenue when we satisfy our performance obligation to our customers by
transferring control of our products to them, which generally occurs at point of shipment or upon delivery. Such
transfer of control is also evidenced by transfer of legal title and other risks and rewards of ownership (giving the
customer the ability to direct the use of, and obtain substantially all of the benefits of, the product), and our
customers becoming obligated to pay us and it is probable we will receive payment. In certain arrangements we
provide shipping and handling activities after the transfer of control to our customer (e.g. when control transfers
prior to delivery) that are considered fulfillment activities, and accordingly, such costs are accrued when the related
revenue is recognized. Sales arrangements with consignment customers occur when our product is shipped to a
consignment customer location but we maintain control until the product is used in the customer’s manufacturing
process. In these instances, we recognize sales when the consignment customer uses our product, as control of our
product has not passed to the customer until that time and all other revenue recognition criteria have been satisfied.

Revenue is recorded in an amount that reflects the net consideration we expect to receive in exchange for
our products. Prices for our products are based on terms specified in published list prices and purchase orders,
which generally do not include financing components, noncash consideration or consideration paid to our customers.
As our standard payment terms are less than one year, we have elected the practical expedient under ASC 606 and
have not assessed whether a contract has a significant financing component. We state sales net of price, early
payment, and distributor discounts and volume rebates (collectively, variable consideration). Variable consideration,
to the extent present, is recognized as the amount to which we are most-likely to be entitled, using all information
(historical, current and forecasted) that is reasonably available to us, and only to the extent that a significant reversal
in the amount of the cumulative revenue recognized is not probable of occurring in a future period. Differences, if
any, between estimates of the amount of variable consideration to which we will be entitled and the actual amount of
such variable consideration have not been material in the past. Amounts received or receivable from our customers
with respect to variable consideration we expect to refund to our customers is recognized as a current liability and
classified as accrued sales discounts and rebates. See Note 9. We report any tax assessed by a governmental
authority that we collect from our customers that is both imposed on and concurrent with our revenue-producing
activities (such as sales, use, value added and excise taxes) on a net basis (meaning we do not recognize these taxes
either in our revenues or in our costs and expenses).

Frequently, we receive orders for products to be delivered over dates that may extend across reporting
periods. We invoice for each delivery upon shipment and recognize revenue for each distinct shipment when all
sales recognition criteria for that shipment have been satisfied. As scheduled delivery dates for these orders are
within a one year period, under the optional exemption provided by ASC 606, we do not disclose sales allocated to
future shipments of partially completed contracts.

ASC 606 requires a disaggregation of our sales into categories that depict how the nature, amount, timing
and uncertainty of revenue and cash flows are affected by economic factors. We have determined such
disaggregation of our sales is the same as the disclosure of our sales by place of manufacture (point of origin) and to
the location of the customer (point of destination). See Note 2.

Selling, general and administrative expense; shipping and handling costs – Selling, general and
administrative expense includes costs related to marketing, sales, distribution, shipping and handling, research and
development, legal and administrative functions such as accounting, treasury and finance, and includes costs for
salaries and benefits not associated with our manufacturing process, travel and entertainment, promotional materials
and professional fees. We include shipping and handling costs in selling, general and administrative expense and
these costs were $105 million in 2018, $111 million in 2019 and $112 million in 2020. We expense research and

F-16

development costs as incurred, and these costs were $16 million in 2018, $17 million in 2019 and $16 million in
2020. We expense advertising costs as incurred and these costs were not material in any year presented.

Note 2 – Geographic information:

Our operations are associated with the production and sale of titanium dioxide pigments (TiO2). TiO2 is
used to impart whiteness, brightness, opacity and durability to a wide variety of products, including paints, plastics,
paper, fibers and ceramics. Additionally, TiO2 is a critical component of everyday applications, such as coatings,
plastics and paper, as well as many specialty products such as inks, foods and cosmetics. At December 31, 2019 and
2020, the net assets of non-U.S. subsidiaries included in consolidated net assets approximated $313 million and
$319 million, respectively.

For geographic information, we attribute net sales to the place of manufacture (point of origin) and to the

location of the customer (point of destination); we attribute property and equipment to their physical location.

2018

Years ended December 31,
2019
(In millions)

2020

Net sales - point of origin:

United States
Germany
Canada
Belgium
Norway
Eliminations

Total

Net sales - point of destination:

Europe
North America
Other

Total

839.4 $
886.1
307.2
272.2
209.6
(852.6)
1,661.9 $

998.5 $
883.6
328.7
270.7
192.2
(942.6)
1,731.1 $

978.8
836.0
319.5
249.5
211.8
(956.8)
1,638.8

817.2 $
542.0
302.7
1,661.9 $

823.5 $
575.6
332.0
1,731.1 $

783.2
569.3
286.3
1,638.8

Identifiable assets - net property and equipment:

Germany
Belgium
Norway
Canada
Other

Total

Note 3 – Accounts and other receivables, net:

Trade receivables
Recoverable VAT and other receivables
Refundable income taxes
Allowance for doubtful accounts

Total

F-17

December 31,

2019

2020

(In millions)

221.9 $
95.3
86.3
72.3
14.8
490.6 $

228.2
107.3
86.7
87.9
14.5
524.6

December 31,

2019

2020

(In millions)
270.5 $
25.4
7.7
(1.1)
302.5 $

294.8
21.3
5.3
(1.9)
319.5

Note 4 – Inventories, net:

Raw materials
Work in process
Finished products
Supplies

Total

December 31,

2019

2020

(In millions)
124.4 $
39.0
269.9
69.7
503.0 $

133.2
36.8
269.2
79.8
519.0

Note 5 – Investment in TiO2 manufacturing joint venture:

We own a 50% interest in Louisiana Pigment Company, L.P. (LPC). LPC is a manufacturing joint venture
whose other 50%-owner is Venator Investments LLC (Venator Investments). Venator Investments is a wholly-
owned subsidiary of Venator Group, of which Venator Materials PLC owns 100% and is the ultimate parent. LPC
owns and operates a chloride-process TiO2 plant near Lake Charles, Louisiana.

We and Venator Investments are both required to purchase one-half of the TiO2 produced by LPC, unless
we and Venator Investments agree otherwise. LPC operates on a break-even basis and, accordingly, we report no
equity in earnings of LPC. Each owner’s acquisition transfer price for its share of the TiO2 produced is equal to its
share of the joint venture’s production costs and interest expense, if any. Our share of net cost is reported as cost of
sales as the related TiO2 acquired from LPC is sold. We report distributions we receive from LPC, which generally
relate to excess cash generated by LPC from its non-cash production costs, and contributions we make to LPC,
which generally relate to cash required by LPC when it builds working capital, as part of our cash flows from
operating activities in our Consolidated Statements of Cash Flows. The components of our net cash distributions
from (contributions to) LPC are shown in the table below.

2018

Years ended December 31,
2019
(In millions)

2020

Distributions from LPC
Contributions to LPC

Net distributions (contributions)

34.3 $
(30.3)
4.0 $

40.6 $
(49.9)
(9.3) $

32.7
(45.5)
(12.8)

Summary balance sheets of LPC are shown below:

ASSETS
Current assets
Property and equipment, net

Total assets

LIABILITIES AND PARTNERS' EQUITY
Other liabilities, primarily current
Partners' equity

Total liabilities and partners' equity

December 31,

2019

2020

(In millions)

94.6 $
121.3
215.9 $

32.8 $
183.1
215.9 $

105.8
134.1
239.9

30.6
209.3
239.9

F-18

Summary income statements of LPC are shown below:

2018

Years ended December 31,
2019
(In millions)

2020

Revenues and other income:

Kronos
Venator Investments

Total revenues and other income

Cost and expenses:
Cost of sales
General and administrative

Total costs and expenses

Net income

165.9 $
167.0
332.9

176.2 $
177.0
353.2

167.8
168.3
336.1

332.5
.4
332.9
- $

352.8
.4
353.2
- $

335.7
.4
336.1
-

We have certain related party transactions with LPC, as more fully described in Note 14.

Note 6 – Marketable securities:

Our marketable securities consist of investments in the publicly-traded shares of related parties: Valhi, NL
and CompX International Inc. NL owns the majority of CompX’s outstanding common stock. All of our
marketable securities are accounted for as available-for-sale securities, which are carried at fair value using quoted
market prices in active markets for each marketable security and represent a Level 1 input within the fair value
hierarchy. Unrealized gains or losses on the securities are recognized in Other income (expense) - Marketable
equity securities on our Consolidated Statements of Income.

Marketable security

December 31, 2019:

Valhi common stock
NL and CompX common stocks

Total

December 31, 2020:

Valhi common stock
NL and CompX common stocks

Total

Fair value
measurement
level

Market
value

Cost
basis
(In millions)

Unrealized
loss

1
1

3.2 $
.1
3.3 $

2.1 $
.1
2.2 $

3.2 $
.1
3.3 $

-
-
-

(1.1)
-
(1.1)

At December 31, 2019 and 2020, we held approximately 144,000 shares of Valhi’s common stock. The per
share quoted market price of Valhi’s common stock was $22.44 and $15.20, at December 31, 2019 and 2020,
respectively. Valhi implemented a reverse split of its common stock at a ratio of 1-for-12 effective on June 1, 2020.
We have adjusted all share and per-share disclosures related to our investment in Valhi stock for all periods prior to
June 2020 to give effect to the reverse stock split. The reverse stock split had no financial statement impact to us,
and our ownership interest in Valhi did not change as a result of the split. We also held a nominal number of shares
of CompX and NL common stocks.

The Valhi, CompX and NL common stocks we own are subject to the restrictions on resale pursuant to
certain provisions of the Securities and Exchange Commission (SEC) Rule 144. In addition, as a majority-owned
subsidiary of Valhi we cannot vote our shares of Valhi common stock under Delaware General Corporation Law,
but we do receive dividends from Valhi on these shares, when declared and paid.

F-19

Note 7 – Leases:

We enter into various operating leases for manufacturing facilities, land and equipment. Our operating
leases are included in operating lease right-of-use assets, current operating lease liabilities and noncurrent operating
lease liabilities on our Consolidated Balance Sheets. See Note 9. Our principal German operating subsidiary leases
the land under its Leverkusen TiO2 production facility pursuant to a lease with Bayer AG that expires in 2050. The
Leverkusen facility itself, which we own and which represents approximately one-third of our current TiO2
production capacity, is located within Bayer’s extensive manufacturing complex.

During 2019 and 2020, our operating lease expense approximated $8.2 million and $7.6 million,
respectively (which amounts approximate the amount of cash paid during each year for our operating leases
included in the determination of our cash flows from operating activities). During 2019 and 2020, variable lease
expense and short-term lease expense were not material. During 2019 and 2020, we entered into new operating
leases which resulted in the recognition of $1.6 million and $2.5 million, respectively, in right-of-use operating lease
assets and corresponding liabilities on our Consolidated Balance Sheets. At December 31, 2019 and 2020, the
weighted average remaining lease term of our operating leases was approximately 14 years and 15 years,
respectively, and the weighted average discount rate associated with such leases was approximately 4.6% and 4.8%,
respectively. Such average remaining lease term is weighted based on each arrangement’s lease obligation, and
such average discount rate is weighted based on each arrangement’s total remaining lease payments.

At December 31, 2020, maturities of our operating lease liabilities were as follows:

Years ending December 31,

2021
2022
2023
2024
2025
2026 and thereafter

Total remaining lease payments
Less imputed interest
Total lease obligations
Less current obligations
Long term lease obligations

Amount
(In millions)

7.4
4.1
2.7
1.8
1.3
20.1
37.4
11.9
25.5
6.7
18.8

With respect to our land lease associated with our Leverkusen facility, we periodically establish the amount
of rent for such land lease by agreement with Bayer for periods of at least two years at a time. The lease agreement
provides for no formula, index or other mechanism to determine changes in the rent of such land lease; rather, any
change in the rent is subject solely to periodic negotiation between Bayer and us. As such, we will account for any
change in the rent associated with such lease as a lease modification. Of the $25.5 million total lease obligations at
December 31, 2020, $7.6 million relates to our Leverkusen facility land lease.

At December 31, 2020, we have no significant lease commitments that have not yet commenced.

Prior to adoption of ASC 842, net rent expense approximated $15 million in 2018.

F-20

Note 8 – Long-term debt:

December 31,

2019

2020

Kronos International, Inc. 3.75% Senior Notes
Other

Total debt
Less current maturities

Total long-term debt

(In millions)
442.6
2.9
445.5
1.5
444.0

485.7
1.7
487.4
.7
486.7

Senior Notes – On September 13, 2017, Kronos International, Inc. (KII), our wholly-owned subsidiary,
issued €400 million aggregate principal amount of its 3.75% Senior Secured Notes due September 15, 2025 (Senior
Notes), at par value ($477.6 million when issued). The Senior Notes:

(cid:129)

bear interest at 3.75% per annum, payable semi-annually on March 15 and September 15 of each year,
payments began on March 15, 2018;

have a maturity date of September 15, 2025. Prior to September 15, 2020, we had an option to redeem
some or all of the Senior Notes at a price equal to 100% of the principal amount thereof, plus a “make-
whole” premium (as defined in the indenture governing the Senior Notes) but we did not elect the
option. On or after September 15, 2020, we may redeem the Senior Notes at redemption prices
ranging from 102.813% of the principal amount, declining to 100% on or after September 15, 2023. In
addition, on or before September 15, 2020, we had an option to redeem up to 40% of the Senior Notes
with the net proceeds of certain public or private equity offerings at 103.75% of the principal amount
but we did not elect this option. If we experience certain specified change of control events, we would
be required to make an offer to purchase the Senior Notes at 101% of the principal amount. We would
also be required to make an offer to purchase a specified portion of the Senior Notes at par value in the
event that we generate a certain amount of net proceeds from the sale of assets outside the ordinary
course of business, and such net proceeds are not otherwise used for specified purposes within a
specified time period;

are fully and unconditionally guaranteed, jointly and severally, on a senior secured basis by Kronos
Worldwide, Inc. and each of our direct and indirect domestic, wholly-owned subsidiaries;

are collateralized by a first priority lien on (i) 100% of the common stock or other ownership interests
of each existing and future direct domestic subsidiary of KII and the guarantors, and (ii) 65% of the
voting common stock or other ownership interests and 100% of the non-voting common stock or other
ownership interests of each non-U.S. subsidiary that is directly owned by KII or any guarantor;

contain a number of covenants and restrictions which, among other things, restrict our ability to incur
or guarantee additional debt, incur liens, pay dividends or make other restricted payments, or merge or
consolidate with, or sell or transfer substantially all of our assets to, another entity, and contain other
provisions and restrictive covenants customary in lending transactions of this type (however, there are
no ongoing financial maintenance covenants); and

contain customary default provisions, including a default under any of our other indebtedness in excess
of $50.0 million.

The carrying value of the Senior Notes at December 31, 2020 is stated net of unamortized debt issuance

costs of $4.7 million (December 31, 2019 - $5.3 million).

Revolving credit facilities

Revolving North American credit facility – We have a $125 million revolving bank credit facility that, as
amended, matures in January 2022. Borrowings under the revolving credit facility are available for our general
corporate purposes. Available borrowings on this facility are based on formula-determined amounts of eligible trade
receivables and inventories, as defined in the agreement, of certain of our North American subsidiaries less any
outstanding letters of credit up to $15 million issued under the facility (with revolving borrowings by our Canadian

F-21

subsidiary limited to $25 million). Any amounts outstanding under the revolving credit facility bear interest, at our
option, at LIBOR plus a margin ranging from 1.5% to 2.0% or at the applicable base rate, as defined in the
agreement, plus a margin ranging from .5% to 1.0%. The credit facility is collateralized by, among other things, a
first priority lien on the borrowers’ trade receivables and inventories. The facility contains a number of covenants
and restrictions which, among other things, restricts the borrowers’ ability to incur additional debt, incur liens, pay
dividends or merge or consolidate with, or sell or transfer all or substantially all of their assets to, another entity,
contains other provisions and restrictive covenants customary in lending transactions of this type and under certain
conditions requires the maintenance of a specified financial covenant (fixed charge coverage ratio, as defined) to be
at least 1.0 to 1.0.

We had no borrowings or repayments under this facility in 2019 and 2020. At December 31, 2020, there
were no outstanding borrowings under this facility and we had $107.6 million available for borrowing under this
revolving facility.

Revolving European credit facility – Our operating subsidiaries in Germany, Belgium, Norway and
Denmark have a €90 million secured revolving bank credit facility that, as amended, matures in September 2022.
Outstanding borrowings bear interest at the Euro Interbank Offered Rate (EURIBOR) plus 1.60% per annum. The
facility is collateralized by the accounts receivable and inventories of the borrowers, plus a limited pledge of all of
the other assets of the Belgian borrower. The facility contains certain restrictive covenants that, among other things,
restricts the ability of the borrowers to incur debt, incur liens, pay dividends or merge or consolidate with, or sell or
transfer all or substantially all of the assets to, another entity, and requires the maintenance of certain financial
ratios. In addition, the credit facility contains customary cross-default provisions with respect to other debt and
obligations of the borrowers, KII and its other subsidiaries.

We had no borrowings or repayments under this facility during 2019 and 2020 and at December 31, 2020,
there were no outstanding borrowings under this facility. Our European revolving credit facility requires the
maintenance of certain financial ratios, and one of such requirements is based on the ratio of net debt to last twelve
months earnings before interest, income tax, depreciation and amortization expense (EBITDA) of the borrowers.
Based upon the borrowers’ last twelve months EBITDA as of December 31, 2020 and the net debt to EBITDA
financial test, the full €90 million amount of this facility ($110.3 million) was available for borrowing at December
31, 2020.

Aggregate maturities and other – Aggregate maturities of debt at December 31, 2020 are presented in the

table below.

Years ending December 31,

2021
2022
2023
2024
2025
2026 and thereafter
Gross maturities
Less debt issuance costs
Total

Amount
(In millions)

.7
.7
.3
-
490.4
-
492.1
4.7
487.4

We are in compliance with all of our debt covenants at December 31, 2020.

F-22

Note 9 – Accounts payable and accrued liabilities:

Accounts payable
Accrued sales discounts and rebates
Employee benefits
Operating lease liabilities
Other

Total

December 31,

2019

2020

(In millions)
137.2 $
32.4
21.1
6.2
40.8
237.7 $

111.0
29.1
27.8
6.7
41.3
215.9

Note 10 – Defined contribution and defined benefit retirement plans:

Defined contribution plans – We maintain various defined contribution pension plans with our
contributions based on matching or other formulas. Defined contribution plan expense approximated $3.3 million in
2018, $3.1 million in 2019 and $3.4 million in 2020.

Defined benefit pension plans – We sponsor various defined benefit pension plans. Certain non-U.S.
employees are covered by plans in their respective countries. Our U.S. plan was closed to new participants in 1996,
and existing participants no longer accrue any additional benefits after that date. The benefits under all of our
defined benefit pension plans are based upon years of service and employee compensation. Our funding policy is to
contribute annually the minimum amount required under ERISA (or equivalent non-U.S.) regulations plus additional
amounts as we deem appropriate. We recognize an asset or liability for the over or under funded status of each of
our individual defined benefit pension plans on our Consolidated Balance Sheets. Changes in the funded status of
these plans are recognized either in net income, to the extent they are reflected in periodic benefit cost, or through
other comprehensive income (loss).

We expect to contribute the equivalent of approximately $17 million to all of our defined benefit pension

plans during 2021. Benefit payments to plan participants out of plan assets are expected to be the equivalent of:

Years ending December 31,

2021
2022
2023
2024
2025
Next 5 years

Amount
(In millions)

23.5
24.9
24.7
26.7
26.8
159.5

F-23

The funded status of our non-U.S. defined benefit pension plans is presented in the table below.

Change in projected benefit obligations (PBO):
Benefit obligations at beginning of the year
Service cost
Interest cost
Participant contributions
Actuarial losses
Settlements
Change in currency exchange rates
Benefits paid

Benefit obligations at end of the year

Change in plan assets:

Fair value of plan assets at beginning of the year
Actual return on plan assets
Employer contributions
Participant contributions
Settlements
Change in currency exchange rates
Benefits paid

Fair value of plan assets at end of year

Funded status

Amounts recognized in the balance sheet:

Noncurrent pension asset
Noncurrent accrued pension costs

Total

Amounts recognized in accumulated other comprehensive loss:

Actuarial losses
Prior service cost
Total

Accumulated benefit obligations (ABO)

December 31,

2019

2020

(In millions)

658.7 $
12.8
13.3
1.6
81.5
(1.0)
(7.2)
(21.5)
738.2

400.3
45.1
15.3
1.6
(1.0)
(2.3)
(21.5)
437.5
(300.7) $

3.1 $

(303.8)
(300.7) $

285.3 $
1.0
286.3 $

738.2
13.3
10.0
1.8
46.6
-
58.6
(21.8)
846.7

437.5
18.7
16.0
1.8
-
29.6
(21.8)
481.8
(364.9)

4.5
(369.4)
(364.9)

304.5
.8
305.3

712.2 $

819.7

F-24

The total net underfunded status of our non-U.S. defined benefit pension plans increased from $300.7
million at December 31, 2019 to $364.9 million at December 31, 2020 due to the change in our PBO during 2020
exceeding the change in plan assets during 2020. The increase in our PBO in 2020 was primarily attributable to
actuarial losses due to the decrease in discount rates from year end 2019 and unfavorable currency fluctuations
resulting primarily from the weakening of the U.S. dollar relative to the euro. The increase in our plan assets in
2020 was primarily attributable to net plan asset returns in 2020, employer contributions and favorable currency
fluctuations resulting primarily from the weakening of the U.S. dollar relative to the euro.

The components of our net periodic defined benefit pension cost for our non-U.S. defined benefit pension
plans are presented in the table below. The amounts shown below for the amortization of prior service cost and
recognized actuarial losses for 2018, 2019 and 2020 were recognized as components of our accumulated other
comprehensive loss at December 31, 2017, 2018 and 2019, respectively, net of deferred income taxes.

2018

Years ended December 31,
2019
(In millions)

2020

Net periodic pension cost (income):

Service cost benefits
Interest cost on PBO
Expected return on plan assets
Recognized actuarial losses
Amortization of prior service cost

Total

11.6 $
13.5
(12.0)
13.1
.2
26.4 $

12.8 $
13.3
(11.7)
12.8
.2
27.4 $

13.3
10.0
(8.7)
17.3
.2
32.1

Information concerning certain of our non-U.S. defined benefit pension plans (for which the ABO exceeds

the fair value of plan assets as of the indicated date) is presented in the table below.

Plans for which the ABO exceeds plan assets:

PBO
ABO
Fair value of plan assets

December 31,

2019

2020

(In millions)

685.4 $
663.3
381.7

790.9
768.1
421.5

The weighted-average rate assumptions used in determining the actuarial present value of benefit
obligations for our non-U.S. defined benefit pension plans as of December 31, 2019 and 2020 are presented in the
table below.

Discount rate
Increase in future compensation levels

Rate

December 31,

2019

2020

1.4%
2.6%

1.0%
2.6%

The weighted-average rate assumptions used in determining the net periodic pension cost for our non-U.S.

defined benefit pension plans for 2018, 2019 and 2020 are presented in the table below.

Rate

Discount rate
Increase in future compensation levels
Long-term return on plan assets

Years ended December 31,
2019

2018

2020

2.1%
2.6%
2.9%

1.4%
2.6%
2.0%

Variances from actuarially assumed rates will result in increases or decreases in accumulated pension

obligations, pension expense and funding requirements in future periods.

F-25

The funded status of our U.S. defined benefit pension plan is presented in the table below.

Change in PBO:

Benefit obligations at beginning of the year
Interest cost
Actuarial losses
Benefits paid

Benefit obligations at end of the year

Change in plan assets:

Fair value of plan assets at beginning of the year
Actual return on plan assets
Employer contributions
Benefits paid

Fair value of plan assets at end of year

Funded status

Amounts recognized in the balance sheet:

Accrued pension costs:

Current
Noncurrent
Total

Amounts recognized in accumulated other comprehensive
loss - actuarial losses

ABO

December 31,

2019

2020

(In millions)

16.9 $
.7
1.8
(1.1)
18.3

13.1
1.7
.9
(1.1)
14.6
(3.7) $

(.1) $
(3.6)
(3.7) $

11.3 $

18.3 $

18.3
.6
1.6
(1.1)
19.4

14.6
2.0
.6
(1.1)
16.1
(3.3)

(.1)
(3.2)
(3.3)

10.9

19.4

The components of our net periodic defined benefit pension cost for our U.S. defined benefit pension plan
is presented in the table below. The amounts shown below for recognized actuarial losses for 2018, 2019 and 2020
were recognized as components of our accumulated other comprehensive loss at December 31, 2017, 2018 and 2019
respectively, net of deferred income taxes.

2018

Years ended December 31,
2019
(In millions)

2020

Net periodic pension cost (income):

Interest cost on PBO
Expected return on plan assets
Recognized actuarial losses

Total

.6 $
(1.0)
.6
.2 $

.7 $
(.7)
.6
.6 $

.6
(.6)
.6
.6

The discount rate assumptions used in determining the actuarial present value of the benefit obligation for
our U.S. defined benefit pension plan as of December 31, 2019 and 2020 are 3.1% and 2.2%, respectively. The
impact of assumed increases in future compensation levels does not have an effect on the benefit obligation as the
plan is frozen with regards to compensation.

F-26

The weighted-average rate assumptions used in determining the net periodic pension cost for our U.S.
defined benefit pension plan for 2018, 2019 and 2020 are presented in the table below. The impact of assumed
increases in future compensation levels also does not have an effect on the periodic pension cost as the plan is frozen
with regards to compensation.

Rate

Discount rate
Long-term return on plan assets

Years ended December 31,
2019

2020

2018

3.5%
7.5%

4.1%
5.5%

3.1%
4.5%

Variances from actuarially assumed rates will result in increases or decreases in accumulated pension

obligations, pension expense and funding requirements in future periods.

The amounts shown in the tables above for actuarial losses and prior service cost at December 31, 2019 and
2020 have not yet been recognized as components of our periodic defined benefit pension cost as of those dates.
These amounts will be recognized as components of our periodic defined benefit cost in future years and are
recognized, net of deferred income taxes, in our accumulated other comprehensive loss at December 2019 and 2020.

The table below details the changes in our consolidated other comprehensive income (loss) during 2018,

2019 and 2020.

2018

Years ended December 31,
2019
(In millions)

2020

Changes in plan assets and benefit obligations
recognized in other comprehensive income (loss):

Current year:

Net actuarial losses

Amortization of unrecognized:

Net actuarial losses
Prior service cost

Total

(24.3) $

(48.5) $

(36.8)

13.7
.2
(10.4) $

13.4
.2
(34.9) $

17.9
.2
(18.7)

Prior to 2018, substantially all of the assets attributable to our U.S. plan were invested in the Combined
Master Retirement Trust (CMRT), a collective investment trust sponsored by Contran to permit the collective
investment by certain master trusts that fund certain employee benefit plans sponsored by Contran and certain of its
affiliates, including us. For 2018, the long-term rate of return assumption for our U.S. plan assets was 7.5%, based
on the long-term asset mix of the assets of the CMRT and the expected long-term rates of return for such asset
components as well as advice from Contran’s actuaries. During 2018, Contran and the other employer-sponsors
(including us) implemented a restructuring of the CMRT, in which a substantial part of each plan’s units in the
CMRT were redeemed in exchange for a pro-rata portion of a substantial part of the CMRT’s investments.
Following such restructuring, the plans held directly in the aggregate the investments previously held directly by the
CMRT which had been exchanged for CMRT units as part of the restructuring. Certain investments held directly by
the CMRT that were not part of such restructuring remained investments of the CMRT at December 31, 2018.
During 2019, the remaining investments of the CMRT allocable to our U.S. plan were transferred and are held as
direct investments of our U.S. plan at December 31, 2019 and December 31, 2020. Such restructuring was
implemented in part so each plan could more easily align the composition of its plan asset portfolio with the plan’s
benefit obligations.

In determining the expected long-term rate of return on our U.S. and non-U.S. plan asset assumptions, we
consider the long-term asset mix (e.g. equity vs. fixed income) for the assets for each of our plans and the expected
long-term rates of return for such asset components. In addition, we receive third-party advice about appropriate
long-term rates of return. Such assumed asset mixes are summarized below:

(cid:129)

In Germany, the composition of our plan assets is established to satisfy the requirements of the
German insurance commissioner. Our German pension plan assets represent an investment in a large

F-27

collective investment fund established and maintained by Bayer AG in which several pension plans,
including our German pension plans and Bayer’s pension plans, have invested. Our plan assets
represent a very nominal portion of the total collective investment fund maintained by Bayer. These
plan assets are a Level 3 in the fair value hierarchy because there is not an active market that
approximates the value of our investment in the Bayer investment fund. We estimate the fair value of
the Bayer plan assets based on periodic reports we receive from the managers of the Bayer fund and
using a model we developed with assistance from our third-party actuary that uses estimated asset
allocations and correlates such allocation to similar asset mixes in fund indexes quoted on an active
market. We periodically evaluate the results of our valuation model against actual returns in the Bayer
fund and adjust the model as needed. The Bayer fund periodic reports are subject to audit by the
German pension regulator.

In Canada, we currently have a plan asset target allocation of 20-30% to equity securities and 70-80%
to fixed income securities. We expect the long-term rate of return for such investments to approximate
the applicable average equity or fixed income index. The Canadian assets are Level 1 inputs because
they are traded in active markets.

In Norway, we currently have a plan asset target allocation of 15% to equity securities, 62% to fixed
income securities, 14% to real estate and the remainder primarily to other investments and liquid
investments such as money markets. The expected long-term rate of return for such investments is
approximately 5%, 3%, 4% and 7%, respectively. The majority of Norwegian plan assets are Level 1
inputs because they are traded in active markets; however approximately 14% of our Norwegian plan
assets are invested in real estate and other investments not actively traded and are therefore a Level 3
input.

In the U.S. we currently have a plan asset target allocation of 38% to equity securities, 54% to fixed
income securities, and the remainder is allocated to multi-asset strategies. The expected long-term rate
of return for such investments is approximately 9%, 3% and 2%, respectively (before plan
administrative expenses). The majority of U.S. plan assets are Level 1 inputs because they are traded
in active markets and approximately 34% of our U.S. plan assets are invested in funds that are valued
at net asset value (NAV) and, in accordance with ASC 820-10, not subject to classification in the fair
value hierarchy.

(cid:129)

(cid:129) We also have plan assets in Belgium and the United Kingdom. The Belgium plan assets are invested
in certain individualized fixed income insurance contracts for the benefit of each plan participant as
required by the local regulators and are therefore a Level 3 input. The United Kingdom plan assets
consist of marketable securities which are Level 1 inputs because they trade in active markets.

We regularly review our actual asset allocation for each plan and will periodically rebalance the
investments in each plan to more accurately reflect the targeted allocation and/or maximize the overall long-term
return when considered appropriate.

F-28

The composition of our pension plan assets by asset category and fair value level at December 31, 2019 and

2020 is shown in the tables below.

Fair Value Measurements at December 31, 2019
Significant
other
observable
inputs
(Level 2)

Significant
unobservable
inputs
(Level 3)

Quoted
prices
in active
markets
(Level 1)

Assets
measured at
NAV

Total

Germany
Canada:

Local currency equities
Non local currency equities
Local currency fixed income
Cash and other

Norway:

Local currency equities
Non local currency equities
Local currency fixed income
Non local currency fixed income
Real estate
Cash and other

U.S.:

Equities
Fixed income
Cash and other

Other

Total

264.5 $

(In millions)
- $

- $

264.5 $

8.3
16.3
80.9
.6

1.6
4.2
22.8
8.3
6.6
8.2

8.3
16.3
80.9
.6

1.6
4.2
14.1
8.3
-
7.4

5.8
7.0
1.8
15.2
452.1 $

1.6
7.0
1.4
4.2
155.9 $

-
-
-
-

-
-
8.7
-
-
-

-
-
-
-
8.7 $

-
-
-
-

-
-
-
-
6.6
.8

.2
-
-
11.0
283.1 $

-
-
-
-

-
-
-
-
-
-

4.0
-
.4
-
4.4

F-29

Fair Value Measurements at December 31, 2020
Significant
other
observable
inputs
(Level 2)

Significant
unobservable
inputs
(Level 3)

Quoted
prices
in active
markets
(Level 1)

Assets
measured at
NAV

Total

Germany
Canada:

Local currency equities
Non local currency equities
Local currency fixed income
Cash and other

Norway:

Local currency equities
Non local currency equities
Local currency fixed income
Non local currency fixed income
Real estate
Cash and other

U.S.:

Equities
Fixed income
Cash and other

Other

Total

292.5 $

(In millions)
- $

- $

292.5 $

.2
26.6
87.3
.9

3.2
6.3
26.4
7.7
7.1
5.5

.2
26.6
87.3
.9

3.2
6.3
16.3
7.7
-
4.8

6.3
8.1
1.7
18.1
497.9 $

.9
8.1
1.3
4.3
167.9 $

-
-
-
-

-
-
10.1
-
-
-

-
-
-
-
10.1 $

-
-
-
-

-
-
-
-
7.1
.7

.2
-
-
13.8
314.3 $

A rollforward of the change in fair value of Level 3 assets follows.

-
-
-
-

-
-
-
-
-
-

5.2
-
.4
-
5.6

Fair value at beginning of year

Gain on assets held at end of year
Gain on assets sold during the year
Assets purchased
Assets sold
Currency exchange rate fluctuations

Fair value at end of year

Note 11 – Other noncurrent liabilities:

Accrued postretirement benefits
Employee benefits
Other

Total

December 31,

2019

2020

(In millions)
258.0 $
30.2
.1
16.0
(14.9)
(6.3)
283.1 $

283.1
4.2
-
14.4
(14.1)
26.7
314.3

December 31,

2019

2020

(In millions)
8.0 $
6.0
14.2
28.2 $

8.7
6.2
11.8
26.7

We recorded an immaterial out-of-period adjustment of $3.9 million ($2.9 million net of income taxes) in
the fourth quarter of 2020 to correct the overstatement of a noncurrent liability related to water control and
monitoring activities.

F-30

Note 12 – Income taxes:

Pre-tax income:

U.S.
Non-U.S.
Total

Expected tax expense, at U.S. federal statutory income
tax rate of 21%
Non-U.S. tax rates
Incremental net tax expense (benefit) on earnings and losses
of U.S. and non-U.S. companies
Valuation allowance
Transition Tax
Global intangible low-tax income, net
Tax rate changes
Canada - Germany APA
Refund of prior tax payments, net
Adjustment to the reserve for uncertain tax positions, net
Nondeductible expenses
U.S. state income taxes and other, net
Income tax expense

Components of income tax expense:

Current payable:

U.S. federal and state
Non-U.S.

Noncurrent payable - U.S. federal

Deferred income taxes (benefit):

U.S. federal and state
Non-U.S.

Income tax expense

Comprehensive provision for income taxes allocable to:

Net income
Other comprehensive income (loss):

Pension plans
OPEB plans
Total

F-31

2018

Years ended December 31,
2019
(In millions)

2020

32.8 $
261.0
293.8 $

37.9 $
83.2
121.1 $

61.7 $
21.0

1.3
-
(1.7)
3.7
(.2)
(1.4)
-
2.1
1.6
.7
88.8 $

25.4 $
5.4

(4.3)
.7
-
2.4
5.5
-
(2.1)
.7
1.4
(1.1)
34.0 $

12.0 $
51.1
63.1

5.5 $
21.9
27.4

(1.6)

(1.8)
29.1
27.3
88.8 $

.8
5.8
6.6
34.0 $

20.9
59.1
80.0

16.8
.7

(5.5)
.8
-
2.7
(.3)
-
(.1)
.1
.9
-
16.1

4.8
14.9
19.7

(2.6)
(1.0)
(3.6)
16.1

88.8 $

34.0 $

16.1

(3.6)
(.2)
85.0 $

(13.7)
(.2)
20.1 $

(6.0)
(.2)
9.9

The amount shown in the preceding table of our income tax rate reconciliation for non-U.S. tax rates
represents the result determined by multiplying the pre-tax earnings or losses of each of our non-U.S. subsidiaries by
the difference between the applicable statutory income tax rate for each non-U.S. jurisdiction and the U.S. federal
statutory tax rate. The amount shown on such table for incremental net tax expense (benefit) on earnings and losses
of U.S. and non-U.S. companies includes, as applicable, (i) deferred income taxes (or deferred income tax benefits)
associated with the current-year earnings of all of our non-U.S. subsidiaries and (ii) current U.S. income taxes (or
current income tax benefit), including U.S. personal holding company tax, as applicable, attributable to current-year
income (losses) of one of our non-U.S. subsidiaries, which subsidiary is treated as a dual resident for U.S. income
tax purposes, to the extent the current-year income (losses) of such subsidiary is subject to U.S. income tax under
the U.S. dual-resident provisions of the Internal Revenue Code.

The components of our net deferred income taxes at December 31, 2019 and 2020 are summarized in the

following table.

Tax effect of temporary differences related to:

Inventories
Property and equipment
Lease assets (liabilities)
Accrued OPEB costs
Accrued pension costs
Other accrued liabilities and deductible differences
Other taxable differences
Tax on unremitted earnings of non-U.S. subsidiaries
Tax loss and tax credit carryforwards
Valuation allowance
Adjusted gross deferred tax assets (liabilities)

Netting by tax jurisdiction

Net noncurrent deferred tax asset (liability)

December 31,

2019
Liabilities Assets

2020
Liabilities

Assets

(In millions)

3.5 $
-
5.9
2.2
79.8
9.3
-
-
80.0
(3.5)
177.2
(49.5)
127.7 $

- $
(51.6)
(6.1)
-
-
-
(1.7)
(10.8)
-
-
(70.2)
49.5
(20.7) $

1.7 $
-
6.4
2.4
100.0
11.7
-
-
86.9
(4.4)
204.7
(53.7)
151.0 $

-
(58.4)
(6.5)
-
-
-
(1.4)
(12.0)
-
-
(78.3)
53.7
(24.6)

We have substantial net operating loss (NOL) carryforwards in Germany (the equivalent of $531 million
for German corporate tax purposes at December 31, 2020) and in Belgium (the equivalent of $20 million for Belgian
corporate tax purposes at December 31, 2020). At December 31, 2020, we have concluded that no deferred income
tax asset valuation allowance is required to be recognized with respect to such carryforwards, principally because (i)
such carryforwards have an indefinite carryforward period, (ii) we have utilized a portion of such carryforwards
during the most recent three-year period and (iii) we currently expect to utilize the remainder of such carryforwards
over the long term. However, prior to the complete utilization of such carryforwards, if we were to generate
additional losses in our German or Belgian operations for an extended period of time, or if applicable law were to
change such that the carryforward period was no longer indefinite, it is possible that we might conclude the benefit
of such carryforwards would no longer meet the more-likely-than-not recognition criteria, at which point we would
be required to recognize a valuation allowance against some or all of the then-remaining tax benefit associated with
the carryforwards.

Prior to the enactment of the 2017 Tax Act, the undistributed earnings of our European subsidiaries were
deemed to be permanently reinvested (we had not made a similar determination with respect to the undistributed
earnings of our Canadian subsidiary). Pursuant to the one-time repatriation tax (Transition Tax) provisions of the
2017 Tax Act which imposed a one-time repatriation tax on post-1986 undistributed earnings, we recognized a
provisional current income tax expense of $76.2 million in the fourth quarter of 2017 based on information available
at that date. During the third quarter of 2018, in conjunction with finalizing our federal income tax return and based
on additional information that became available (including proposed regulations issued by the IRS in August 2018
with respect to the Transition Tax), we recognized a provisional income tax benefit of $1.7 million which amount is

F-32

recorded as a measurement-period adjustment, reducing the provisional income tax expense recognized in the fourth
quarter of 2017. We elected to pay such tax over an eight year period beginning in 2018. At December 31, 2020,
the balance of our unpaid Transition Tax is $56.6 million, which will be paid in annual installments over the
remainder of the eight year period. Of such $56.6 million, $50.6 million is recorded as a noncurrent payable to
affiliate (income taxes payable to Valhi) classified as a noncurrent liability on our Consolidated Balance Sheet at
December 31, 2020, and $6.0 million is included with our current payable to affiliate (income taxes payable to
Valhi) classified as a current liability (a portion of our noncurrent income tax payable to affiliate was reclassified to
our current payable to affiliate for the portion of our 2020 Transition Tax installment due within the next twelve
months).

In the fourth quarter of 2019, we recognized an income tax benefit of $3.0 million primarily related to the
favorable settlement of a prior year tax matter in Germany, with $1.5 million recognized as a current cash tax benefit
and $1.5 million recognized as a non-cash deferred income tax benefit related to an increase to our German net
operating loss carryforward. In addition, we recognized a non-cash deferred income tax expense of $5.5 million
primarily related to the revaluation of our net deferred income tax asset in Germany resulting from a decrease in the
German trade tax rate.

As a result of prior audits in certain jurisdictions, which are now settled, in 2008 we filed Advance Pricing
Agreement Requests with the tax authorities in the U.S., Canada and Germany. These requests have been under
review with the respective tax authorities since 2008 and prior to 2016, it was uncertain whether an agreement
would be reached between the tax authorities and whether we would agree to execute and finalize such agreements.
During the first quarter of 2018, our German subsidiary executed and finalized the related Advance Pricing
Agreement with the Competent Authority for Germany effective for tax years 2005 - 2017. In the first quarter of
2018, we recognized a net $1.4 million non-cash income tax benefit related to an APA tax settlement payment
between our German and Canadian subsidiaries.

Tax authorities are examining certain of our U.S. and non-U.S. tax returns and may propose tax
deficiencies, including penalties and interest. Because of the inherent uncertainties involved in settlement initiatives
and court and tax proceedings, we cannot guarantee that these tax matters, if any, will be resolved in our favor, and
therefore our potential exposure, if any, is also uncertain. We believe we have adequate accruals for additional taxes
and related interest expense which could ultimately result from tax examinations. We believe the ultimate
disposition of tax examinations should not have a material adverse effect on our consolidated financial position,
results of operations or liquidity.

On March 27, 2020, the “Coronavirus Aid, Relief and Economic Security (CARES) Act” was signed into
law in response to the COVID-19 pandemic. The CARES Act, among other things, includes provisions relating to
refundable payroll tax credits, deferment of employer side social security payments, modifications to the limitation
of business interest for tax years beginning in 2019 and 2020 and technical corrections to tax depreciation methods
for qualified improvement property. The modification to the business interest provisions increases the business
interest limitation from 30% of adjusted taxable income to 50% of adjusted taxable income which increases our
allowable interest expense deduction for 2019 and 2020. Consequently, in the first quarter of 2020 we recognized a
cash tax benefit of $.5 million related to the reversal of the valuation allowance recognized in 2019 for the portion of
the disallowed interest expense we did not expect to fully utilize at December 31, 2019 and we have considered such
modifications in our 2020 provision for income taxes. We have determined other provisions of the CARES Act did
not have a material impact on our provision for income taxes in 2020.

We accrue interest and penalties on our uncertain tax positions as a component of our provision for income
taxes. The amount of interest and penalties we accrued during 2018, 2019 and 2020 was not material and at
December 31, 2019 and 2020, we had no accrual for interest and penalties for our uncertain tax positions.

F-33

The following table shows the changes in the amount of our uncertain tax positions (exclusive of the effect

of interest and penalties discussed above) during 2018, 2019 and 2020:

2018

Years ended December 31,
2019
(In millions)

2020

Changes in unrecognized tax benefits:

Unrecognized tax benefits at beginning of year
Net increase (decrease):

Tax positions taken in prior periods
Tax positions taken in current period
Lapse due to applicable statute of limitations
Change in currency exchange rates

Unrecognized tax benefits at end of year

2.1 $

4.1 $

1.4
.7
-
(.1)
4.1 $

(.8)
.7
-
(.1)
3.9 $

3.9

(.3)
.6
(.5)
.4
4.1

At December 31, 2020, all of our uncertain tax benefits are classified as a component of our noncurrent
deferred tax asset. If our uncertain tax position at December 31, 2020 was recognized, a benefit of $4.1 million
would affect our effective income tax rate. We currently estimate that our unrecognized tax benefits will decrease
by approximately $.7 million during the next twelve months due to the expiration of certain statutes of limitations.

We and Contran file income tax returns in U.S. federal and various state and local jurisdictions. We also
file income tax returns in various non-U.S. jurisdictions, principally in Germany, Canada, Belgium and Norway.
Our U.S. income tax returns prior to 2017 are generally considered closed to examination by applicable tax
authorities. Our non-U.S. income tax returns are generally considered closed to examination for years prior to 2016
for Germany, 2017 for Belgium, 2015 for Canada and 2011 for Norway.

Note 13 – Stockholders’ equity:

Long-term incentive compensation plan – Prior to 2018, our board of directors adopted a plan that
provides for the award of stock to our board of directors, up to a maximum of 200,000 shares. We awarded 5,600
shares in 2018, 9,000 shares in 2019 and 13,500 shares in 2020 under this plan. At December 31, 2020, 127,400
shares are available for awards.

Stock repurchase program – Prior to 2018, our board of directors authorized the repurchase of up to
2.0 million shares of our common stock in open market transactions, including block purchases, or in privately-
negotiated transactions at unspecified prices and over an unspecified period of time. We may repurchase our
common stock from time to time as market conditions permit. The stock repurchase program does not include
specific price targets or timetables and may be suspended at any time. Depending on market conditions, we may
terminate the program prior to its completion. We use cash on hand or other sources of liquidity to acquire the
shares. Repurchased shares are added to our treasury and subsequently cancelled upon approval of the board of
directors. We did not make any purchases under the program in 2018. In 2019, we acquired 264,992 shares of our
common stock in market transactions for an aggregate purchase price of $3.0 million and subsequently cancelled all
of such shares. In 2020, we acquired 122,489 shares of common stock in market transactions for an aggregate
purchase price of $1.0 million and subsequently cancelled all of such shares. At December 31, 2020, 1,563,519
shares are available for repurchase under this stock repurchase program.

F-34

Accumulated other comprehensive loss – Changes in accumulated other comprehensive loss for 2018,

2019 and 2020 are presented in the table below.

Accumulated other comprehensive loss, net of tax:

Currency translation:

Balance at beginning of year
Other comprehensive income (loss)
Balance at end of year

Defined benefit pension plans:
Balance at beginning of year
Other comprehensive income (loss):

Amortization of prior service cost and net
losses included in net periodic pension cost
Net actuarial loss arising during year

Balance at end of year

OPEB plans:

Balance at beginning of year
Other comprehensive income (loss):

Amortization of prior service credit and net
losses included in net periodic OPEB cost
Net actuarial loss arising during year

Balance at end of year

Marketable securities:

Balance at beginning of year
Change in accounting principle
Balance at beginning of period, as adjusted
Other comprehensive income -

Unrealized gains arising during the year

Balance at end of year

Total accumulated other comprehensive loss:

Balance at beginning of year
Change in accounting principle
Balance at beginning of period, as adjusted
Other comprehensive income (loss)
Balance at end of year

2018

Years ended December 31,
2019
(In millions)

2020

(211.9) $
(33.1)
(245.0) $

(245.0) $
(1.8)
(246.8) $

(246.8)
13.4
(233.4)

(172.8) $

(180.0) $

(202.2)

10.4
(17.6)
(180.0) $

9.5
(31.7)
(202.2) $

13.4
(25.7)
(214.5)

1.2 $

.7 $

(.3)
(.2)
.7 $

4.8 $
(4.8)
-

-
- $

(.3)
(.2)
.2 $

- $
-
-

-
- $

(.2)
(.3)
(.3)

-
-
-

-
-

(378.7) $
(4.8)
(383.5)
(40.8)
(424.3) $

(424.3) $
-
(424.3)
(24.5)
(448.8) $

(448.8)
-
(448.8)
.6
(448.2)

See Note 6 for further discussion on our marketable securities, Note 10 for amounts related to our defined

benefit pension plans and Note 11 for our OPEB plans.

Note 14 – Related party transactions:

We may be deemed to be controlled by Ms. Simmons and the Family Trust. See Note 1. Corporations that
may be deemed to be controlled by or affiliated with such individuals sometimes engage in (a) intercorporate
transactions such as guarantees, management and expense sharing arrangements, shared fee arrangements, joint
ventures, partnerships, loans, options, advances of funds on open account, and sales, leases and exchanges of assets,
including securities issued by both related and unrelated parties and (b) common investment and acquisition
strategies, business combinations, reorganizations, recapitalizations, securities repurchases, and purchases and sales

F-35

(and other acquisitions and dispositions) of subsidiaries, divisions or other business units, which transactions have
involved both related and unrelated parties and have included transactions which resulted in the acquisition by one
related party of a publicly-held noncontrolling interest in another related party. While no transactions of the type
described above are planned or proposed with respect to us other than as set forth in these financial statements, we
continuously consider, review and evaluate, and understand that Contran and related entities consider, review and
evaluate such transactions. Depending upon the business, tax and other objectives then relevant, it is possible that
we might be a party to one or more such transactions in the future.

Receivables from and payables to affiliates are summarized in the table below.

Current receivables from affiliates:

LPC
Other

Current payables to affiliates:

LPC
Income taxes payable to Valhi

Noncurrent payable to affiliate -

Income taxes payable to Valhi (See Note 12)

December 31,

2019

2020

(In millions)

4.7 $
2.2
6.9 $

16.4 $
4.9
21.3 $

-
3.5
3.5

19.3
8.6
27.9

56.6 $

50.6

Amounts payable to LPC are generally for the purchase of TiO2, while amounts receivable from LPC are
generally from the sale of TiO2 feedstock. See Note 5. Purchases of TiO2 from LPC were $165.9 million in 2018,
$176.2 million in 2019 and $167.8 million in 2020. Sales of feedstock to LPC were $66.9 million in 2018, $84.1
million in 2019 and $84.2 million in 2020.

From time to time, we may have loans and advances outstanding between us and various related parties
pursuant to term and demand notes. We generally enter into these loans and advances for cash management
purposes. When we loan funds to related parties, we are generally able to earn a higher rate of return on the loan
than we would earn if we invested the funds in other instruments, and when we borrow from related parties, we are
generally able to pay a lower rate of interest than we would pay if we had incurred third-party indebtedness. While
certain of these loans to affiliates may be of a lesser credit quality than cash equivalent instruments otherwise
available to us, we believe we have considered the credit risks in the terms of the applicable loans.

In this regard, prior to 2018 we entered into an unsecured revolving demand promissory note with Valhi
whereby, as amended, we agreed to loan Valhi up to $60 million. At December 31, 2020, we amended the
promissory note and reduced the loan amount to $40 million. Our loan to Valhi bears interest at prime plus 1.00%,
payable quarterly, with all principal due on demand, but in any event no earlier than December 31, 2022. Loans
made to Valhi at any time are at our discretion. At December 31, 2019 and December 31, 2020, we had no
outstanding loans to Valhi under this promissory note.

Interest income (including unused commitment fees) on our loan to Valhi was $.3 million in 2018, $.5

million in 2019 and $.3 million in 2020.

F-36

Under the terms of various intercorporate services agreements (ISAs) entered into between us and various
related parties, including Contran, employees of one company will provide certain management, tax planning,
financial and administrative services to the other company on a fee basis. Such charges are based upon estimates of
the time devoted by the employees of the provider of the services to the affairs of the recipient, and the
compensation and associated expenses of such persons. Because of the number of companies affiliated with
Contran, we believe we benefit from cost savings and economies of scale gained by not having certain management,
financial and administrative staffs duplicated at each entity, thus allowing certain individuals to provide services to
multiple companies but only be compensated by one entity. We negotiate fees annually and agreements renew
quarterly. The net ISA fee charged to us by Contran is included in selling, general and administrative expense and
corporate expense and was $21.1 million in 2018, $22.8 million in 2019 and $23.3 million in 2020.

Contran and certain of its subsidiaries and affiliates, including us, purchase certain of their insurance
policies as a group, with the costs of the jointly-owned policies being apportioned among the participating
companies. Tall Pines Insurance Company, a subsidiary of Valhi, underwrites certain insurance policies for Contran
and certain of its subsidiaries and affiliates, including us. Tall Pines purchases reinsurance from third-party
insurance carriers with an A.M. Best Company rating of generally at least A-(excellent) for substantially all of the
risks it underwrites. EWI RE, Inc., a subsidiary of Valhi, brokered certain of our insurance policies, provided claims
and risk management services and, where appropriate, engaged certain third-party risk management consultants
prior to NL’s sale of EWI’s insurance and risk management business to a third party in November 2019. Consistent
with insurance industry practices, Tall Pines receives commissions from reinsurance underwriters and/or assesses
fees for certain of the policies that it underwrites, and prior to November 2019 EWI received commissions from
insurance and reinsurance underwriters for the policies that it brokered. The aggregate amounts we paid under the
group insurance program were $10.4 million in 2018 and $12.5 million through the date of the sale in 2019. These
amounts principally represent insurance premiums paid to Tall Pines or EWI, including amounts paid to EWI that
EWI then remitted, net of brokerage commissions, to insurers. Following the sale of EWI’s insurance and risk
management business, Contran engaged the third-party insurance broker that purchased the business to provide
many of the services previously provided by EWI, and we continue to utilize Tall Pines to underwrite certain
insurance risks. During 2020, we and our joint venture paid $19.1 million under the group insurance program,
which amount principally represents insurance premiums, including $14.8 million for policies written by Tall Pines.
Amounts paid under the group insurance program also include payments to insurers or reinsurers (which prior to the
sale were made through EWI) for the reimbursement of claims within our applicable deductible or retention ranges
that such insurers and reinsurers paid to third parties on our behalf, as well as amounts for claims and risk
management services and various other third-party fees and expenses incurred by the program. We expect these
relationships will continue in 2021.

With respect to certain of such jointly-owned policies, it is possible that unusually large losses incurred by
one or more insureds during a given policy period could leave the other participating companies without adequate
coverage under that policy for the balance of the policy period. As a result, and in the event that the available
coverage under a particular policy would become exhausted by one or more claims, Contran and certain of its
subsidiaries and affiliates, including us, have entered into a loss sharing agreement under which any uninsured loss
arising because the available coverage had been exhausted by one or more claims will be shared ratably by those
entities that had submitted claims under the relevant policy. We believe the benefits, in the form of reduced
premiums and broader coverage associated with the group coverage for such policies, justifies the risk associated
with the potential for any uninsured loss.

Contran and certain of its subsidiaries, including us, participate in a combined information technology data
recovery program that Contran provides from a data recovery center that it established. Pursuant to the program,
Contran and certain of its subsidiaries, including us, as a group share information technology data recovery services.
The program apportions its costs among the participating companies. We paid Contran $.1 million in 2018, $.2
million in 2019 and $.3 million in 2020 for such services. Under the terms of a sublease agreement between
Contran and us, we lease certain office space from Contran. We paid Contran $.1 million in 2019 and $.4 million in
2020 for such rent and related ancillary services. We expect that these relationships with Contran will continue in
2021.

F-37

Note 15 – Commitments and contingencies:

Environmental matters – Our operations are governed by various environmental laws and regulations.
Certain of our operations are and have been engaged in the handling, manufacture or use of substances or
compounds that may be considered toxic or hazardous within the meaning of applicable environmental laws and
regulations. As with other companies engaged in similar businesses, certain of our past and current operations and
products have the potential to cause environmental or other damage. We have implemented and continue to
implement various policies and programs in an effort to minimize these risks. Our policy is to maintain compliance
with applicable environmental laws and regulations at all of our facilities and to strive to improve our environmental
performance and overall sustainability. We update our Kronos Sustainability Report biennially, which highlights
our focus on sustainability of our manufacturing operations, as well as our environmental, social and governance
strategy. From time to time, we may be subject to environmental regulatory enforcement under U.S. and non-U.S.
statutes, the resolution of which typically involves the establishment of compliance programs. It is possible that
future developments, such as stricter requirements of environmental laws and enforcement policies thereunder,
could adversely affect our production, handling, use, storage, transportation, sale or disposal of such substances. We
believe all of our manufacturing facilities are in substantial compliance with applicable environmental laws.

Litigation matters – We are involved in various environmental, contractual, product liability, patent (or
intellectual property), employment and other claims and disputes incidental to our business. At least quarterly our
management discusses and evaluates the status of any pending litigation to which we are a party. The factors
considered in such evaluation include, among other things, the nature of such pending cases, the status of such
pending cases, the advice of legal counsel and our experience in similar cases (if any). Based on such evaluation,
we make a determination as to whether we believe (i) it is probable a loss has been incurred, and if so if the amount
of such loss (or a range of loss) is reasonably estimable, or (ii) it is reasonably possible but not probable a loss has
been incurred, and if so if the amount of such loss (or a range of loss) is reasonably estimable, or (iii) the probability
a loss has been incurred is remote. We have not accrued any amounts for litigation matters because it is not
reasonably possible we have incurred a loss that would be material to our consolidated financial statements, results
of operations or liquidity.

Concentrations of credit risk – Sales of TiO2 accounted for 94% of our net sales in 2018 and 2019 and
93% in 2020. The remaining sales result from the mining and sale of ilmenite ore (a raw material used in the sulfate
pigment production process), and the manufacture and sale of iron-based water treatment chemicals and certain
titanium chemical products (derived from co-products of the TiO2 production processes). TiO2 is generally sold to
the paint, plastics and paper industries. Such markets are generally considered “quality-of-life” markets whose
demand for TiO2 is influenced by the relative economic well-being of the various geographic regions. We sell TiO2
to approximately 4,000 customers, with the top ten customers approximating 33% of net sales in 2018, 36% in 2019
and 34% in 2020. We did not have sales to a single customer comprising 10% or more of our net sales in 2018.
One customer accounted for approximately 10% of our net sales in 2019 and 2020.

The table below shows the approximate percentage of our TiO2 sales by volume for our significant markets,

Europe and North America, for the last three years.

Europe
North America

2018

2019

2020

44%
37%

46%
34%

46%
36%

Long-term contracts – We have long-term supply contracts that provide for certain of our TiO2 feedstock
requirements through 2023. The agreements require us to purchase certain minimum quantities of feedstock with
minimum purchase commitments aggregating approximately $1.2 billion over the life of the contracts in years
subsequent to December 31, 2020. In addition, we have other long-term supply and service contracts that provide
for various raw materials and services. These agreements require us to purchase certain minimum quantities or
services with minimum purchase commitments aggregating approximately $86 million at December 31, 2020.

Income taxes – We are a party to a tax sharing agreement with Contran and Valhi providing for the
allocation of tax liabilities and tax payments as described in Note 1. Under applicable law, we, along with every
other member of the Contran Tax Group, are each jointly and severally liable for the aggregate federal income tax
liability of Contran and the other companies included in the Contran Tax Group for all periods in which we are

F-38

included in the Contran Tax Group. Valhi has agreed, however, to indemnify us for any liability for income taxes of
the Contran Tax Group in excess of our tax liability computed in accordance with the tax sharing agreement.

Note 16 – Financial instruments:

See Note 6 for information on how we determine fair value of our marketable securities.

The following table presents the financial instruments that are not carried at fair value but which require

fair value disclosure as of December 31, 2019 and 2020.

December 31, 2019
Fair
value

Carrying
amount

December 31, 2020
Fair
value

Carrying
amount

Cash, cash equivalents and restricted cash
Long-term debt - Fixed rate Senior Notes

392.3 $
442.6

(In millions)
392.3 $
457.0

362.0 $
485.7

362.0
499.9

At December 31, 2020, the estimated market price of our Senior Notes was €1,019 per €1,000 principal
amount. The fair value of our Senior Notes was based on quoted market prices; however, these quoted market
prices represented Level 2 inputs because the markets in which the Senior Notes trade were not active. Due to their
near-term maturities, the carrying amounts of accounts receivable and accounts payable are considered equivalent to
fair value. See Notes 3 and 9.

Note 17 – Recent accounting pronouncement:

In December 2019, the Financial Accounting Standards Board issued ASU 2019-12, Simplifying the
Accounting for Income Taxes, which changes the accounting for certain income tax transactions and reduces
complexity in accounting for income taxes in certain areas. The ASU introduces new guidance including providing
a policy election for an entity to not allocate consolidated current and deferred tax expense when a member of a
consolidated tax return is not subject to income tax in its separate financial statements and is a disregarded entity by
the taxing authority; and providing guidance to evaluate whether a step-up in tax basis of goodwill relates to a
business combination in which book goodwill was recognized or a separate transaction. The ASU also changes
existing guidance in a number of areas, including: the method of making an intraperiod allocation of total income
tax expense if there is a loss in continuing operations and gains outside of continuing operations; determining when
a deferred tax liability is recognized after an investor in a non-U.S. entity transitions to or from the equity method of
accounting; accounting for tax law changes and year-to-date losses in interim periods; and determining how to apply
the income tax guidance to franchise taxes that are partially based on income. We adopted this ASU as of January 1,
2020. The adoption of this ASU did not have a material effect on our Consolidated Financial Statements.

F-39

Note 18 – Quarterly results of operations (unaudited):

Year ended December 31, 2019

Net sales
Gross margin
Net income
Basic and diluted income per share

Year ended December 31, 2020

Net sales
Gross margin
Net income
Basic and diluted income per share

Quarter ended
March 31 June 30 September 30 December 31
(In millions, except per share data)

436.5 $
109.3
30.3
.26 $

484.5 $
109.5
29.5
.25 $

421.0 $
88.1
27.0

386.0 $
95.8
18.6

437.4 $
87.7
17.9
.16 $

416.9 $
80.6
8.1

372.7
79.7
9.4
.08

414.9
86.7
10.2

.23 $

.16 $

.07 $

.09

We recognized the following amounts during 2019:

(cid:129)

non-cash deferred income tax expense of $5.5 million in the fourth quarter primarily related to the
revaluation of our net deferred income tax asset in Germany resulting from a decrease in the German
trade tax rate (see Note 12),

income tax benefit of $3.0 million in the fourth quarter related to the favorable settlement of a prior
year tax matter in Germany (see Note 12), and

pre-tax insurance settlement gain of $2.6 million in the fourth quarter related to a property damage
claim.

In the first quarter of 2020, we recognized a pre-tax insurance settlement gain of $1.5 million related to a

property damage claim.

The sum of the quarterly per share amounts may not equal the annual per share amounts due to relative

changes in the weighted average number of shares used in the per share computations.

F-40

SUBSIDIARIES OF THE REGISTRANT

EXHIBIT 21.1

NAME OF CORPORATION
Kronos Canada, Inc.
Kronos International, Inc.
Kronos Titan GmbH
Société Industrielle du Titane, S.A.
Kronos Limited
Kronos Denmark ApS

Kronos Europe S.A./N.V.
Kronos Norge A/S

Kronos Titan A/S
Titania A/S

Elkania DA

Kronos Louisiana, Inc.
Kronos (US), Inc.
Louisiana Pigment Company, L.P.

Jurisdiction of
incorporation
or organization
Canada
Delaware
Germany
France
United Kingdom
Denmark
Belgium
Norway
Norway
Norway
Norway
Delaware
Delaware
Delaware

% of voting
securities held at
December 31, 2020(a)
100
100
100
99
100
100
100
100
100
100
50

100
100
50

(a)

Held by the Registrant or the indicated subsidiary of the Registrant

Kronos Worldwide, Inc.
Three Lincoln Centre
5430 LBJ Freeway, Suite 1700
Dallas, TX 75240-2620
News Release

FOR IMMEDIATE RELEASE

Contact: Janet Keckeisen

Vice President, Corporate
Strategy and Investor Relations
(972) 233-1700

KRONOS WORLDWIDE REPORTS FOURTH QUARTER 2020 RESULTS

DALLAS, TEXAS…March 10, 2021… Kronos Worldwide, Inc. (NYSE:KRO) today reported net income of
$10.2 million, or $.09 per share, in the fourth quarter of 2020 compared to net income of $9.4 million, or
$.08 per share, in the fourth quarter of 2019. For the full year of 2020, Kronos Worldwide reported net
income of $63.9 million, or $.55 per share, compared to net income of $87.1 million, or $.75 per share for
the full year of 2019. We reported higher net income in the fourth quarter of 2020 as compared to the
fourth quarter of 2019 primarily due to higher income from operations resulting from higher sales volumes
and lower production costs, partially offset by lower average TiO2 selling prices. We reported lower net
income for the full year of 2020 compared to the full year of 2019 primarily due to lower income from
operations resulting from the effects of lower sales volumes, lower average TiO2 selling prices and higher
raw materials and other production costs, as discussed below. Our results of operations for the full year of
2020 were significantly impacted by the COVID-19 pandemic, specifically through sharply reduced
demand for certain of our products resulting from the rapid contraction across the global economy
occurring in the second quarter, with demand continuing to strengthen throughout the second half of
2020.

Net sales of $414.9 million in the fourth quarter of 2020 were $42.2 million, or 11%, higher than in the
fourth quarter of 2019. Net sales of $1.6 billion in the full year of 2020 were $92.3 million, or 5%, lower
than in the full year of 2019. Net sales increased in the fourth quarter of 2020 compared to the same
period in 2019 primarily due to higher sales volumes partially offset by lower average TiO2 selling prices.
Net sales decreased in the full year of 2020 compared to the full year of 2019 primarily due to lower sales
volumes and lower average TiO2 selling prices. TiO2 sales volumes were 12% higher in the fourth quarter
of 2020 as compared to the fourth quarter of 2019 primarily due to higher demand in our European and
North American markets. TiO2 sales volumes were 6% lower in the full year of 2020 as compared to the
full year of 2019 due to lower sales volumes in all major markets, primarily resulting from demand
contraction related to the COVID-19 pandemic. Our average TiO2 selling prices were 3% lower in the
fourth quarter of 2020 as compared to the fourth quarter of 2019 and 2% lower in the full year of 2020 as
compared to the full year of 2019. Our average TiO2 selling prices at the end of 2020 were comparable to
our average TiO2 selling prices at the end of the third quarter of 2020 and 3% lower than the beginning of
the year. Fluctuations in currency exchange rates (primarily the euro) also affected net sales
comparisons, increasing net sales by approximately $13 million in the fourth quarter of 2020 and
increasing net sales by approximately $9 million in the full year of 2020 as compared to the same periods
in 2019. The table at the end of this press release shows how each of these items impacted net sales.

Our TiO2 segment profit (see description of non-GAAP information below) in the fourth quarter of 2020
was $23.4 million as compared to $21.1 million in the fourth quarter of 2019. For the full year of 2020, our
segment profit was $130.3 million as compared to $162.3 million in 2019. Segment profit increased in
the fourth quarter of 2020 as compared to the fourth quarter of 2019 primarily due to higher income from
operations resulting from higher sales volumes and lower production costs, partially offset by lower
average TiO2 selling prices. Segment profit decreased for the full year of 2020 compared to the full year
of 2019 primarily due to lower income from operations resulting from the effects of lower sales volumes,

Page 1 of 5

lower average TiO2 selling prices and higher raw materials and other production costs. Kronos’ TiO2
production volumes were 8% lower in the fourth quarter of 2020 and 5% lower in the full year of 2020 as
compared to the same periods in 2019. We operated our production facilities at overall average capacity
utilization rates of 92% in the full year of 2020 (95%, 96%, 86% and 92% in the first, second, third, and
fourth quarters of 2020, respectively) compared to 98% in 2019 (97% in each of the first, second and third
quarters and at full practical capacity in the fourth quarter of 2019). Early in the third quarter of 2020, we
decreased production levels to correspond with a temporary decline in market demand, then increased
production levels later in the third quarter and into the fourth quarter to align with improved demand and
our market expectations for the near term. Fluctuations in currency exchange rates increased segment
profit by approximately $6 million in the full year of 2020 as compared to the full year of 2019, while
fluctuations in currency exchange rates had only a nominal effect on the fourth quarter segment profit
comparison.

Our net income before interest expense, income taxes and depreciation and amortization expense
(EBITDA) (see description of non-GAAP information below) in the fourth quarter of 2020 was $30.7
million compared to EBITDA of $31.3 million in the fourth quarter of 2019. For the full year of 2020, the
Company’s EBITDA was $157.1 million compared to $187.9 million for the full year of 2019.

Other income (expense) in 2020 includes a pre-tax insurance settlement gain of $1.5 million ($1.2 million,
or $.01 per share, net of income tax expense) related to a property damage claim recognized in the first
quarter. Other income (expense) in 2019 includes a pre-tax insurance settlement gain of $2.6 million
($2.0 million, or $.02 per share, net of income tax expense) related to a property damage claim
recognized in the fourth quarter.

The Company’s income tax expense in 2019 includes a fourth quarter non-cash deferred income tax
expense of $5.5 million ($.05 per share) primarily related to the revaluation of our net deferred income tax
asset in Germany resulting from a decrease in the German trade tax rate and a fourth quarter income tax
benefit of $3.0 million ($.03 per share) related to the favorable settlement of a prior year tax matter in
Germany.

Our results of operations for the full year of 2020 were significantly impacted by the COVID-19 pandemic,
primarily in the second and third quarters. The extent of the impact of the COVID-19 pandemic on our
future operations will depend on the time period and degree to which the COVID-19 pandemic persists in
the global economy, including the timing and extent to which our customers’ operations continue to be
impacted, our customers’ perception as to when consumer demand for their products will return to pre-
pandemic levels and on any future disruptions in our operations or our suppliers’ operations, all of which
are difficult to predict.

The statements in this release relating to matters that are not historical facts are forward-looking
statements that represent management's beliefs and assumptions based on currently available
information. Although we believe that the expectations reflected in such forward-looking statements are
reasonable, we cannot give any assurances that these expectations will prove to be correct. Such
statements by their nature involve substantial risks and uncertainties that could significantly impact
expected results, and actual future results could differ materially from those described in such forward-
looking statements. While it is not possible to identify all factors, we continue to face many risks and
uncertainties. The factors that could cause actual future results to differ materially include, but are not
limited to, the following:

Future supply and demand for our products
The extent of the dependence of certain of our businesses on certain market sectors
The cyclicality of our business

(cid:129)
(cid:129)
(cid:129)
(cid:129) Customer and producer inventory levels
(cid:129) Unexpected or earlier-than-expected industry capacity expansion
(cid:129) Changes in raw material and other operating costs (such as energy and ore costs)
(cid:129) Changes in the availability of raw materials (such as ore)
(cid:129) General global economic and political conditions that harm the worldwide economy, disrupt our
supply chain, increase material costs or reduce demand or perceived demand for our TiO2
products or impair our ability to operate our facilities (including changes in the level of gross

Page 2 of 5

domestic product in various regions of the world, natural disasters, terrorist acts, global conflicts
and public health crises such as COVID-19)
(cid:129) Competitive products and substitute products
(cid:129) Customer and competitor strategies
(cid:129)
(cid:129)
(cid:129)
(cid:129) Competitive technology positions
(cid:129)

Potential consolidation of our competitors
Potential consolidation of our customers
The impact of pricing and production decisions

Potential difficulties in upgrading or implementing accounting and manufacturing software
systems
The introduction of trade barriers or trade disputes
Fluctuations in currency exchange rates (such as changes in the exchange rate between the U.S.
dollar and each of the euro, the Norwegian krone and the Canadian dollar and between the euro
and the Norwegian krone), or possible disruptions to our business resulting from uncertainties
associated with the euro or other currencies

(cid:129)
(cid:129)

(cid:129) Our ability to renew or refinance credit facilities
(cid:129) Our ability to maintain sufficient liquidity
(cid:129)

The ultimate outcome of income tax audits, tax settlement initiatives or other tax matters,
including future tax reform

(cid:129) Our ability to utilize income tax attributes, the benefits of which may or may not have been

(cid:129)

recognized under the more-likely-than-not recognition criteria
Environmental matters (such as those requiring compliance with emission and discharge
standards for existing and new facilities)

(cid:129) Government laws and regulations and possible changes therein including new environmental

health and safety regulations (such as those seeking to limit or classify TiO2 or its use)
Possible future litigation.

(cid:129)

Should one or more of these risks materialize (or the consequences of such a development worsen), or
should the underlying assumptions prove incorrect, actual results could differ materially from those
forecasted or expected. The Company disclaims any intention or obligation to update or revise any
forward-looking statement whether as a result of changes in information, future events or otherwise.

In an effort to provide investors with additional information regarding the Company's results of operations
as determined by accounting principles generally accepted in the United States of America (GAAP), the
Company has disclosed certain non-GAAP information which the Company believes provides useful
information to investors:

(cid:129)

The Company discloses segment profit, which is used by the Company’s management to assess
the performance of the Company’s TiO2 operations. The Company believes disclosure of
segment profit provides useful information to investors because it allows investors to analyze the
performance of the Company’s TiO2 operations in the same way that the Company’s
management assesses performance. The Company defines segment profit as income before
income taxes, interest expense and certain general corporate items. Corporate items excluded
from the determination of segment profit include corporate expense and interest income not
attributable to the Company’s TiO2 operations; and

The Company discloses EBITDA, which is also used by the Company’s management to assess
the performance of the Company’s TiO2 operations. The Company believes disclosure of
EBITDA provides useful information to investors because it allows investors to analyze the
performance of the Company’s TiO2 operations in the same way that the Company’s
management assesses performance. The Company defines EBITDA as net income before
interest expense, income taxes and depreciation and amortization expense.

Kronos Worldwide, Inc. is a major international producer of titanium dioxide products.

Page 3 of 5

KRONOS WORLDWIDE, INC.
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(In millions, except per share and metric ton data)

Net sales
Cost of sales

Gross margin

Selling, general and administrative expense
Other operating income (expense):
Currency transactions, net
Other income, net
Corporate expense

Three months ended
December 31,

Year ended
December 31,

2019

2020

2019

2020

(unaudited)

372.7
293.0

414.9 $ 1,731.1
1,344.9
328.2

$ 1,638.8
1,287.6

79.7

55.7

(3.6)
.3
(3.5)

86.7

386.2

351.2

56.8

228.2

218.6

(7.2)
.7
(3.0)

2.0
.9
(15.1)

(4.0)
1.4
(13.8)

Income from operations

17.2

20.4

145.8

116.2

Other income (expense):
Trade interest income
Other interest and dividend income
Insurance settlement gain
Marketable equity securities
Other components of net periodic pension

and OPEB cost

Interest expense

.4
1.1
2.6
-

(3.8)
(4.6)

-
.3
-
.2

1.4
5.3
2.6
(.1)

(5.0)
(4.9)

(15.2)
(18.7)

Income before income taxes

12.9

11.0

121.1

.3
1.5
1.5
(1.1)

(19.4)
(19.0)

80.0

16.1

Income tax expense

Net income

Net income per basic and diluted share

Weighted average shares used in the
calculation of net income per share

TiO2 data - metric tons in thousands:

Sales volumes
Production volumes

3.5

34.0

9.4

10.2 $

87.1

63.9

.08

.09 $

.75

.55

115.7

115.5

115.8

115.6

121
140

135
130

566
546

531
517

Page 4 of 5

KRONOS WORLDWIDE, INC.
RECONCILIATION OF INCOME FROM
OPERATIONS TO SEGMENT PROFIT
(In millions)
(unaudited)

Three months ended
December 31,

Year ended

December 31,

2019 2020

Income from operations

17.2

20.4

$ 145.8

116.2

Adjustments:

Trade interest income
Corporate expense

.4
3.5

-
3.0

1.4
15.1

.3
13.8

Segment profit

21.1

23.4

$ 162.3

130.3

RECONCILIATION OF NET INCOME TO EBITDA
(In millions)
(unaudited)

Net income

Adjustments:

Depreciation expense
Interest expense
Income tax expense

Three months ended
December 31,

Year ended

December 31,

2019 2020

9.4

10.2

87.1

63.9

13.8
4.6
3.5

14.8
4.9
.8

48.1
18.7
34.0

58.1
19.0
16.1

EBITDA

31.3

30.7

$ 187.9

157.1

IMPACT OF PERCENTAGE CHANGE IN NET SALES
(unaudited)

Three months ended
December 31,
2020 vs. 2019

Year ended

December 31,
2020 vs. 2019

Percentage change in net sales:

TiO2 product pricing
TiO2 sales volumes
TiO2 product mix/other
Changes in currency exchange rates

Total

(3)%
12
(2)
4

11 %

(2)%
(6)
2
1

(5)%

Page 5 of 5

[THIS PAGE INTENTIONALLY LEFT BLANK]

Kronos Worldwide, Inc.

Three Lincoln Centre

5430 LBJ Freeway, Suite 1700

Dallas, TX 75240-2620

(972) 233-1700